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aim and outline of the thesis
Partially based on: Boers SA, Jansen R, Hays JP. Understanding and overcoming the 
pitfalls and biases of next-generation sequencing (NGS) for use in the routine clinical 
microbiological diagnostic laboratory. Submitted for publication.
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GenerAl introduction
Over millions of years of co-evolution, microorganisms (including bacteria, archaea, 
fungi, protists and viruses) have adapted to form microbial communities that occupy 
virtually every accessible environmental niche, such as in or on living organisms (plant 
or animal life), soil, oceans, and air. There, these microbial communities can participate 
in important biological processes, such as biogeochemical processes that sustain life 
on our planet.1 Humans also possess such microbial communities, where microorgan-
isms usually live in close harmony with their human host, and with each other, forming 
symbiotic relationships that have a central role in the development and promotion of 
human health and disease.2 The current recognition of the essential importance of these 
communities means that the microbial composition, structure and function of a wide 
variety of microbial communities are now being actively investigated by the scientific 
and medical community, from microbial communities on the International Space Station 
(ISS) to communities collected from many different human body sites here on earth.3,4 
Importantly however, the rapid increase of research activities within this field has been 
accompanied by confusion in the vocabulary used to describe different aspects of the 
microbial communities and environments under investigation. In order to avoid confu-
sion, in this thesis the terms used to describe microbial community analysis are based 
on those terms defined previously by Marchesi and Ravel: microbiota, metagenome and 
microbiome.5
The microorganisms present within a defined environment is referred to as the micro-
biota, and the assemblage of their genomes (i.e. genes) as the metagenome. The term 
microbiome refers to the entire habitat, including the microbiota, metagenome and the 
surrounding environmental conditions (Figure 1).
History of microbiome research
Early investigations into the microbial communities from different environments fo-
cused on traditional techniques for isolating and culturing individual microorganisms. 
Although these culture-based methods were able to determine the viable population 
within a particular environment using broad-range or selective artificial growth media, 
obtaining a comprehensive overview of the microbial communities using these cultur-
ing methods was proven difficult as many microorganisms require specific growth 
conditions that cannot be (easily) mimicked within a laboratory environment.6 How-
ever, more recent advances in technologies able to detect the presence of microbial 
genes (via DNA amplification and sequencing), such as the polymerase chain reaction 
(PCR),7 dideoxy termination sequencing (Sanger sequencing),8 and more recently next-
generation sequencing (NGS),9 means that it is now possible to detect a theoretically 
unlimited number of microorganisms, present in all kinds of microbial samples, using 
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a culture-independent approach. Specifically, Venter and colleagues were the first re-
search group to apply DNA sequencing-based methods on a large scale in order to study 
microbial dynamics within environmental samples.10 As a proof of concept, Venter et al. 
investigated water samples obtained from the Sargasso See, as it was thought that this 
region of the North Atlantic Ocean contained only a small number of microbial species 
due to its low nutrient levels. Surprisingly however, their research revealed the presence 
of at least 1,800 different microbial species, including 148 new bacterial species and 
over 1.2 million previously unknown genes. This pioneering research illustrated that 
DNA sequencing-based methods, which are not hampered by the traditional limitations 
associated with microbial culture, generate more comprehensive characterizations of 
microbial communities.
the human microbiome and associations with disease
In 2006, Gill and colleagues used the same culture-independent methodology, as de-
scribed by Venter et al., in order to study the human microbiome.11 Their study revealed 
that the microbiome of the human gastrointestinal tract encodes for a larger portion of 
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Figure 1. Differentiation of terms used to describe different aspects of research that focus on microbial 
communities and their environments.
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human genome itself. This finding highlighted the crucial importance of the human gut 
microbiome in health and lay the groundwork for further research to discover new as-
sociations between the human microbiota and disease. In the following years, a tremen-
dous amount of (circumstantial) evidence has been collected to suggest a crucial role 
for the human gut microbiota in health and disease, including for example, in allergic 
diseases,12-14 inflammatory bowel diseases,15,16 and metabolic diseases.17,18 Additionally, 
recent discoveries also suggest that the gut microbiota are able to influence psycho-
logical disorders, such as anxiety and depressive-like behaviours, via the gut-brain axis.19 
However, the best evidence to indicate the importance of the human gut microbiota in 
health and disease comes from the clinic, where patients are treated with antibiotics. 
Antibiotics change the normal composition of the healthy gut microbiota, generating 
dysbiosis and facilitating the overgrowth of pathobionts such as Clostridium difficile bac-
teria, which are responsible for recurrent diarrhoea.20 Patients infected with C. difficile 
may be transplanted with a healthy gut microbiota that restores the healthy microbial 
gut composition, thereby reversing dysbiosis and preventing recurrent episodes of diar-
rhoea. These so-called faecal microbiota transplantations (FMT) have proven to be more 
successful for treating recurrent C. difficile infections than prescribing yet more antibiot-
ics in order to try to kill or inhibit the overgrowth of C. difficile.21 Interestingly, FMT has 
also showed promising results for patients diagnosed with Crohn’s disease as well.22,23
the importance of microbiota detection in routine clinical microbiological 
diagnostics
The culture-independent microbiota profiling methods used to detect and identify all 
microbial taxa within a sample should be available not only for research purposes, but 
also to routine clinical microbiological diagnostics, where the detection and identifica-
tion of microbial pathogens is the major step in establishing appropriate antimicrobial 
treatment for infectious diseases. For a long time, routine clinical microbiological diag-
nostic testing has been performed almost exclusively using culture-based methods that 
have been highly optimized for the efficient cultivation of known clinically-relevant mi-
croorganisms. However, the causative agent of an infection may not always be detected 
using current ‘gold standard’ culturing methods and, therefore, culture-independent 
molecular detection methods are required to identify ‘non-culturable’ microorganisms. 
For example, the discovery of the causative pathogens of bacillary angiomatosis (Bar-
tonella quintana) and Whipple’s disease (Tropheryma whipplei) were made possible using 
Sanger sequencing-based methods, as both aerobic bacteria are very difficult to culture 
in a laboratory.24,25 In addition, the use of NGS-based methods has also been shown to 
improve the detection of obligate anaerobic bacteria in clinical samples.26,27 Obligate an-
aerobes are known to cause serious infections, yet their detection may be sub-optimal 
within routine clinical microbiological diagnostic laboratories as special precautions 
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are required to help preserve the anaerobic environment during specimen collection, 
transport and culture.28 Therefore, culture-independent microbiota profiling methods 
could play an important role in the identification of the aetiology of anaerobic infec-
tions, or any other infections caused by fastidious and/or unexpected microorganisms. 
A second important point is that obtaining a comprehensive overview of polymicrobial 
populations within clinical samples means that the whole microbial community per se 
could be taken into account when making clinical decisions. However, before steps can 
be taken to implement such testing in the routine clinical microbiological diagnostic 
laboratory, it is important to understand the current NGS-based methodologies avail-
able for characterizing microbial communities, and the potential pitfalls and biases that 
can influence the results obtained. Armed with this information, the aim and outline of 
the current thesis will become clearer to the reader.
nGS-based methodologies for characterizing microbial communities
The advent of NGS has enabled researchers to investigate the composition and function 
of microbial populations in very diverse environments with unprecedented resolution 
and throughput. Currently, the majority of these investigations apply NGS by focussing 
on either targeted amplicon sequencing with the 16S ribosomal RNA (rRNA) gene as 
phylogenetic target (i.e. 16S rRNA gene NGS) or on shotgun metagenomics. A general 
overview of both methods is shown in Figure 2 and the strengths and weaknesses of 
each method will be discussed in the following section.
targeted amplicon sequencing. Amplicon sequencing methods have been widely 
used as a targeted approach for characterizing microbial communities. Here, DNA is 
extracted from all cells in a sample and subjected to PCR amplification using a taxonomi-
cally informative genetic marker that is common to virtually all microorganisms of inter-
est. The resultant amplicons are sequenced and then characterized using bioinformatics 
tools in combination with reference databases to determine which microorganism are 
present in the sample and at what relative abundance. Advances in this technology 
now mean that the latest amplicon-based NGS protocols enable extensive multiplexing, 
which allows researchers to process and analyse millions of PCR amplicons derived from 
hundreds of samples on a single NGS-run.29
The 16S rRNA gene is by far the most established genetic marker used for prokaryotic 
identification and classification ever since Woese and Fox first utilized rRNA sequence 
characterization to define the three domains of life in 1977.30 Because the 16S rRNA gene 
encodes for the RNA component of the small subunit (SSU) of prokaryotic ribosomes, 
which performs essential functions within the translation process, it is present among 
all bacteria and archaea and possess a slow rate of evolution that allows researchers to 
infer microbial phylogenetic relationships. The 16S rRNA gene is approximately 1,500 
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base pairs (bp) in size and its gene structure is defined by an alteration of nine highly 
conserved and nine hypervariable regions (V1-V9). The conserved regions can serve as 
universal primer binding sites for the PCR amplification of gene fragments, whereas the 
hypervariable regions contain considerable sequence diversity, useful for prokaryotic 
identification.31 By comparing these hypervariable regions to 16S rRNA gene sequences 
of designated type strains that are available on large public databases (e.g. SILVA, RDP, 
GreenGenes, or NCBI), researchers can obtain accurate taxonomic identifications of 
prokaryotic taxa.32-35 However, it is important to note that the sequencing of partial 16S 
rRNA genes, which is currently the most commonly used microbiota profiling strategy, 
often lacks the discriminatory power to differentiate prokaryotes at the species taxo-
nomic level and is generally restricted to genus-level classifications.36 For this reason, 
there has been a continuous search for alternative marker genes that can improve 
phylogenetic resolution among prokaryotic species. For example, sequence-based 
analysis of the rpoB gene has previously been demonstrated to improve the discrimina-
tive power for characterizing prokaryotic species (when compared to 16S rRNA gene 
sequencing methods) among several bacterial families and genera, including Bacillus,37 
Enterobacteriaceae,38 Staphylococcus,39 and others.40 The rpoB gene encodes the highly 






















Figure 2. General overview of 16S rRNA gene NGS and shotgun metagenomics methods. Both methods 
start with the extraction of nucleic acids from a microbial sample. Next, the extracted DNA is either subject-
ed to 16S rRNA gene PCR amplification (16S rRNA gene NGS) or sheared into small DNA fragments (shotgun 
metagenomics). The resultant 16S rRNA gene amplicons, or sheared DNA fragments, are sequenced using 
NGS-based techniques. Finally, all sequence data are processed using an extensive array of bioinformatics 
algorithms that allows the researcher to explore the taxonomic composition and/or the functional capacity 
of the sample tested.
OTU = operational taxonomic units, a group of very similar sequences.
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conserved beta subunit of the prokaryotic RNA polymerase and apparently possesses 
the same key attributes as the 16S rRNA gene.41 However, 16S rRNA gene sequencing 
studies profit from the massive amounts of sequence information already available in 
large publicly accessible reference databases. Hence, although alternative phylogenetic 
markers such as rpoB (and many others) are very promising,42 these biomarkers still 
face the challenge of competing with thousands of publications that utilize extensive 
databases of 16S rRNA gene sequencing information.
The characterization of eukaryotic communities is also an active research area that 
often employs targeted amplicon sequencing approaches. For this, the 18S rRNA gene, 
which is the eukaryotic nuclear homologue of the 16S rRNA gene in prokaryotes, have 
been used as a genetic marker in studies investigating fungi and protists. For example, 
novel phylogenetic groups of fungal microorganisms have been defined using 18S rRNA 
gene based sequencing,43 and a diversity of small eukaryotes were for the first time 
reported at high ocean depths (250 – 3,000 meters) using the same method.44 Despite 
these efforts, a multi-laboratory consortium proposed the nuclear ribosomal internal 
transcribed spacer (ITS) region as the primary genetic marker for fungi in 2012.45 The 
ITS region was preferred over the 18S rRNA gene due to the higher sequence variability 
in the ITS region and the presence of a more curated and comprehensive reference 
database. Nevertheless, it is argued that the uneven lengths of ITS fragments may pro-
mote preferential PCR amplification of shorter ITS sequences that could lead to a biased 
quantification of relative abundances of fungal taxa and, therefore, the (additional) use 
of non-ITS targets in sequencing-based microbiota studies for fungi is desirable.46
Finally, the detection and characterization of viruses requires a different detection 
approach altogether. Unlike for cellular life forms, there is not a single gene or genomic 
region that is homologous across all viral genomes.47 For virus detection, microarrays 
that span the ‘middle ground’ between NGS-based and PCR-based methodologies have 
been developed. These microarrays are designed to detect known viruses (including 
phages), sometimes in combination with the simultaneous detection of prokaryotes 
and microbial eukaryotes.48-50 The main advantage of these methods is the ability to 
simultaneously test for the presence of hundreds of viruses in a single assay and thereby 
remove the need for an a priori knowledge of the presence of a suspected virus. How-
ever, the range of detectable viruses is limited by the content of the viral probes that are 
initially spotted on the detection microarray, which may not represent the full genetic 
diversity of a viral community derived from a microbial sample.
Shotgun metagenomics. Shotgun metagenomics is an alternative approach to char-
acterize microbial communities that, in contrast to targeted amplicon methods, uses 
the entire nucleic acid content of a microbial sample and produces relative abundance 
information for all genes, functions and microorganisms. Here, nucleic acids are again 
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extracted from the sample, but are sheared into small fragments that are independently 
sequenced. The first shotgun metagenomics approaches to characterize microbial com-
munities used cloned libraries to facilitate DNA sequencing using automated Sanger 
sequencing instruments.10,11 However, advances in NGS technologies mean that the 
cloning step is no longer necessary and greater yields of sequencing data can be ob-
tained without this cloning bias-sensitive, labour-intensive and costly step.
Since shotgun metagenomics is PCR-independent and, therefore, not biased by prim-
ers designed on the basis of expectations of sequence conservation, this method is able 
to detect microorganisms which may not be detected using targeted amplicon-based 
NGS methods. For example, Brown and colleagues described a notable subset of bacte-
rial taxa – known as candidate phyla radiation (CPR) bacteria – that could evade detec-
tion by 16S rRNA gene NGS methods due to self-splicing introns and proteins encoded 
within their rRNA genes, both because they occur in regions targeted by PCR primers 
and because they increase the length of the target sequence.51 Of note, four members 
of the Thiotrichaceae family are the only other bacteria outside the CPR known to have 
self-splicing introns within their 16S rRNA genes, illustrating their rarity in bacteria.52 In 
addition, there are no broad-range genetic markers for viruses as mentioned before. 
For that reason, shotgun metagenomics has revolutionized the field of virology with 
comprehensive applications that includes viral detection and virus discovery in clinical 
and environmental samples.53,54 In fact, the genomes of DNA viruses can be recovered 
through shotgun metagenomics of DNA that was directly extracted from a sample, 
whereas extracted RNA has to be converted to complementary DNA (cDNA) first in order 
to detect RNA viruses.55
Obtaining genome sequences using shotgun metagenomics improves the research-
ers’ ability to discriminate microorganisms on a species-level, or even strain-level, 
taxonomically. This is in contrast to 16S rRNA gene NGS methods that offer often limited 
resolution at lower taxonomic levels due to the high sequence conservation at these 
taxonomic levels of the amplicons produced.36 The identification of microbial strains is 
of particular importance during epidemic outbreaks caused by microorganisms, where 
rapid and accurate pathogen identification and characterization is essential for the 
management of individual cases and of an entire outbreak. For example, the genome 
sequence of the outbreak strain of Shiga-toxigenic Escherichia coli (STEC) 0104:H4, which 
caused over 50 deaths in Germany in 2011, was reconstructed early in the outbreak 
using a culture-dependent whole-genome sequencing method.56 As a result, rapid 
PCR screening tests were quickly developed using the available genome sequence,57,58 
which aided in tracing back the source of the outbreak to fenugreek seeds from Egypt.59 
Importantly, two years later, researchers were able to reconstruct the genome sequence 
of this outbreak strain using shotgun metagenomics directly on faecal samples that 
were collected from subjects during the outbreak.60 This result highlights the potential 
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of shotgun metagenomics to identify and characterize pathogens directly from (clinical) 
samples and supports its future prospective use during outbreaks of life threatening 
infections caused by unknown pathogens.
Finally, shotgun metagenomics provides access to the functional gene composition 
of microbial communities and thus gives a much broader description of microbial 
community genetics than single gene phylogenetic surveys. In general, functional an-
notation involves two steps, namely gene prediction and gene annotation. During the 
gene prediction step, various bioinformatics algorithms are used to determine which 
sequences may (partially) encode proteins. Once identified, protein coding sequences 
are compared to a database of protein families and functionally annotated with the 
matching family’s function.61 This information can then be used to discover new genes 
and to formulate functional pathways.62 Importantly, since shotgun metagenomics 
generally targets genomic DNA, it cannot distinguish whether the predicted genes are 
actually expressed under particular conditions. The measurement of gene expression 
can be achieved by using metatranscriptomics approaches,63 which are beyond the 
scope of this chapter.
experimental pitfalls and biases
Regardless of the types of microorganisms targeted, or the methodology used to char-
acterize them, choices made at every step – from sample handling to data analysis – can 
have a serious impact on biasing the final results obtained. The effects of bias can lead to 
the discovery of spurious correlations and to missing true correlations. Therefore, it is rec-
ommended that technicians and researchers use synthetic microbial community (SMC) 
mixes (also known as mock samples), containing multiple fully-characterized microbial 
species, in order to calibrate their chosen protocols and identify biases introduced by 
their techniques.64 In the following section, the focus is primarily directed towards the 
potential biases created for protocols utilizing 16S rRNA gene NGS methods, which are 
shown in Figure 3. This is because 16S rRNA gene NGS methods are more rapid, less 
complicated and cheaper compared to techniques such as shotgun metagenomics and 
therefore more likely to be implemented in routine (clinical) microbiological diagnostic 
laboratories within a shorter timeframe.
Sample handling. The choice of the most optimal sampling protocol depends on 
the sample type to be investigated. However, they all have in common that samples 
are transported to the laboratory and stored for a certain period of time before these 
samples are processed. The transport and storage conditions of biological samples are 
important factors that can impact DNA yield and DNA quality prior to microbiota inves-
tigations. Therefore, several studies have evaluated how different storage and transit 
conditions may affect the stability of the microbial composition. For example, Carroll et 
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al. demonstrated microbial stability of faecal samples over a 24-hours period at room 
temperature and 6 months of long-term storage at -80°C.65 Others have shown that stor-
age of faecal samples for three days at room temperature did not aff ect total DNA purity 
and relative 16S rRNA gene contents,66 but that DNA became fragmented when samples 
were inconsistently freeze thawed or when samples had been kept for over 2 weeks at 
room temperature.67 Interestingly, a recent study by Shaw et al. illustrated that faecal 
samples stored for more than 2 years at -80°C are still largely representative of the origi-
nal microbial community composition.68 Although these studies show that the eff ects of 
storage and transit conditions on microbial diversity and structure are surprisingly small 
Step 1: sample collection
• Sampling protocol
• Transport and storage conditions
• Contamination
Step 2: DNA extraction
• Lysis method
• Contamination
Step 3: PCR amplification
• Selection of PCR primers 
• PCR competition effects
• Chimera formation
• Contamination
Step 4: next-generation sequencing
• Technical limitations of the NGS-platform
Step 5: bioinformatics analysis
• Choice of algorithms and their settings
• Quality/completeness of reference databases
Figure 3. Schematic overview of the workfl ow for 16S rRNA gene-based analysis of microbial communities, 
showing the potential biases created for each step of the process.
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for faecal samples, the most widely accepted protocols for optimal preservation involves 
immediate freezing followed by long-term storage at -80°C.69
dnA extraction. All DNA-based methods, including 16S rRNA gene NGS methods, rely 
on the effective lysis of microorganisms to liberate genomic material for downstream 
analysis. In order to achieve effective lysis, several procedures have been developed, in-
cluding the chemical or mechanical disruption of cells, lysis using detergents, or a com-
bination of these approaches. However, some cell types may resist common mechanical 
or chemical lysis methods that may result in important differences in the performance of 
commercially available DNA extraction kits.70,71 For example, some methods have been 
previously shown to yield in a reduced recovery of Gram-positive microorganisms com-
pared to Gram-negative microorganisms (presumably due to differences in the compo-
sition of the respective microbial cell envelopes),72 and an effective cell lysis becomes 
even more problematic for microorganisms whose cell envelope contains the difficult 
to lyse component mycolic acid, such as in mycobacteria.73 Essentially, the choice of 
the most optimal DNA extraction method is greatly dependent on the sample type and 
target microbial species to be investigated, but should be employed consistently within 
a microbiota study.
contaminating dnA. The validity of microbiota results is threatened by the presence 
of contaminating DNA derived from the (laboratory) environment and/or the reagents/
consumables used during sample processing. For example, PCRs may yield billions of 
amplicons, which combined with the extreme sensitivity of PCR amplification, means 
that there is a high risk of amplicon contamination within research and diagnostic 
laboratories that regularly use PCR. For this reason, many laboratories spatially separate 
pre- and post-PCR steps in order to limit the risk of amplicon cross-contamination be-
tween distinct PCR experiments. Additionally, Glassing et al. showed that commercially 
available DNA extraction and PCR amplification kits may generate up to 20,000 16S 
rRNA gene sequences, representing more than 80 prokaryotic genera, even without 
the addition of any sample.74 These contamination issues are particularly important for 
the accurate analysis of the microbial composition of low biomass samples. Salter et al. 
clearly illustrated how contaminating DNA can affect the microbiota results obtained.75 
These researchers sequenced a pure culture of the bacterium Salmonella bongori as well 
as a series of diluted versions and showed that DNA contamination increased with each 
dilution and quickly drowned out the original S. bongori signal. Therefore, in order to 
minimize the chance of erroneous conclusions derived from microbiota surveys, it is 
essential that negative extraction controls (specifically, template-free ‘blanks’ processed 
with the same DNA extraction and PCR amplification kits as the actual samples) be 
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included in 16S rRNA gene NGS protocols in order to allow for the identification of 
amplicon sequences that originate from DNA contamination.
Selection of 16S rrnA gene Pcr primers. Universal 16S rRNA gene PCR primer sets are 
designed to amplify as many different 16S rRNA gene sequences from as wide a range 
of prokaryotic species as possible. However, it is well-known that there are no suitable 
100% conserved regions of the 16S rRNA gene available for PCR amplification, which 
can lead to inaccurate microbiota profiles due to inefficient PCR primer binding. In order 
to ensure the detection of the specific microbial taxa of interest in a particular study, 
several researchers have reported on the adaptation of universally applicable 16S rRNA 
gene PCR primer sets via the introduction of degenerate base pairs at the positions of 
16S rRNA gene/primer sequence mismatches.76,77 In addition, the multiple hypervari-
able regions of each 16S rRNA gene exhibit different degrees of sequence diversity 
resulting in an ongoing debate about the most efficient hypervariable regions to be 
used for accurate phylogenetic analysis and taxonomic classification.78,79 However, the 
choice for a particular hypervariable region also depends on the technological limita-
tions of the NGS-platforms used. For example, the short length of the 16S rRNA gene 
V4 region (~250 bp) allows for a full overlap of DNA sequences that are obtained from 
both ends of the PCR amplicon using Illumina’s MiSeq NGS-platform, which is currently 
the most commonly used NGS-platform. This strategy generates the lowest error rates, 
which have resulted in more accurate taxonomic classifications, compared to the results 
obtained from the not completely overlapping V3-V4 and V4-V5 regions.29 Indeed, the 
amplification and sequencing of multiple hypervariable regions,64 or even the genera-
tion of (near) full-length 16S rRNA gene sequences using upcoming third generation 
sequencing platforms,80,81 give the most complete description of microbiota profiles 
within a microbial sample.
Pcr competition effects. Although often neglected in 16S rRNA gene NGS studies, PCR 
is a competitive process meaning that the presence of multiple 16S rRNA gene template 
molecules in a single reaction tube may lead to the preferential PCR amplification of a 
subset of 16S rRNA gene targets that amplify more efficiently compared to other 16S 
rRNA gene targets.82 These differences in template DNA amplification efficiencies may 
lead to inaccurate microbiota profiling results. There are several mechanisms (relating to 
the differences in 16S rRNA gene target sequence composition) that could lead to such 
preferential PCR amplification, including primer binding capacity, sequence length, and 
GC-content.82,83 However, compensating for these different amplification efficiencies re-
quires optimized PCR conditions that guarantee equal amplification efficiency for each 
individual 16S rRNA gene target, which is practically impossible when investigating 
polymicrobial samples of unknown composition. An extra complication based on our 
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own experience investigating clinical samples (Chapter 4, this thesis), is that PCR ampli-
fication efficiencies of 16S rRNA gene template molecules may be reduced in samples 
that contain high levels of human DNA and low levels of prokaryotic DNA, probably via 
the formation of competing non-specific amplicons. Thus, although NGS is a very sensi-
tive detection platform, differences in PCR amplification efficiency of 16S rRNA gene 
targets within a polymicrobial sample may lead to a biased (and even false) outcome of 
the original sample composition. Therefore, methodological steps should be taken to try 
to reduce the effect of PCR amplification efficiency bias.
chimera formation. 16S rRNA gene PCRs will generate chimeric amplification products 
(whereby a single DNA amplicon comprises sequences that originate from multiple dif-
ferent 16S rRNA genes), which may be falsely interpreted as a novel microorganism or 
an existing but absent microorganism, thus inflating the apparent sample richness (i.e. 
the number of microbial taxa present within a sample). The most commonly described 
mechanism of chimera formation involves prematurely terminated PCR products that 
can serve as PCR primers to amplify related template DNA molecules on subsequent 
PCR cycles.84 In addition, chimera formation might also occur due to template-switching 
events during DNA synthesis,85 or via the incorporation of random DNA fragments, 
such as shortened PCR primers and degraded amplicons that might be produced by 
proofreading enzymes during PCR amplification.86 Importantly, chimeras are frequent 
artefacts in 16S rRNA gene NGS studies and have been detected at a frequency of up to 
30%, although the frequency of chimera production decreases, as expected, when tem-
plate DNA similarity diminishes.87 In order to reduce the chance of chimera formation, 
optimized PCR protocols have been proposed that include the use of a highly processive 
polymerase and a minimized number of PCR cycles,88 but no method has been shown 
to eliminate these artefacts entirely. In addition, numerous computational approaches 
have been developed over the years to detect and remove chimeric sequences from 
16S rRNA gene NGS datasets,84,89-91 but these different methods often disagree with one 
another.84,92 Thus, chimeras continue to be of a major cause of concern to researchers 
performing 16S rRNA gene NGS research, and even more disturbing, public 16S rRNA 
gene reference databases are already suspected of containing a significant number 
of chimeric sequences that further complicate the reliable taxonomic classifications 
obtained from 16S rRNA gene NGS experiments.90 Optimized methodologies need to 
be developed that reduce the generation of chimeric amplification products without 
relying on bioinformatics-based chimera identification and filtering steps.
Bioinformatics analysis. The analysis of 16S rRNA gene NGS data requires an extensive 
array of bioinformatics algorithms that are involved in computational intensive steps 
such as quality filtering, operational taxonomic units (OTU) clustering, and sequence 
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classification. Currently, there are many different bioinformatics algorithms available 
for this purpose, which makes it difficult for non-bioinformatics educated scientists to 
identify the most accurate approaches for 16S rRNA gene NGS analysis. Importantly 
however, multiple studies have shown that the choice of certain bioinformatics algo-
rithms and their settings can affect the final microbiota results obtained.93,94 For this 
reason, popular open-source programs, such as mothur and QIIME, have aided in these 
issues through rewriting specific bioinformatics algorithms (e.g. mothur) or combining 
original published bioinformatics algorithms (e.g. QIIME) into single optimized software 
packages.95-96 These programs have excellent online tutorials and forums to further 
support the (inexperienced) user, but their use remains complex as both programs 
have implemented a collection of command-line tools that represent a large number 
of bioinformatics algorithms and settings. Therefore, there remains a strong need for 
‘easy-to-use’ bioinformatics pipelines that can be operated by non-bioinformatics edu-
cated users, including most employees in routine (clinical) microbiological diagnostic 
laboratories.
In summary, the experimental pitfalls and biases that are described in this chapter frus-
trate the standardization of the many 16S rRNA gene NGS protocols currently published. 
Standardization of methods is arguably best-practice to ensure quality, as well as a ne-
cessity to compare results obtained in different laboratories. Although the urgent need 
for standardized 16S rRNA gene NGS protocols has been recognized in recent years,97 
improvements in reproducibility and accuracy are still required before these methods 
can make the transition from research tool to diagnostic applications.
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AiM And outline oF tHe tHeSiS
The overall aim of this thesis was to develop and validate an accurate and standardized 
16S rRNA gene NGS platform for use in the routine (clinical) microbiological diagnostic 
laboratory. For this, several issues relating to the previously described experimental 
pitfalls and biases of current 16S rRNA gene NGS protocols needed to be overcome. 
These include inevitable PCR amplification biases, such as chimera formation and PCR 
competition, and the introduction of contaminating DNA derived from the laboratory 
environment and reagents used in the experimental set-up. In addition, analysis of 16S 
rRNA gene NGS data requires a combination of bioinformatics skills and computational 
resources that is nowadays mostly absent in routine (clinical) microbiological diagnostic 
laboratories. In this respect, special emphasis has been placed on: i) the development 
of a novel PCR amplification protocol to reduce chimera formation and PCR competi-
tion biases, ii) the development of a protocol to remove DNA contamination from 16S 
rRNA gene NGS results, and iii) the establishment of an ‘easy-to-use’ and fully automated 
bioinformatics pipeline for 16S rRNA gene NGS data analysis (in conjunction with col-
leagues from the Department of Bioinformatics at the Erasmus MC).
chapter 1 contains a general introduction and short outline of the thesis. This intro-
duction particularly focusses on the experimental pitfalls and biases associated with 
current microbiota profiling research that could for example easily result in erroneous 
conclusions of associations between the human microbiota and disease. In chapter 2, 
we described a ‘Ten-E’ protocol that can be used by scientists and clinicians to quickly 
and critically evaluate claims derived from microbiota-based research. The subsequent 
six chapters are then divided into two themes relating to the development (chapters 
3, 4, 5, 6) and the evaluation (chapters 7 and 8) of the newly developed 16S rRNA gene 
NGS platform referred to as ‘MYcrobiota’.
Current 16S rRNA gene NGS methods involve PCR amplification protocols that simul-
taneously amplify multiple 16S rRNA gene template molecules in a single reaction tube. 
Such multi-template PCRs are known to generate chimeric amplicons and can also be 
affected by PCR competition effects, thereby reducing the accuracy of 16S rRNA gene 
NGS results. To overcome these limitations, we first developed a novel micelle-based 
PCR (micPCR) amplification strategy, which is described in chapter 3. In chapter 4, we 
described the addition of an internal calibrator (IC) to our micPCR protocol, which allows 
for the standardization of microbiota profiling results, thereby generating quantitative 
microbiota profiles and facilitating the subtraction of contaminating DNA. In order to 
develop a comprehensive 16S rRNA gene profiling platform, we provided access to com-
plex command-line bioinformatics tools via the ‘Galaxy mothur Toolset (GmT)’, which al-
lows non-bioinformatics educated users to build and apply bioinformatics pipelines for 
16S rRNA gene NGS data analysis through an ‘easy-to-use’ Galaxy web interface (chap-
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ter 5).   chapter 6 describes how a dedicated GmT-based bioinformatics pipeline was 
coupled to our specific micPCR use-case in order to generate an ‘end-to-end’ microbiota 
diagnostic analysis service. The resulting platform (MYcrobiota) was evaluated for use in 
the field of routine clinical microbiological diagnostics by processing a range of clinical 
samples and comparing the results obtained using MYcrobiota to those obtained using 
routine culture-based methods.
In chapter 7, the performance of MYcrobiota to detect bacterial DNA in clinical 
samples was further evaluated. In this respect, we analysed low biomass joint fluids 
obtained from patients suspected of bacterial septic arthritis and compared the results 
from MYcrobiota to routine cultures. Additionally, in chapter 8, the universal applicabil-
ity of MYcrobiota was assessed by employing the methodology as a microbial monitor-
ing tool in the field of drinking water management. Here, the microbial dynamics was 
investigated within an operational drinking water distribution system using MYcrobiota 
and conventional techniques (including heterotrophic plate counts, adenosine triphos-
phate measurements and flow cytometry) as comparator.
chapter 9 summarizes and discusses the research presented in the thesis, as well 
as the future perspectives of MYcrobiota and microbiota profiling per se for use in the 
routine (clinical) microbiological diagnostic laboratory. Finally, the main findings of the 
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Recently there has been an explosion in the number of publications linking the human 
microbiota to various diseases. These microbiota profiles are obtained by either PCR 
amplification and sequencing of regions of the 16S ribosomal RNA (rRNA) gene of bac-
teria, or by performing shotgun metagenomics directly on sampled environments. As a 
simple guide to the critical analysis of microbiota-based publications, the authors pres-
ent here the ‘Ten-E’ method. The majority of the described ‘Es’ can be readily applied to 
both 16S rRNA gene amplicon sequencing, as well as to shotgun metagenomics-based 
microbiota profiling studies. As a further note, the authors recommend the adoption 
of consistent and defined terms within the field of microbiome/microbiota research, 
as previously published.1 The ten Es are presented in chronological order of a typical 
microbiota profiling project, starting with the E of Extraction.
extraction (e1) – Different DNA extraction methods can seriously impact the final 
microbiota profiling results. As shown by Kennedy et al., there are significant differences 
in microbial composition when comparing microbiota profiles obtained from the same 
specimen using different DNA extraction kits.2 Therefore caution is necessary when 
comparing microbiota studies that have used different DNA extraction methodologies.
environment (e2) – Negative extraction controls should be included and analysed in 
the experimental protocol for low biomass specimens such as nose swabs, blood or 
other normally sterile sites. These controls are required to accurately assess the influ-
ence of contaminating DNA molecules that may be present in the experimental set-up. 
These contaminating DNA molecules may already be present in laboratory reagents or 
commonly used DNA extraction kits. Additionally, contaminating DNA molecules from 
the laboratory environment may be present on the surface of consumables used during 
PCR and/or metagenomic microbiota profiling experiments.3
efficiency (e3) – During PCR amplification certain 16S rRNA gene sequences may be 
amplified more efficiently than others, biasing the resultant microbiota profiles. Ampli-
fication efficiency differences are prominent when applying standard PCR protocols but 
can be overcome by using clonal amplification by micelle PCR. In a micelle PCR, the 
template DNA molecules are separated into a large number of physically distinct PCR 
compartments, preventing amplification bias and increasing the accuracy of microbiota 
profiling methods.4 Scientists should be aware of the potential for amplification bias 
during PCRs.
exaggeration (e4) – Standard 16S rRNA gene PCRs will generate chimeric amplification 
products, whereby a single DNA amplicon comprises sequences that originate from 
multiple 16S rRNA genes. Importantly, the inclusion of chimeric sequences that were 
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not recognized by computational filtering software, leads to incorrect taxonomic iden-
tifications and an overestimated microbiota richness in the final microbiota profiling 
results. These chimeric sequences may be incorrectly identified as new bacterial spe-
cies. Essentially, the prevention of chimeric sequences will prevent the microbiologist 
unwittingly becoming a ‘bacterial creationist’. One method that can be used to reduce 
chimera formation is clonal amplification via the use of micelle PCR.4
evaluation (e5) – The evaluation of sequence data by different clustering algorithms 
may lead to different microbiota results and this fact should be appreciated by scien-
tists.5 In addition, accurate taxonomic identification of 16S rRNA gene microbiota data 
depends on the quality and completeness of the reference databases used to identify 
and classify the sequence data produced, e.g. SILVA, RDP, GreenGenes and NCBI. Since 
most reference databases contain some unidentified and poorly annotated sequences, 
and are also inevitably incomplete, manual evaluation of the main sequencing results 
is to be encouraged. This to ensure that the taxonomic identification of ‘key’ bacterial 
genera and species within the microbiota profile are correct.
elongation (e6) – In general, only short regions of bacterial 16S rRNA genes tend to be 
sequenced, meaning that these sequences may not have the discriminative power to 
identify bacteria to the species level. Though some bacterial genera may show sufficient 
inter-species 16S rRNA gene sequence diversity to allow their accurate identification 
(e.g. Akkermansia muciniphila), other genera may not have sufficient inter-species varia-
tion to allow their accurate speciation.6 Additionally, the naming of species may vary 
over time.7 In general, restricting sequence identification to the genus level (when using 
short 16S rRNA gene sequences), is recommended.
equality (e7) – 16S rRNA gene sequencing does not generate accurate information 
regarding the quantification of bacterial species. Different bacterial species carry dif-
ferent numbers of 16S rRNA genes and copy numbers for all bacteria are not known. 
For example, the Mycobacterium tuberculosis genome carries one 16S rRNA gene copy, 
whereas the Clostridium beijerinckii genome carries up to 14 copies of the gene. There-
fore, it is recommended that microbiota profiles are expressed as ratios or percentages 
of ‘16S rRNA gene copies’ rather than ratios of ‘species’ (which would suggest that bacte-
rial cell or genome copy numbers are being expressed). To provide an accurate number 
of bacterial genome copies, the use of methods such as calibrated quantitative PCR or 
digital PCR have to be employed.
evidence (e8) – Microbiota profiles are generated using bioinformatics approaches 
and speculations about the clinical importance of the bacterial species usually ignore 
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Koch’s postulates and/or the updated version of Koch’s postulates for molecular diag-
nostics.8,9 For example, a correlation between an operational taxonomic unit-associated 
disease, and its corresponding organism, should not be made without first fulfilling 
Koch’s postulates. Currently, many potential disease-associated organisms discovered 
by microbiota analysis cannot be cultured (although this situation is slowly changing).10 
More effort should be spent on isolating these currently ‘non-culturable’ organisms 
before they can be truly associated with a particular disease or condition. Moreover, 
DNA-based studies do not allow for accurate differentiation between viable, non-viable 
or dead bacterial cells. This could be important for example, in specimens that have 
previously been treated with bacteriostatic antibiotics or in environmental samples 
where ‘relic DNA’ from dead cells can persist from weeks to years.11 Therefore, scientists 
and stakeholders should remain sceptical regarding the scientific claims associated with 
a microbiota-based article.
enrolment (e9) – Microbiota results are often obtained using small cohort-sized studies. 
However, the microbiota of many ecosystems and environments may be very complex 
and highly variable, even among similar samples. Many small-scale studies lack the sta-
tistical power to test microbiota-based hypotheses to a valid statistical conclusion. This 
lack of statistical evidence has resulted in a lack of agreement about the microbial com-
position of many studies published within the scientific literature.12 Therefore, a larger 
sample of cohorts and/or meta-cohort analyses should be enrolled when generating 
conclusions regarding the ‘typical’ composition of a clinical or environmental sample.
expectations (e10) – Be aware of possible conflicts of interest between sponsors of 
microbiota research and the researchers themselves in this highly competitive scientific 
field. Most journals specifically ask authors to state possible conflicts of interest in their 
manuscripts. However, readers should still be alert to potential funding biases that may 
skew published microbiota profiling results.
Finally, the authors hope that the ‘Ten-E’ protocol published here will aid microbiolo-
gists, clinicians, environmentalists, food technologists, journalists and even the general 
public, to be more critical of the scientific literature when it comes to the reporting of 
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16S rRNA gene profiling has revolutionized the field of microbial ecology. Many 
researchers in various fields have embraced this technology to investigate bacterial 
compositions of samples derived from many different ecosystems. However, it is impor-
tant to acknowledge the current limitations and drawbacks of 16S rRNA gene profiling. 
Although sample handling, DNA extraction methods and the choice of universal 16S 
rRNA gene PCR primers are well known factors that could seriously affect the final re-
sults of microbiota profiling studies, inevitable amplification artefacts, such as chimera 
formation and PCR competition, are seldom appreciated. Here we report on a novel 
micelle-based amplification strategy, which overcomes these limitations via the clonal 
amplification of targeted DNA molecules. Our results show that micelle PCR drastically 
reduces chimera formation by a factor of 38 (1.5% vs. 56.9%) compared with traditional 
PCR, resulting in improved microbial diversity estimates. In addition, compartmentaliza-
tion during micelle PCR prevents PCR competition due to unequal amplification rates of 
different 16S rRNA gene template molecules, generating robust and accurate 16S rRNA 
gene microbiota profiles required for comparative studies (e.g. longitudinal surveys).
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introduction
Microbiota profiling methods are greatly enhancing our insights into the microbial diver-
sity and taxonomy of many different types of environments and ecosystems, including 
the relationship between microbiota and host in health and disease.1 The development 
of next-generation sequencing (NGS) technologies has highlighted the difficulties 
of assessing the microbiota using conventional culture methods, as PCR-based NGS 
of bacterial 16S rRNA genes yields a large diversity of 16S rRNA gene sequences that 
may be associated with a complex assortment of bacterial taxonomies – from phylum 
to genus level.2 Although sequence-based approaches are incredibly powerful, it is im-
portant that scientists and bioinformaticians understand and acknowledge the current 
limitations and drawbacks of NGS technologies and appreciate that the choices made, 
from study design to DNA extraction and from DNA amplification to data analysis, can 
have serious impact on the microbiota profiles obtained.3 For example, Kennedy et al. 
previously reported significant differences in DNA yield and bacterial DNA composition 
when comparing DNA extracted from the same faecal sample with different extraction 
kits.4 In addition, the use of universal 16S rRNA gene PCR primers has led to inconsisten-
cies in the literature regarding the abundance of the bacteria within similar ecosystems.5 
Essentially, the choice of the most optimal cell lysis procedures, and the most sensitive/
specific universal 16S rRNA gene primer pair to be used, are greatly dependent on the 
sample type and target species to be investigated. Importantly however, even when 
using the correct choice of cell lysis procedure and 16S rRNA gene primer pair, ampli-
fication artefacts (chimeras) are inevitably generated during PCR amplifications due to 
the presence of multiple PCR targets in a single reaction chamber. Such chimeras are 
generated independent of the sample type used. Importantly, the formation of these 
chimeric sequences can lead to erroneous taxonomic identifications and overestimated 
microbiota richness.6 Further, although sequences can be filtered out of NGS results us-
ing specialized software,7,8 the generation of chimeric products can still seriously reduce 
the amount of useful information obtained in a single sequencing run.9 Importantly, and 
this is seldom appreciated by users of NGS technologies, PCR is a competitive reaction 
meaning that the presence of multiple PCR targets in a single amplification reaction may 
lead to the preferential amplification of a particular subset of 16S rRNA gene copies.10 
The results could then be biased by factors related to the amplification efficiency of par-
ticular 16S rRNA gene amplicons rather than the relative abundance of 16S rRNA genes 
in the test sample. To overcome these sample-independent limitations, we developed 
and evaluated a micelle-based amplification strategy targeting the 16S rRNA gene that 
greatly reduces chimera production during PCR amplification and prevents the forma-
tion of PCR competition products.
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Micelle PCR (micPCR) is designed as a beadless emulsion PCR whereby a single mol-
ecule of template DNA is clonally amplified. Template DNA molecules are separated 
into a large number of physically distinct reaction compartments using water-in-oil 
emulsions. This compartmentalization per molecule reduces the probability of chimera 
formation and restrains PCR competition. For example, emulsion based amplification 
has been successfully applied for aptamer selection to reduce product-product and 
primer-product hybridizations.11 Also, emulsion PCRs may be performed in BEAMing ex-
periments, reliable and sensitive assays for the identification and quantification of varia-
tions in gene sequences and transcripts.12 Finally, NGS platforms such as Ion Torrent (Life 
Technologies) and 454 (Roche) have adopted emulsion-based amplification strategies in 
their standard NGS workflows to clonally re-amplify DNA sequencing libraries, as their 
molecular detection methods are not sensitive enough for single molecule sequencing 
and to prevent mixed sequences.
reSultS
To evaluate the ability of micPCR to increase the accuracy of 16S rRNA gene sequencing, 
universal 357F and 926R primers were used to amplify the 16S rRNA gene V3–V5 region 
from a synthetic microbial community containing equimolar 16S rRNA operon counts 
derived from 20 different bacterial species (HM-782D supplied by BEI Resources).13 The 
protocol utilized a two-step micPCR protocol, as well as a two-step traditional PCR pro-
tocol – used for comparative purposes – for NGS library preparation.14 Importantly, the 
final number of amplification cycles of a two-step PCR protocol is higher compared to a 
one-step PCR protocol, resulting in an increased formation of chimeric sequences, mak-
ing it suitable for evaluating the micPCR.15 Results of triplicate experiments showed that 
micPCR/NGS generated only 1.5% (± 1.2%) chimeric sequences in the synthetic com-
munity compared to 56.9% (± 1.7%) chimeras using traditional PCR/NGS (Supplemen-
tary Table 1). For the micPCR/NGS, the rarefaction analysis rapidly reached horizontal 
equilibrium at the expected 20 operational taxonomic units (OTUs), indicating a highly 
reliable calculation of richness (Figure 1). In contrast, the traditional PCR/NGS resulted in 
72 OTUs in the synthetic community, with rarefaction analysis showing that the number 
of OTUs steadily increased as the number of sequence reads increased. It was found that 
the excess of OTUs consisted of chimeras of the sequences of the 20 bacterial species in 
the synthetic mix that had not been recognized as such by the mothur software package 
(https://www.mothur.org/).
Another important factor that influences NGS-related microbiota profiling is com-
petition between different 16S rRNA gene molecules, resulting in unequal/preferential 
amplification rates for certain amplicon sequences. The result of competition can be an 
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over- or underestimation of particular OTUs. For example, in our current experiments 
we utilized a synthetic community consisting of 20 bacterial species that are each pres-
ent at an equimolar concentration of 5% of 16S rRNA genes. MicPCR/NGS data showed 
an average 0.85-fold diff erence from the 5% OTU frequency expected in the synthetic 
community, with a maximum overestimation of 1.73-fold for Listeria monocytogenes and 
a maximum underestimation of 0.28-fold for Streptococcus pneumoniae (Figure 2). In 
contrast, the OTU diff erences associated with PCR competition and traditional PCR/NGS 
were more extreme, yielding an average 0.65-fold diff erence in OTU frequency above 
the expected frequency, with an overestimated maximum of 2.31-fold for Bacteroides 
vulgatus and an underestimated maximum of 0.04-fold for Helicobacter pylori. These 
fi ndings are in agreement with the previously reported consistent overestimation of 
Bacteroides spp. and underestimation of Helicobacter spp. in four diff erent laboratories 
when investigating an identical synthetic community.13
In order to determine the usefulness of the micPCR/NGS protocol in determining the 
























Figure 1. Comparison of rarefaction analyses between micPCR/NGS and traditional PCR/NGS using an 
equimolar, synthetic microbial community. The number of observed OTUs in the synthetic microbial com-
munity is shown as the function of the number of sequences obtained using micPCR/NGS reactions con-
taining 2E+05 (dark blue) and 2E+03 (light blue) input molecules, and traditional PCR/NGS reactions con-
taining 2E+05 (dark red) and 2E+03 (light red) input molecules. Data points represent average values from 
triplicate experiments and error bars show standard deviations. Rarefaction curves were generated using 
mothur19 with an OTU defi ned at 97% similarity. Analysis was performed on a random 1,000-sequence sub-
set from each sample. Staphylococcus aureus and Staphylococcus epidermidis present in the synthetic com-
munity could not be diff erentiated at a 97% similarity level, resulting in a maximum of 19 expected OTUs.
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micPCR/NGS to determine the microbiota profiles for samples possessing a low diversity 
of bacteria (nose swabs), a medium bacterial diversity (faeces), and samples containing 
a high diversity of bacteria (sludge). Results for three independent samples per sample 
type (nose, faeces, sludge) revealed that chimeric sequences were reduced in all samples 
from an average of 38.0% (± 15.7%) using traditional PCR/NGS to an average of 1.2% (± 
1.3%) using micPCR/NGS (Supplementary Tables 2-4). The reduction of chimera forma-
tion resulted in decreased richness values among all samples, particularly among the 
bacterially diverse faeces and sludge specimens in which micPCR/NGS generated 212 (± 
30) OTUs less per 1,000 normalized sequences per sample than the traditional PCR/NGS 
protocol (Supplementary Figures 1-3). In addition, differences were also observed in the 
quantitative OTU composition between individual clinical and environmental samples 
when comparing the micPCR/NGS results to the results obtained using traditional PCR/






































Listeria monocytogenes 0,86 0,78 0,97 0,94 0,68 0,53 0,82 0,38 0,51 0,26 0,26 0,60
Clostridium beijerinckii 0,60 0,51 0,91 0,33 0,08 0,49 1,36 1,36 1,21 0,68 1,29 0,64
Bacillus cereus 0,53 0,40 0,75 -0,12 -0,25 0,06 -0,89 -0,89 -0,74 0,11 -0,56 -0,32
Streptococcus agalactiae 0,51 0,38 0,26 0,06 0,24 0,26 -0,12 -0,22 0,29 0,44 0,16 0,44
Propionibacterium acnes 0,49 0,40 -0,56 1,03 0,80 0,78 -0,18 -0,29 -0,09 0,80 -0,09 -0,15
Bacteroides vulgatus 0,16 -0,03 -0,03 -0,22 0,21 -0,06 0,94 1,19 1,16 1,33 1,26 1,37
Streptococcus mutans 0,16 0,55 0,11 0,26 0,51 0,19 0,46 0,40 0,29 0,38 0,75 0,42
Escherichia coli 0,14 0,08 -0,84 0,14 0,24 0,21 -1,32 -1,25 -1,64 -0,74 -1,12 -1,06
Staphylococcus aureus/epidermidis 0,14 0,45 0,62 0,16 0,11 0,43 -0,09 -0,18 -0,20 -0,22 -0,17 0,06
Neisseria meningitidis 0,11 -0,09 0,53 -0,06 0,33 0,26 0,64 1,06 0,99 0,53 0,82 1,00
Pseudomonas aeruginosa 0,11 0,38 -1,00 -0,32 0,31 -0,69 -0,69 -0,74 -1,18 -0,06 -0,94 -1,40
Lactobacillus gasseri -0,06 -0,32 0,38 0,33 -0,84 -0,09 0,03 0,40 0,51 0,31 0,53 -0,03
Deinococcus radiodurans -0,22 -0,89 -0,84 -0,15 -0,43 -0,25 0,19 0,00 0,19 0,33 0,03 0,29
Enterococcus faecalis -0,36 -0,40 0,06 -0,15 -0,18 0,11 -1,12 -1,32 -1,56 -2,06 -1,06 -1,84
Acinetobacter baumanni -0,40 -0,47 -1,00 -0,47 -0,29 -0,43 -1,00 -1,32 -0,84 -0,94 -0,06 -1,94
Actinomyces odontolyticus -1,12 -1,47 -3,06 -0,89 -1,64 -2,32 -3,06 -2,47 -4,64 -3,64 -4,06 -2,47
Rhodobacter sphaeroides -1,47 -1,06 -1,25 -2,06 -0,69 -1,06 -0,64 -0,64 -0,64 -1,25 -1,40 -0,84
Helicobacter pylori -1,84 -1,25 -0,64 -1,56 -1,40 -1,74 -4,64 -4,64 -5,64 -4,06 -5,64 -2,47
Streptococcus pneumoniae -2,18 -1,74 -1,47 -1,94 -1,94 -1,64 -2,64 -2,18 -2,06 -3,32 -2,47 -1,74
Figure 2. Quantitative accuracy of micPCR/NGS compared to traditional PCR/NGS from synthetic microbial 
community 16S rRNA gene profiling. The observed species-level frequency data, corrected for the expected 
species-level frequency ratio for each of the synthetic community members, is shown as a heatmap using 
a binary logarithm scale. The expected frequency ratio is based on the reported equimolar 16S rRNA op-
eron counts derived from 20 bacterial species. Blue shades indicate an overestimation of species frequency 
and red colours an underestimation of species frequency. Data from triplicate experiments are presented 
individually.
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NGS. The maximum relative difference between identical OTUs within the same sample 
obtained by micPCR/NGS compared to traditional PCR/NGS was 17.0, 6.1, and 7.6% mea-
sured for the nose, faeces, and sludge samples respectively (Supplementary Tables 5-7).
Finally, single molecule amplification using micPCR actually prevented the generation 
of chimeric products, due to the fact that we found an increase in chimeric sequences in 
the micPCR/NGS as the amount of template DNA molecules in micPCRs was increased 
(Supplementary Table 1). Importantly, the total template DNA molecules in a micelle 
PCR/NGS protocol should be kept below 10% of total micelle count to avoid any de-
tectable chimera formation due to individual micelles hosting more than one template 
molecule. Therefore, the final numbers of target DNA molecules have to be carefully 
adjusted for each micPCR/NGS project to balance reaction yield and reaction specificity 
according to the experimental requirements.
diScuSSion
In this report, we show that the use of micelle PCR is particularly suitable for 16S rRNA 
gene microbiota profiling experiments and strongly reduces the formation of the 
chimeric 16S rRNA gene amplicons that are a major source of unidentifiable OTUs in 
microbiome studies. The authors developed and evaluated the use of a micelle-based 
amplification strategy for 16S rRNA gene profiling of complex samples. Micelle or emul-
sion based amplification strategies have been successfully applied for a variety of DNA-
targeted enzymatic reactions.11,17 Most notably, Williams et al. published a protocol in 
2006 describing the use of emulsion PCR to amplify complex gene libraries that reduce 
such amplification biases as chimeric sequences and competition between fragments 
of different lengths.17 However, standardized commercial kits are now available to buy, 
which our micPCR protocol used, to offer a straightforward, easy and reproducible 
method to perform 16S rRNA gene micelle PCR.
Our results show that the use of micelle PCR/NGS greatly reduces chimera forma-
tion without the reliance on complex computational methods, resulting in improved 
microbial diversity estimates. An often-used approach to circumvent the overestimation 
of richness is to restrict analysis to OTUs that are found more than once, though the 
accompanying cost is a loss of sequencing sensitivity and accuracy due to the potential 
removal of singletons that are genuinely very low abundant representatives of their taxa 
within the total microbiota being profiled.16 Further, it is true that the confidence of 
identifying: 1) truly low abundant OTUs and 2) singleton chimeric OTUs, increases as 
the number of sequence reads per sample is increased when using traditional PCR/NGS. 
This is because there is an increased chance of detecting multiple (>1) low abundant 
OTUs as the number of sequence reads increases. However, the researcher has more 
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confidence that singletons obtained using a micPCR/NGS protocol actually originate 
from low abundance bacterial species. This is because the number of chimeras formed 
using micPCR/NGS is very low and independent of the depth of sequencing.
The compartmentalization of template DNA molecules using micPCR/NGS prevents 
amplicon competition in PCRs, resulting in the generation of more accurate quantita-
tive microbiota profiles. In addition to the standardized synthetic community experi-
ments, different quantification values were also obtained from micPCR/NGS compared 
to traditional PCR/NGS performed on actual clinical and environmental samples. This 
results in different interpretations of sample composition and inter-sample variation. 
For example, micPCR/NGS showed a 3.3-fold reduction in Staphylococcus abundance 
among nose sample 1 compared to nose sample 3 (2.4% vs. 7.8%), whereas traditional 
PCR/NGS showed a 4.7-fold increase in Staphylococcus abundance among nose sample 
1 compared to nose sample 3 (12.2% vs. 2.6%). Although the actual composition of 
these samples is unknown, the quantitative microbiota profiles obtained using micPCR/
NGS likely represents a more accurate reflection of the true microbiota profiles as in-
dicated previously using the synthetic community. Therefore, the use of micPCR/NGS 
will improve and help standardize microbiota profiling during comparative studies (e.g. 
longitudinal surveys). However, it should be noted that possible effects of sample han-
dling, cell lysis and primer specificity on the final results of these microbiota profiles still 
exist. These factors should still be optimized for each type of test sample the researcher 
is investigating.
Taken together, our results show that micPCR/NGS increases the accuracy of 16S rRNA 
gene microbiota profiling when compared to traditional PCR/NGS, and its use should be 
recommended for future NGS projects due to the fact that chimera formation and PCR 
amplicon competition can potentially affect the accuracy of current microbiota profiling 
results.
MetHodS
Sample collection and dnA extraction
Genomic DNA from microbial mock community B (even, low concentration), v5.1 L, 
catalogue no. HM-782D for 16S rRNA gene microbiota profiling was obtained from BEI 
Resources, NIAID, NIH as part of the Human Microbiome Project and consists of genomic 
DNA from 20 bacterial strains with equimolar ribosomal RNA operon counts (100,000 
copies per organism per μL). The microbial mock community contains species with dif-
ferent 16 rRNA gene copy numbers in their genomes, ranging from two for Helicobacter 
pylori to 14 for Clostridium beijerinckii. Nose swabs and faecal samples were collected 
from healthy adult volunteers. DNA was extracted from both types of samples using 
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the QIAsymphony instrument (Qiagen) according to the manufacturer’s instructions. 
DNA was extracted from three sludge samples from river bed, using the Powersoil DNA 
isolation kit (MO BIO Laboratories, Inc.). The total number of 16S rRNA genes within each 
sample was quantified as described previously.18 Prior to use as template for micelle and 
traditional PCR amplification, the samples were normalized to 1E+03 16S rRNA genes/μL 
(nasal swabs) or 1E+05 16S rRNA genes/μL (faeces and sludge samples).
Micelle Pcr amplification
The micPCR consisted of two PCR rounds of micPCR amplification. This was necessary, 
because micPCR only yields a limited number of amplicons per template molecule, 
which is a consequence of the limited reaction volume contained in a single micelle. We 
estimated that after a micPCR only 1E+04 amplicon molecules were formed in a single 
micelle starting with a single genomic DNA fragment carrying a 16S rRNA gene copy. 
This low number of amplicon molecules is not sufficient for NGS of samples containing 
low amounts of bacterial DNA, such as nose swabs. However, using a second round of 
micPCR allowed us to increase the number of amplicon molecules for NGS, as well as al-
lowing the addition of molecular identification (MID) sequences and Roche 454 specific A 
and B sequences. In the first step, micPCR was performed using modified 357F and 926R 
primers that amplified the V3-V5 regions of 16S rRNA genes and which incorporated 
universal sequence tails at their 5’ ends. In the second step, a micPCR was again used, 
but to amplify micPCR amplicons obtained from the first step micPCR. The second step 
micPCR utilized primers containing complementary sequences to the universal tails and 
included additional 454 sequencing-specific nucleotides, and specimen-specific MIDs. 
For both amplification steps, water-in-oil emulsions were prepared using the Micellula 
DNA Emulsion Kit (Roboklon). The oil phase comprised ~73% Emulsion component 1, 
~7% Emulsion component 2, and 20% Emulsion component 3, which was mixed for 5 
minutes in a cold room as described by the manufacturer. The aqueous phase was a PCR 
mix comprising 0.01 mg/mL BSA, 2 μM of each primer, 200 μM dNTP mix, and 2.5 U Taq 
polymerase with 1x PCR Buffer B (EURx). Template DNA and water were added to give a 
final volume of 50 μL for each sample. Water-in-oil emulsions were prepared by adding 
50 μL of pre-cooled PCR mix to 300 μL of pre-cooled oil phase. The first round of micPCR 
was carried out using the following cycling conditions: 95°C for 2 minutes followed by 
25 cycles of PCR, with cycling conditions of 15 seconds at 95°C, 30 seconds at 55°C, and 
60 seconds at 72°C, and a final extension at 72°C for 7 minutes. Emulsions were broken 
by the addition of 1 mL 2-butanol, and 400 μL of Orange-DX buffer (Roboklon) was 
added to the broken emulsion solution. This solution was centrifuged for phase separa-
tion. For the purification of DNA within the water phase, NucliSENS EasyMAG reagents 
(Biomérieux) were used according to the manufacturer’s instructions. To normalize DNA 
concentration and reduce the number of template molecules for the second round of 
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amplification, the purified DNA was diluted 1E+04 or 1E+02-fold for high and low inputs, 
respectively, during the first micPCR. The second round of micPCR was performed under 
the following conditions: initial denaturation at 95°C for 2 minutes followed by 25 cycles 
of PCR, with cycling conditions of 15 seconds at 95°C, 30 seconds at 50°C and 60 seconds 
at 72°C. During the first 10 cycles of PCR, the annealing temperature was increased by 
0.5°C per cycle to an annealing temperature of 55°C. The PCR was stopped after a final 
extension at 72°C for 7 minutes. Again, emulsions were broken using 2-butanol, and 
DNA was purified using NucliSENS EasyMAG reagents (Biomérieux).
traditional Pcr amplification
PCRs were performed in 10 μL volumes using the FastStart High Fidelity Reaction Kit 
(Roche) with the addition of 0.5 μM of each PCR primer. Resolight Dye (Roche) was added 
to measure DNA amplification in real-time using a LightCycler 480 instrument (Roche). 
The 16S rRNA gene V3-V5 regions were amplified by PCR using modified 357F and 926R 
primers to allow for a two-step amplification strategy, using the following cycling condi-
tions: initial denaturation at 95°C for 2 minutes followed by 35 cycles of PCR, with cycling 
conditions of 30 seconds at 95°C, 30 seconds at 55°C, and 60 seconds at 72°C. After PCR 
amplification, the amplicons were purified from unincorporated dNTPs, primers, primer 
dimers and salts using magnetic AMPure XP beads (Agencourt). The purified 16S rRNA 
gene amplicons were re-amplified to incorporate 454 sequencing-specific nucleotides 
and specimen-specific MIDs. All PCRs were performed in 10 μL reaction volumes using 
the FastStart High Fidelity Reaction Kit with the addition of 0.5 μM of each PCR primer 
and the Resolight Dye. The PCRs were performed on a LightCycler 480 instrument, but 
under modified conditions: initial denaturation at 95°C for 2 minutes followed by 35 
cycles of PCR, with cycling conditions of 30 seconds at 95°C, 30 seconds at 50°C, and 
60 seconds at 72°C. During the first 10 cycles of PCR, the annealing temperature was 
increased by 0.5°C per cycle to an annealing temperature of 55°C. Bar-coded amplicons 
were mixed in equimolar concentrations and the complete pool was purified by gel 
extraction using the QIAquick Gel Extraction Kit (Qiagen), followed by a second purifica-
tion with magnetic AMPure XP beads.
Quantification of 16S rrnA gene molecules
In preparation for 454 sequencing (Roche), the concentration of purified amplicons ob-
tained by micPCR and traditional PCR was measured using a 16S rRNA gene quantitative 
PCR (qPCR). The qPCRs were performed in 10 μL reaction volumes using the LightCycler 
FastStart DNA Master SYBR Green I Kit (Roche) with the addition of 0.5 μM of amplifica-
tion primer 357F and 926R without the universal tails. The PCRs were performed on a 
LightCycler 1.0 instrument (Roche), under the following conditions: initial denaturation 
at 95°C for 10 minutes followed by 45 cycles of PCR, with cycling conditions of 1 second 
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at 95°C, 5 seconds at 55°C, and 30 seconds at 72°C. The concentration of purified ampli-
cons obtained by micPCR and traditional PCR were normalized to 1E+05 molecules/μL 
using a serial dilution of a standard solution containing 16S rRNA genes derived from a 
highly bacterial diverse sludge sample that was calibrated using the Quant-iT PicoGreen 
dsDNA Assay Kit (Life Technologies).
data analysis
The composition of microbiota was determined by sequencing 16S rRNA genes using 
the 454 GS Junior Sequencer platform (Roche) according to the manufacturer’s instruc-
tions. NGS-data were automatically processed using the ‘Full Processing Amplicon’ 
pipeline available through the Run Wizard on the GS Junior Attendant PC (Roche). 
FASTA-formatted sequences were extracted from the .sff data files and processed using 
modules implemented in the mothur v. 1.33.0 software platform.19 Primer sequences 
were trimmed and sequences with length smaller than 400 were removed from the 
analysis. In addition, only the first 450 bases of each sequence were used for further 
analysis. In order to characterize the number of chimeric sequences more precisely, no 
additional quality filtering was applied. Unique sequences were aligned using the ‘align.
seqs’ command and an adaptation of the Bacterial SILVA SEED database release 119 as a 
template (available at: https://www.mothur.org/wiki/Silva_reference_ files). Potentially 
chimeric sequences were detected and removed with the Uchime source code, using 
firstly the sequences as their own reference and sequentially the SILVA alignment version 
of the gold database (available at: https://www.mothur.org/wiki/Silva_reference_files) 
as reference. The remaining aligned sequences were classified using a naïve Bayesian 
classifier with the SILVA SEED database release 119 and clustered into OTUs defined by 
97% similarity. To reduce the effects of uneven sampling, all nose swab samples were 
rarefied to 500 sequences per sample and all other samples, including the synthetic 
community, faeces, and sludge samples, were rarefied to 1,000 sequences per sample. 
For all samples, rarefaction curves were plotted and the inverse Simpson’s diversity index 
and Good’s coverage were calculated. Finally, OTUs corresponding to the Streptococcus 
genus within the synthetic community were determined at species-level by checking 
the representative sequences against the reference sequences using BioNumerics ver-
sion 5.10 (Applied Math).
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In the last decade, many researchers have embraced 16S rRNA gene sequencing tech-
niques, which has led to a wealth of publications and documented differences in the 
composition of microbial communities derived from many different ecosystems. How-
ever, comparison between different microbiota studies is currently very difficult due to 
the lack of a standardized 16S rRNA gene sequencing protocol. Here we report on a novel 
approach employing micelle PCR (micPCR) in combination with an internal calibrator 
that allows for standardization of microbiota profiles via their absolute abundances. The 
addition of an internal calibrator allows the researcher to express the resulting opera-
tional taxonomic units (OTUs) as a measure of 16S rRNA gene copies by correcting the 
number of sequences of each individual OTU in a sample for efficiency differences in 
the NGS process. Additionally, accurate quantification of OTUs obtained from negative 
extraction control samples allows for the subtraction of contaminating bacterial DNA 
derived from the laboratory environment or chemicals/reagents used. Using equimolar 
synthetic microbial community samples and low biomass clinical samples, we demon-
strate that the calibrated micPCR/NGS methodology possess a much higher precision 
and a lower limit of detection compared with traditional PCR/NGS, resulting in more 
accurate microbiota profiles suitable for multi-study comparison.
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introduction
The number of microbiota studies has rapidly increased since the introduction of 
next-generation sequencing (NGS) technologies and opened numerous new fields 
of research. This research often studies microbial changes as a result of various kinds 
of interventions and focusses on changes in the proportional microbial composition 
rather than actual microbial quantities. However, obtaining accurate and quantitative 
microbiota profiles makes high demands on the analytical sensitivity, specificity and 
reproducibility of standard NGS methodologies and requires a careful consideration of 
potential biases and bacterial DNA contaminations that can be introduced during the 
many steps of sample processing and sequencing.1,2
Recently, the authors published a micelle PCR/NGS (micPCR/NGS) methodology that 
limits both chimera formation and PCR competition, thereby reducing the introduction 
of PCR amplification biases into microbiota profiles.3 However, 16S rRNA gene sequenc-
ing techniques still remain semi-quantitative methods, where the results are presented 
as proportional abundances of operational taxonomic units (OTUs), rather than absolute 
abundances of OTUs. This restriction lowers the reproducibility of microbiota profiling 
between different laboratories and does not reveal differences in absolute abundances 
of specific OTUs. For example, Hiergeist et al. observed high inter-laboratory deviations 
from an external quality assessment of 16S rRNA gene sequencing methods and con-
cluded that there is an urgent need to develop microbiota profiling methods with an 
increased cross-study comparability.4 This is of particular importance for the increasing 
implementation of 16S rRNA gene sequencing methods in the field of medical diagnos-
tics, which requires high quality demands on the methods used. Further, the validity of 
16S rRNA gene sequencing results are threatened by the presence of contaminating 
bacterial DNA derived from the laboratory environment and the consumables used in 
the experimental set-up.5 Such contamination is particularly relevant for an accurate 
analysis of microbiota composition of low biomass samples (e.g. skin swabs).6,7 These 
contaminating DNA molecules can be derived from two sources: 1) contaminating 
bacterial DNA present within the sample-processing environment, and 2) contaminat-
ing bacterial DNA already present in the reagents/consumables used during sample 
processing. The introduction of contaminating bacterial DNA derived from the process-
ing environment will occur randomly within the samples being processed and can be 
recognized by their non-reproducibility in multiple determinations of the microbiota 
of a particular sample. In contrast, the variety of contaminating bacterial DNA from re-
agents/consumables will be dependent on the manufacturer and batch numbers of the 




In this report, we present a novel approach that employs micPCR/NGS in combination 
with an internal calibrator (IC) to determine the composition and absolute quantity of 
microbial genera. The IC used for this study consisted of quantified genomic DNA from 
a Synechococcus bacterium species that is absent in the natural microbial flora of the 
samples under investigation and allows the researcher to express the resulting OTUs as a 
measure of 16S rRNA gene copies by the use of a correction factor (sample OTU copies = 
sample OTU reads x (initial IC copies/IC OTU reads)). We utilized this calibrated micPCR/
NGS approach to process a range of samples in triplicate in order to increase accuracy and 
to correct for contaminating bacterial DNA derived from the laboratory environment. In 
addition, contaminating bacterial DNA derived from the reagents/consumables used 
during micPCR/NGS were subtracted from samples via the use of a negative extraction 
control (NEC). To validate the calibrated micPCR/NGS approach (including the two-step 
strategy for removing contaminating bacterial DNA – as described above), we used a 
series of dilutions of an equimolar synthetic microbial community (SMC) sample and 
compared the results obtained against traditional PCR/NGS. Additionally, we evaluated 
the performance of our method to generate accurate quantitative microbiota profiles 
from actual low biomass clinical samples.
reSultS
In order to determine the accuracy (trueness and precision) of the calibrated micPCR/
NGS methodology, we utilized a 10-fold dilution series of a SMC sample containing 
equimolar 16S rRNA gene copies of Clostridium perfringens, Staphylococcus aureus, Hae-
mophilus influenzae, and Moraxella catarrhalis (ranging from 2.5 to 2,500 16S rRNA gene 
copies per (mic)PCR of each bacterial species). Prior to amplification, Synechococcus DNA 
was added in such a concentration that each SMC sample contained 10% of IC 16S rRNA 
gene copies with a minimum of 50 copies for samples that contained less than 500 16S 
rRNA gene copies. The 16S rRNA gene V3-V4 regions were amplified in triplicate, using 
the same SMC/IC sample for each replicate, and sequenced using both micPCR/NGS and 
traditional PCR/NGS (as comparator). As shown in Supplementary Table 1, we obtained 
an average of 4,201 (± 2,398) QC-passed sequence reads per SMC sample using both 
methods, of which the percentage of chimeric sequences was much lower for micPCR/
NGS compared to traditional PCR/NGS (0.01% ± 0.03% vs. 4.56% ± 2.97%). Further, Table 
1 shows the results obtained from triplicate experiments and indicates the accuracy for 
both methodologies used. The micPCR/NGS data, as well as the traditional PCR/NGS 
data, showed a median value of only a 1.3-fold difference between the measured 16S 
rRNA gene copies (average of triplicate experiments) and the expected 16S rRNA gene 
copies. Although these data suggest a similar and good trueness among both methods, 
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table 1. Accuracy of 16S rRNA gene copy determination using synthetic microbial community (SMC) sam-
ples comparing the results of micPCR/NGS to traditional PCR/NGS.
micPcr/nGS
otu expected replicate 1 replicate 2 replicate 3 trueness Precision
Clostridium 2500 6,735 3,840 4,347 2.0 0.3
Staphylococcus 2500 4,776 3,147 4,875 1.7 0.2
Haemophilus 2500 4,082 3,133 2,611 1.3 0.2
Moraxella 2500 3,714 2,213 1,056 0.9 0.6
Clostridium 250 487 631 641 2.3 0.1
Staphylococcus 250 486 579 375 1.9 0.2
Haemophilus 250 238 225 183 0.9 0.1
Moraxella 250 225 363 214 1.1 0.3
Clostridium 25 28 31 52 1.5 0.3
Staphylococcus 25 57 47 52 2.1 0.1
Haemophilus 25 10 9 54 1.0 1.1
Moraxella 25 19 5 29 0.7 0.7
Clostridium 2.5 0 4 0 0.6 1.6
Staphylococcus 2.5 1 15 19 4.6 0.8
Haemophilus 2.5 1 0 9 1.3 1.6
Moraxella 2.5 1 3 0 0.6 1.1
traditional Pcr/nGS
otu expected replicate 1 replicate 2 replicate 3 trueness Precision
Clostridium 2500 953 6,638 7,340 2.0 0.7
Staphylococcus 2500 403 3,793 4,075 1.1 0.7
Haemophilus 2500 370 2,483 2,509 0.7 0.7
Moraxella 2500 36 3,034 3,604 0.9 0.9
Clostridium 250 736 513 497 2.3 0.2
Staphylococcus 250 302 210 284 1.1 0.2
Haemophilus 250 281 226 261 1.0 0.1
Moraxella 250 240 188 231 0.9 0.1
Clostridium 25 119 29 36 2.4 0.8
Staphylococcus 25 15 27 50 1.2 0.6
Haemophilus 25 112 28 28 2.3 0.9
Moraxella 25 116 2 0 1.6 1.7
Clostridium 2.5 0 11 1 1.7 1.5
Staphylococcus 2.5 243 6 1 33.3 1.7
Haemophilus 2.5 0 0 10 1.3 1.7
Moraxella 2.5 0 7 0 1.0 1.6
The expected and measured values (Replicate 1-3) represent the number of 16S rRNA gene copies obtained 
for each individual bacterial species at four different input DNA concentrations (2,500, 250, 25 and 2.5 16S 
rRNA gene copies). The trueness shows the closeness of measurement results to the true (expected) value 
and was calculated by dividing the number of 16S rRNA gene copies measured (as an average of triplicate 
results) to the expected number of 16S rRNA gene copies present in the calibrated synthetic microbial com-
munity (SMC). The precision shows the coefficient of variation that was calculated by dividing the standard 
deviation obtained from triplicate results to the average number of 16S rRNA gene copies measured.
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the dispersal of replicate results varied greatly using traditional PCR/NGS. As shown in 
Figure 1, the dispersal of replicate results obtained using micPCR/NGS was much smaller 
than using traditional PCR/NGS, indicating the higher precision of the micPCR/NGS 
methodology. For example, traditional PCR/NGS resulted in a coeffi  cient of variation of 
0.8, 0.5, 0.9 and 3.0 for the SMC samples containing 2,500, 250, 25 and 2.5 16S rRNA 
gene copies per bacterial species, respectively. In contrast, identical experiments using 
micPCR/NGS showed a coeffi  cient of variation of only 0.4, 0.4, 0.6 and 1.4, respectively. 
The higher precision of the micPCR/NGS methodology lowers the number of random er-
rors within 16S rRNA gene measurements and increases the repeatability of microbiota 
profi ling results (Paired Wilcoxon signed-rank test; p < 0.01). As expected, the accuracy 
for both methods decreases as the number of template DNA molecules decreased due 
to the limited chance of successfully generating 16S rRNA gene amplicons at very low 
starting concentrations of DNA.
Microbiota analysis is prone to the introduction of contaminating bacterial DNA mol-
ecules during sample processing. This is illustrated by the fi nding of 114 distinct OTUs 
that are represented by at least two or more sequence reads in our SMC experiments 
(Supplementary Tables 2-5). As expected, the number of distinct OTUs was maximal in 
the samples containing low amounts of input DNA, or no input DNA (NEC), leading to an 
unintended overestimation of microbial diversity. To correct for random bacterial DNA 
contamination from the laboratory environment, we processed each sample in triplicate 
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Figure 1. Precision of 16S rRNA gene copy determination using synthetic microbial community samples 
comparing the results of micPCR/NGS to traditional PCR/NGS. The synthetic microbial community (SMC) 
samples tested contained equimolar 16S rRNA gene copy numbers derived from four diff erent bacterial 
species and ranged from 2,500 to 2.5 16S rRNA gene copies per species. Coloured data points represent 
the individual measurements per bacterial OTU from triplicate experiments, corrected for the number of 
expected 16S rRNA gene copies and plotted using a binary logarithmic scale.
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correct for bacterial DNA contamination from the reagents/consumables used, we sub-
tracted the contribution of the NEC from each sample. The bacterial DNA contamination 
from reagents/consumables was calculated as the mean plus three standard deviations 
of 16S rRNA gene copies per OTU that were present in all three independent NEC mea-
surements (Supplementary Tables 6 and 7). The quantified microbiota profiles obtained 
using micPCR/NGS and traditional PCR/NGS, before and after the correction of contami-
nating bacterial DNA, are shown in Figure 2. Correcting for both types of bacterial DNA 
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Figure 2. 16S rRNA gene microbiota profiles obtained from synthetic microbial community samples com-
paring the results of micPCR/NGS to traditional PCR/NGS before and after correction for contaminating 
bacterial DNA. The synthetic microbial community (SMC) samples tested comprised equimolar 16S rRNA 
gene copies derived from C. perfringens, S. aureus, H. influenzae, and M. catarrhalis and ranging from 2,500 
to 2.5 16S rRNA gene copies per bacterial species. Averages of triplicate micPCR/NGS and triplicate tradi-
tional PCR/NGS results are shown in 100% stacked bars before and after correction for contaminating bac-
terial DNA. The correction of contaminating bacterial DNA comprises two steps: 1) eliminating OTUs that 
could not be reproducibly measured in triplicate experiments, and 2) subtracting 16S rRNA gene copies 
that were also quantified in triplicate measurements of a negative extraction control (NEC) sample. Values 
within bars represent the calculated number of 16S rRNA gene copies per bacterial OTU.
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SMC samples generated using the micPCR/NGS methodology. In contrast, traditional 
PCR/NGS results still showed contaminating bacterial DNA present at 25 and 2.5 16S 
rRNA gene copies per organism, even after correction. This finding illustrates the higher 
accuracy of the micPCR/NGS methodology to quantify contaminating bacterial DNA 
from NEC samples and its requirement for the accurate subtraction of contaminating 
bacterial DNA from actual samples. In addition, the traditional PCR/NGS methodology 
failed to recover 25 16S rRNA gene copies of M. catarrhalis and hugely overestimated 
the abundance of S. aureus 16S rRNA gene copies in the SMC samples containing 2.5 
16S rRNA gene copies per bacterium. Additionally, micPCR/NGS successfully detected 
all four bacterial species at 2,500, 250 and 25 16S rRNA gene molecules per bacterium, 
but failed to detect any of these species in triplicate experiments using 2.5 16S rRNA 
gene copies. We therefore estimated that the analytical sensitivity, indicated as the limit 
of detection (LOD), for micPCR/NGS is 25 16S rRNA gene molecules per OTU, whereas 
the LOD of traditional PCR/NGS was estimated as 250 16S rRNA gene copies per OTU.
In order to investigate the performance of the calibrated micPCR/NGS protocol using 
clinical samples, we selected four human skin swab samples that contained a low num-
ber of 16S rRNA gene copies (range: 64-604 16S rRNA gene copies/μL). The four samples, 
including an NEC, were processed in triplicate using micPCR/NGS and traditional PCR/
NGS in parallel. Using micPCR/NGS, we obtained an average of 7,126 (± 1,702) QC-passed 
sequence reads per sample, of which only 2 (± 3) sequences per sample were identified 
and removed as chimeric sequences (Supplementary Table 8). Next, we were able to 
detect 3 to 13 OTUs in the samples, of which Staphylococcus and Neisseria species were 
commonly found and could be confirmed by bacterial culture. In addition, the micPCR/
NGS method also detected the skin inhabitants Streptococcus, Paracoccus, Enhydrobac-
ter, Gemella, Sphingomonas, Alloprevotella, Propionibacterium, Brevundimonas, Roseomo-
nas, Rothia, Granulicatella, Rhodococcus, and Flavobacteriaceae species.8,9 Importantly, 
correcting for contaminating bacterial DNA using the two-step strategy as described 
above removed 92% (range 89 − 96%) of the resultant OTUs found in the skin swab 
samples (Supplementary Table 9). Finally, we measured a high concordance between 
the total bacterial biomass when estimated indirectly using calibrated micPCR/NGS, 
without the correction for contaminating bacterial DNA, compared to the total 16S rRNA 
gene copies obtained when estimated directly using a 16S rRNA gene qPCR according 
to Yang et al.,10 with an average of only a 1.03-fold difference (± 0.34), demonstrating 
the accuracy of the micPCR/NGS method. In contrast to micPCR/NGS, traditional PCR/
NGS was not able to generate any 16S rRNA gene amplicons from these low biomass 
skin swab samples as this method only generated non-specific, low molecular weight 
amplicons. These non-specific PCR products were most like generated by the relative 
excess of human DNA – compared to bacterial DNA – in the samples, as the PCR/NGS 
methodology successfully generated 16S rRNA gene amplicons in SMC samples (where 
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only bacterial DNA and no human DNA was present). This result indicates that the LOD 
for the traditional PCR/NGS methodology is even higher for actual clinical samples than 
was previously estimated using our SMC samples.
diScuSSion
In this report, we show that a micelle PCR/NGS methodology (micPCR/NGS), in combina-
tion with a unique internal calibrator (IC) generates robust and accurate quantitative 
microbiota profiles. Micelle PCR is characterized by the clonal amplification of template 
DNA by the physical separation of reaction ingredients into a large number of reaction 
compartments. In contrast to traditional PCR, which is performed in a single reaction 
volume, the compartmentalization during micPCR allows accurate quantification of 
target sequences due to a lower susceptibility to variations in PCR amplicon efficiencies 
and amplification biases such as chimera formation, false priming and primer dimer 
formation.3 Therefore, our calibrated micPCR/NGS method allows for the utilization of 
just a single correction factor, obtained from a single IC, to convert 16S rRNA gene se-
quence reads to 16S rRNA gene copies for each individual OTU present within a sample. 
In contrast, optimized traditional PCR amplification protocols,11 or alternative spike-in 
approaches that employ traditional PCR amplification methods, such as SCML,12 remain 
vulnerable to template-specific variations in PCR efficiencies that could easily result in 
error-derived microbiota profiles. However, it is true that the number of 16S rRNA gene 
copies produced using micPCR depends on the actual volume of individual micelles 
and that possible quantitation biases might be introduced due to differences in micelle 
sizes. This may be particularly relevant for the accurate quantification of low abundant 
taxa that are more vulnerable to the possible stochastic distribution of template DNA 
molecules into unevenly shaped micelles. However, the randomness of micelle size 
frequency distributions generated in independent experiments will tend to average 
out any possible quantification bias generated due to differences in the distribution of 
micelle sizes between independent experiments, as indicated by the results obtained 
using our synthetic microbial community (SMC).
The absolute quantification of OTUs using micPCR/NGS in combination with an 
internal calibrator improves the standardization of microbiota profiling results by re-
moving the susceptibility to compositional effects. For example, traditional 16S rRNA 
gene sequencing methods require specific tools and methods that properly account for 
the statistical implications from the compositional structure of the data obtained.13 But 
despite the growing interest and recent efforts to develop these sophisticated methods, 
the problems of spurious correlations in compositional data remain as yet unsolved.14 
In contrast, our results show that the use of the calibrated micPCR/NGS strategy greatly 
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improves standardization of microbiota research without the reliance on (complex) 
compositional data analysis. However, these results remain vulnerable to contaminating 
bacterial DNA molecules derived from the sample processing environment. In order to 
correct for contaminating bacterial DNA, we eliminated OTUs that could not be repro-
ducibly measured in triplicate experiments and subtracted 16S rRNA gene copies that 
were also quantified from negative extraction control (NEC) samples. The comparison of 
the micPCR/NGS and traditional PCR/NGS results showed that both methods possess a 
similar trueness when profiling the microbiota of synthetic microbial community (SMC) 
samples. However, the precision of the micPCR/NGS was much higher compared to the 
traditional PCR/NGS method. The low precision of the traditional PCR/NGS methodol-
ogy resulted in unpredictable random errors within the microbiota profiles obtained, 
including those obtained from NEC samples. The increased random errors observed 
using traditional PCR/NGS makes the accurate subtraction of bacterial DNA contamina-
tion unreliable, whilst in contrast, the high precision of micPCR/NGS resulted in highly 
accurate quantification of (contaminating) 16S rRNA gene copies resulting in improved 
quantitative microbiota profiles that were free of contaminating bacterial DNA from 
environmental sources.
Using micPCR/NGS, we determined the quantitative microbiota profiles of low bio-
mass skin swab samples. As expected, most OTUs (> 89%) obtained from these clinical 
samples could not be reliably determined in triplicate, or the quantified number of 16S 
rRNA gene copies did not exceed the quantified number of the same 16S rRNA gene 
copies determined within NEC samples, and were removed accordingly. This finding 
stresses the importance of removing contaminating bacterial DNA from microbiota 
profiles obtained using low biomass samples. Additionally, traditional PCR/NGS was 
not able to generate any useful 16S rRNA gene sequencing data using the same clini-
cal samples. This result is probably caused by other sample components than bacterial 
DNA, such as human DNA, that interferes with traditional PCRs (via inhibition or compe-
tition). This finding also illustrates the specific nature of PCR in micelles. Since all sample 
components (both 16S rRNA gene templates and non-templates) are limited to a single 
micelle, micPCRs are not affected by inhibiting or competing components and are still 
able to generate 16S rRNA gene amplicons successfully. However, it is important to note 
that possible effects of sample storage conditions,15 cell lysis,16 and primer specificity17 
on the final results of these microbiota profiles still exist.
In summary, a combination of micPCR/NGS and an internal calibrator generates ro-
bust and accurate quantitative microbiota profiles. The high accuracy and low limit of 
detection of the calibrated micPCR/NGS, makes this method the preferential method to 
determine accurate and quantitative microbiota profiles for low biomass samples that 
are hampered by contaminating bacterial DNA. The general adoption of this approach 
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by microbiota investigators will greatly improve the standardization of microbiota pro-
filing results between individual experiments, laboratories and scientific publications.
MetHodS
Synthetic microbial community samples
The DNA used to create the SMC samples was extracted from four independently cul-
tured bacterial strains; Moraxella catarrhalis (ATCC 25240), Staphylococcus aureus (ATCC 
43300), Haemophilus influenzae (ATCC 10211), and Clostridium perfringens (ATCC 12915), 
using a phenol/bead-beating protocol combined with the AGOWA mag Mini DNA Isola-
tion Kit (LGC) as described previously.6 In addition, DNA from elution buffer BL (LGC) 
was extracted as a negative extraction control (NEC) sample at the same time to assess 
the composition of contaminating bacterial DNA in the experimental methodologies. In 
order to generate an equimolar mixture of 16S rRNA gene targets from the four bacterial 
DNA extracts, and to normalize the Synechococcus sp. (ATCC 27264D-5) DNA used as IC, 
the total dsDNA concentration from each DNA isolate was determined individually using 
the Quant-iT PicoGreen dsDNA assay Kit (Life Technologies) and normalized for genome 
sizes and 16S rRNA gene copy numbers based on bacterial whole-genome sequences 
that are publicly available at the NCBI database. Next, a 10-fold dilution series of the 
equimolar SMC sample was made, ranging from 2,500 to 2.5 16S rRNA gene copies per 
organism. Prior to amplification by either micPCR or traditional PCR, 1,000, 100, 100, 50 
and 50 16S rRNA gene copies of Synechococcus DNA was added as IC to the SMC DNA 
extracts containing 2,500, 250, 25, 2.5 16S rRNA gene copies per bacterial species and 
the NEC DNA extract, respectively.
Skin swab samples
An acknowledged national ethics committee from the Netherlands (Medisch Ethische 
Toetsingscommissie Noord-Holland, http://www.metc.nl) approved the study protocol 
(M015–021) and all experiments were performed in accordance with the relevant 
guidelines and regulations. Skin swab samples were collected from patients with atopic 
dermatitis after written, informed consent was obtained from all subjects. Skin swab 
samples were collected using E-swabs (490CE, Copan) by gently rubbing the dry flocked 
swab over the dermatitis lesion (~2 cm2) for 10 seconds after which the entire sample 
was eluted upon contact with 1 mL liquid Amies preservation medium. All samples were 
cultured according to standard laboratory protocols performed in our laboratory and 
stored at −80°C for subsequent 16S rRNA gene sequencing analysis. The routine culture 
methods included aerobic overnight culture at 35°C on CAP, TSASB and CLED agar plates 
after which Matrix-Assisted Laser Desorption Ionization Time-Of-Flight (MALDI-TOF) 
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mass spectrometry was used for the identification of cultured bacterial species. For 16S 
rRNA gene sequencing analysis, DNA was extracted from the skin swab samples using 
the High Pure PCR Template Preparation Kit (Roche) according to the manufacturer’s 
instructions. In addition, DNA from Amies medium (490CE, Copan) was extracted as an 
NEC sample at the same time to allow contaminating bacterial DNA subtraction after 
NGS processing. Note that in this study we did not focus on DNA extraction efficiencies 
and the DNA extraction kit used may not be 100% efficient for determining microbial 
communities from skin swab samples. The total number of 16S rRNA gene copies within 
each DNA extract was measured using a 16S rRNA gene quantitative PCR (qPCR) accord-
ing to Yang et al.10 For this, CT-values were related to a serial dilution of the previously 
calibrated and normalized SMC sample and ranged from a total of 100 to 10,000 16S 
rRNA gene copies per PCR. Prior to amplification by either micPCR or traditional PCR, 
50 16S rRNA gene copies of Synechococcus DNA was added as IC to the skin swab DNA 
extracts and the NEC DNA extract.
Micelle Pcr and traditional Pcr amplification
16S rRNA gene amplicon library preparation using micPCR and traditional PCR was 
performed as previously published,3 but with a slight modification. In this study, both 
amplification strategies were performed using modified 341F (5’-GAC ACT ATA GCC 
TAC GGG RSG CAG CAG-3’) and 806R (5’-CAC TAT AGG GAC TAC NVG GGT WTC TAAT-3’) 
primers that amplified the V3-V4 regions of 16S rRNA genes and which incorporated 
universal sequence tails at their 5’ ends to allow for a two-step amplification strategy. 
Also, both micPCR and traditional PCR were performed using the same PCR reagents 
(except for the oil phase used to generate the micelles) and PCR conditions following 
the Micelle PCR Amplification protocol as previously published.3 Finally, both micPCR/
NGS and the traditional PCR/NGS methodology utilized the same amplicon purification 
steps to synchronize experimental conditions.
16S rrnA gene sequencing and data analysis
Bidirectional sequencing of the 16S rRNA gene amplicon libraries was performed us-
ing the 454 Genome Sequencer (GS) Junior platform (Roche), with FASTA-formatted 
sequences being extracted from the GS Junior machine and further processed using the 
mothur v. 1.33.0 software package.18 Primer sequences were trimmed and sequences 
that had an ambiguous base call (N) in the sequence or with lengths smaller than 400 
were removed from the analysis. Unique sequences were then aligned against a custom-
ized reference alignment based on the SILVA reference alignment release 119 (available 
at: https://www.mothur.org/wiki/Silva_reference_files). The reference sequences 
were trimmed to only include the V3-V4 region of the 16S rRNA gene using the pcr.
seqs command. Sequences that did not align to this region were culled from further 
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analysis and the alignments were trimmed so that the sequences fully overlapped 
the same alignment coordinates. Potentially chimeric sequences were removed using 
Uchime, as implemented in mothur. The remaining sequences were classified using the 
classify.seqs command with the customized SILVA alignment release 119 as reference. 
Next, sequences were clustered into OTUs at 97% similarity using the default settings 
of the dist.seq and cluster commands respectively. The classify.otu algorithm was used 
to get a consensus taxonomy for each OTU. Finally, all SMC samples were rarefied to 
1,000 sequences per sample and all skin swab samples were rarefied to 5,000 sequences 
per sample. The sequencing data that are connected to this article are uploaded to the 
Sequence Read Archive database with accession number SRP076831.
Statistical analyses
The Kolmogorov-Smirnov test was used to check the normality of data distribution. 
Precision analyses were performed by calculating the coefficient of variation for each 
of the four OTUs obtained from the SMC samples. The paired Wilcoxon signed-rank 
test was used to compare the coefficients of variation obtained using micPCR/NGS and 
traditional PCR/NGS (SPSS version 23, IBM Corporation).
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The determination of microbial communities using the mothur tool suite (https://
www.mothur.org) is well established. However, mothur requires bioinformatics-based 
proficiency in order to perform calculations via the command-line. Galaxy is a project 
dedicated to providing a user-friendly web interface for such command-line tools 
(https://usegalaxy.org).
results
We have integrated the full set of 125+ mothur tools into Galaxy as the Galaxy mothur 
Toolset (GmT) and provided a set of workflows to perform ‘end-to-end’ 16S rRNA gene 
analyses and integrate with third-party visualization and reporting tools. We demon-
strate the utility of GmT by analysing the mothur MiSeq standard operating procedure 
(SOP) data set (https://www.mothur.org/wiki/MiSeq_SOP).
conclusions
GmT is available from the Galaxy Tool Shed, and a workflow definition file and full Galaxy 
training manual for the mothur SOP have been created. A Docker image with a fully 
configured GmT Galaxy is also available.
key PointS
• GmT provides a user-friendly interface to mothur by implementing mothur soft-
ware in Galaxy
• A Galaxy workflow and full training manual for the mothur SOP are provided
• GmT provides integration with third-party visualization and reporting tools
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16S rRNA gene profiling analysis can be achieved using an extensive array of sophisti-
cated software including mothur,1 QIIME,2 MG-RAST,3 and many more.4 Whilst some of 
these applications have a graphical user interface (GUI) to provide access to these tech-
nologies for the research scientist, their use remains complex for non-bioinformaticians. 
In this respect, the Galaxy project was developed in order to simplify the use of complex 
command-line software tools.5 Galaxy offers extensive support for both 16S rRNA gene-
based and broader metagenomic analyses, with over 100 tools in the metagenomics 
section of the Galaxy Tool Shed, including QIIME,2 KRONA,6 PyNAST,7 PICRUSt,8 Kraken,9 
MetaPhlAn2,10 HUMAnN2,11 PrinSEQ,12 Nonpareil,13 VEGAN,14 and many more.
mothur is an open-source application that was designed as a single piece of software 
capable of analysing and comparing microbial communities from 16S rRNA gene data 
derived from next-generation sequencing (NGS). The creators of mothur did not only 
provide an extensive set of tools, but also a collection of standard operating procedures 
(SOPs) that detail the recommended analytical protocol for different types of input data.
The latest version of mothur consists of over 125 components, lending it great flex-
ibility, but at the same time, great complexity. To address this challenge, we have inte-
grated the full set of 125+ mothur components into Galaxy that are collectively called 
the ‘Galaxy mothur Toolset (GmT)’. To simplify usage of GmT we provide the full workflow 
definition files, usage of which shields the end-user from the full complexities of the 
analysis. By simultaneously providing access to all the individual components present in 
mothur as separate tools, expert users and bioinformaticians retain the ability to utilize 
the full flexibility of mothur by creating custom workflows or by modifying or extending 
our workflows to fit their use-case.
GmT also leverages Galaxy’s collections framework to enable easy analysis of large 
numbers (many thousands) of samples at once. Many mothur components support 
parallel computing, and the Galaxy tools will utilize the maximum amount of process-
ing power allotted to them by the instance administrator. As part of GmT, datatypes 
were also contributed to the Galaxy core codebase to facilitate the handling of mothur-
specific datatypes within Galaxy. Furthermore, a Galaxy data manager was also created 
for the automatic installation and configuration of reference datasets utilized by the 
mothur tool suite. And lastly, a Galaxy interactive environment (GIE)15 for Phinch16 was 
also developed.17
GmT includes tools to produce standard file formats, such as the BIOM format18 to 
facilitate interoperability with these downstream analysis components. Where no clear 
file standards exist, GmT provides custom tools for conversion of mothur datatypes to 
other tools (e.g. the taxonomy-2-krona tool). This allows for integration with third-party 
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tools such as PICRUSt for prediction of functional content, or visualisation tools such as 
Phinch, KRONA, and certain QIIME components. The mothur tools also natively support 
incorporation of some third-party analysis tools, such as UCHIME and ChimeraSlayer for 
chimera detection or VSEARCH for clustering, which are also available in GmT.
The Galaxy Training Network (GTN) is a network of people and groups that present 
Galaxy and Galaxy-based training around the world. The GTN has created a central 
repository for Galaxy training materials.19 In order to further facilitate the use of GmT to 
end-users, we have contributed training materials to the GTN that illustrate how to run 
mothur’s MiSeq SOP within Galaxy.20 This work has also been incorporated in a larger-
scale framework to easily and quickly explore microbiota data in a reproducible and 
transparent environment.21
Purpose of this work
The work performed and described in this technical note has four objectives. First to 
provide end-users and bioinformaticians with easy access to all the mothur tools as 
the GmT. Second is to provide open-access online training material to demonstrate/
complete the mothur SOP in Galaxy. Third is to deliver an ‘end-to-end’ workflow for the 
mothur SOP in Galaxy that is available for upload to any Galaxy that has the GmT in-
stalled. Fourth is to provide a summarization of results in a web report using the iReport 
Galaxy tool.22 Our aim is to provide 16S rRNA gene NGS analysis tools and awareness on 
how to use them in a format that supports FAIR data principles.23
worked example
To illustrate the utility of our toolkit, we present results on example data below. GmT is 
designed to take short-read 16S rRNA gene NGS data as input and to output a dynamic 
web report for prokaryotic taxonomical classification using the Galaxy platform. A GmT 
workflow follows essentially a four-step process:
(i.) Data upload. The Galaxy platform provides the users with standard data upload 
functionality for single and multi-sample datasets.
(ii.) Collection creation. For multi-sample and/or paired-end datasets a Galaxy collec-
tion must be created in the Galaxy interface. Here datasets can also be assigned to 
groups. Galaxy will make intelligent suggestions for pairings of datasets based on 
the file names.
(iii.) 16S rRNA gene analysis. mothur has been wrapped as a tool suite in Galaxy. Re-
quired steps included for a full ‘end-to-end’ 16S rRNA gene sequencing analysis 
consist of read-pair merging (mothur command: make.contigs), trimming of 
primer sequences (trim.seqs), additional quality control (screen.seqs), alignment of 
sequences to a (customized) reference alignment (align.seqs, screen.seqs), removal 
of chimeric sequences (chimera.uchime), classifying sequences using a Bayesian 
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classifier in combination with a reference database such as SILVA or GreenGenes 
(classify.seqs), and clustering of sequences into operational taxonomic units (OTUs) 
at a predefined percentage – usually 97 percent – of similarity (dist.seqs, cluster, 
and classify.otu) (Figure 1).
(iv.) Experimental summary and reporting. iReport in combination with KRONA6 is used 
to deliver an HTML report in Galaxy. The iReport consists of multiple tabs to group 
results topically (e.g. taxonomy, rarefaction, diversity, quality control) and is highly 
customizable and easily tailored to an end-user’s specific use-case. The entire re-
port may be downloaded from the Galaxy interface to be viewed or shared offline. 
To compare the output from a single experiment or across multiple experiments 
we utilized Phinch,16 a dynamic web application which uses BIOM-formatted files 
to explore and analyse biological patterns in 16S rRNA gene NGS datasets.


























Large-scale analyses have become the norm in the field, both large in disk space as in 
the number of files, and this can pose a challenge for analysis. For large files, Galaxy 
offers the option of uploading via FTP rather than web transfer. The introduction of the 
concept of ‘collections’ in Galaxy has enabled users to analyse datasets consisting of a 
large number of files (>100K) as easily as they would a single file.
Galaxy mothur toolset
Many mothur components support parallelization, and our Galaxy wrappers will run 
these components with the maximum number of CPUs allotted to them by the Galaxy 
administrator. In order to diagnose potential failures, Galaxy outputs the full standard 
and error logs, which the users can inspect. Furthermore, we have contributed mothur 
datatype definitions to the Galaxy core code, meaning that the users will be protected 
from inputting the wrong datasets and thus reduce the number of errors they will make 
with the tools. All tools in GmT use only conda dependencies, making their installation in 
Galaxy a painless experience that requires nothing more than a single press of a button.
The mothur tool wrappers have been submitted to the Intergalactic Utilities Com-
mission (IUC) tool repository,24 and are available from the Galaxy Tool Shed.25 The IUC 
is a group of community members dedicated to developing and upholding Galaxy tool 
development best practices and guidelines, thus by contributing our tools to this repo 
we ensure that the tools will be well-maintained. A metagenomics Galaxy flavour is 
available which contains all components presented here.26 The full mothur suite has also 
been installed to Galaxy’s main server.27
kronA visualization
KRONA is a data viewer which provides the ability to interactively explore hierarchical 
data.6 A Galaxy KRONA wrapper that works directly on mothur data formats was devel-
oped for this project.
Phinch visualization
Galaxy offers integration with Phinch BIOM format viewer16 in two ways; as a Galaxy in-
teractive environment (GIE) developed in the context of this project,17 and more recently 
also as an external display application hosted by the Galaxy team.
ireport summarization
To facilitate the evaluation of 16S rRNA gene sequencing analysis results, integration 
with the iReport tool are also provided.22 This tool creates a web report to present the 
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analysis results in an organized fashion and provides links to external resources such as 
BLAST searches (Figure 2).
OTU DX01 DX02 Kingdom Phylum Class Order Family Genus BLAST
Otu0002 0 8,265 Bacteria Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Morganella send to BLAST
Otu0003 6,565 0  Bacteria Firmicutes Clostridia Clostridiales Family_XI Anaerococcus send to BLAST
Otu0004 0 6,607 Bacteria Bacteroidetes Bacteroidia Bacteroidales Prevotellaceae Alloprevotella send to BLAST
Otu0005 0 3,868 Bacteria Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus send to BLAST
Otu0006 0 502 Bacteria Firmicutes Bacilli Bacillales Staphylococcaceae Staphylococcus send to BLAST
Otu0007 1,219 0 Bacteria Firmicutes Clostridia Clostridiales Family_XI Peptoniphilus send to BLAST
Otu0008 1,108 0 Bacteria Bacteroidetes Bacteroidia Bacteroidales Prevotellaceae Prevotella send to BLAST
Otu0009 939 0 Bacteria Firmicutes Clostridia Clostridiales Family_XI Parvimonas send to BLAST
Otu0010 787 0 Bacteria Firmicutes Clostridia Clostridiales Family_XI Peptoniphilus send to BLAST
Otu0011 16 0 Bacteria Firmicutes Bacilli Lactobacillales Streptococcaceae Streptococcus send to BLAST
Showing 1 to 10 of 37 entries Previous Next
Search:Show entries10

















Taxonomy Rarefaction Diversity Quality Control
Figure 2. Example iReport. This web report contains the interactive KRONA visualization, the (multi-sam-
ple) OTU table, rarefaction plots, diversity calculations, diff erential abundance analysis, and an extensive 
overview of the quality control measurements taken during the analysis. iReports are highly customizable 
and can be easily tailored to fi t specifi c use-cases and end-user needs.
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AvAilABility oF Source code And reQuireMentS
• Project name: Galaxy mothur Toolset (GMT)
• Project home page: https://github.com/erasmusmc-bioinformatics/galaxy-mothur- 
toolset
• Tool shed repository: https://toolshed.g2.bx.psu.edu/view/iuc/suite_mothur/ 
768c2e48b706
• Training manual: http://galaxyproject.github.io/training-material
• GmT Docker image: https://quay.io/shiltemann/galaxy-mothur-toolset:16.07
• Galaxy Metagenomics Docker Flavour (Docker): https://quay.io/reposi-
tory/shiltemann/galaxy-metagenomics, https://github.com/shiltemann/galaxy-
metagenomics
• Phinch interactive environment: https://github.com/shiltemann/phinch-galaxy-ie
• Operating system(s): Unix (Platform independent with Docker)
• License: GNU GPL v3
AvAilABility oF SuPPortinG dAtA And MAteriAlS
The data presented here to illustrate our work is the same data used in the training 
manual, and is available from Zenodo.28
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Microbiota profiling has the potential to greatly impact on routine clinical diagnostics 
by detecting DNA derived from live, fastidious and dead bacterial cells present within 
clinical samples. Such results could potentially be used to benefit patients by influenc-
ing antibiotic prescribing practices, or to generate new classical-based diagnostic 
methods e.g. culture or PCR. However, technical flaws in 16S rRNA gene next-generation 
sequencing (NGS) protocols, together with the requirement for access to bioinformatics, 
currently hinders the introduction of microbiota analysis into clinical diagnostics. Here 
we report on the development and evaluation of an ‘end-to-end’ microbiota profiling 
platform (MYcrobiota), which combines our previously validated micelle PCR/NGS 
(micPCR/NGS) methodology with an ‘easy-to-use’, dedicated bioinformatics pipeline. 
The newly designed bioinformatics pipeline processes micPCR/NGS data automatically 
and summarizes the results in interactive, but simple web reports. In order to explore 
the utility of MYcrobiota in clinical diagnostics, 47 clinical samples (40 ‘damaged skin’ 
samples and 7 synovial fluids) were investigated using routine bacterial culture as com-
parator. MYcrobiota confirmed the presence of bacterial DNA in 37/37 culture-positive 
samples and detected bacterial taxa in 2/10 culture-negative samples. Moreover, 36/38 
potentially relevant aerobic bacterial taxa and 3/3 mixtures of anaerobic bacteria were 
identified using culture and MYcrobiota, with the sensitivity and specificity being 95%. 
Interestingly, the majority of the 448 bacterial taxa identified using MYcrobiota were not 
identified using culture, which could potentially have an impact on clinical decision-
making. Taken together, the development of MYcrobiota is a promising step towards the 
introduction of microbiota analysis into clinical diagnostic laboratories.
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introduction
The detection and identification and further characterization of pathogenic microor-
ganisms is the major step in establishing appropriate (antibiotic) treatment for infec-
tious diseases. However, the causative microorganism of an infection may not always be 
detected using current ‘gold standard’ culturing techniques. Further, most molecular-
based detection methods e.g. PCR, require a priori knowledge of the potential pathogen 
before a test is performed. To overcome these limitations, the bacterial composition can 
be detected and genera identified using a culture-free, broad-range PCR strategy that 
targets the prokaryotic 16S rRNA gene followed by next-generation sequencing (NGS).1 
However, to date, 16S rRNA gene NGS methods to profile microbial compositions have 
been focussed on research questions mostly, with only a few studies having evaluated 
the utility of 16S rRNA gene NGS methods for clinical microbiology.2,3 Currently, the 
utilisation of 16S rRNA gene NGS methods within routine clinical diagnostics has been 
hindered by issues relating to the generation of PCR artefacts (e.g. chimera formation 
and PCR competition) and the susceptibility of 16S rRNA gene NGS methods to DNA 
contamination that is derived from the laboratory environment and/or the reagents/
consumables used. These limitations hinder the standardization of current 16S rRNA 
gene NGS methods to such an extent that non-identical microbiota results may be 
obtained when repeatedly analysing the same sample.4
Recently, the authors published a micelle PCR/NGS (micPCR/NGS) methodology that 
limits the formation of chimeric sequences and prevents PCR competition via the clonal 
amplification of targeted 16S rRNA gene molecules.5 In addition, the micPCR/NGS meth-
odology allows for the utilization of an internal calibrator (IC) to calculate the number 
of 16S rRNA gene copies for each individual operational taxonomic unit (OTU) present 
within a (clinical) sample, which conveniently enables the subtraction of contaminating 
bacterial DNA via the quantification of 16S rRNA gene copies within negative extrac-
tion control (NEC) samples. The authors showed that the microbiota results obtained 
using micPCR/NGS possess a much higher accuracy (precision and trueness) compared 
to traditional 16S rRNA gene NGS protocols and that the ability to determine and sub-
tract contaminating 16S rRNA gene copies, results in contamination-free quantitative 
microbiota profiles – with a limit of detection (LOD) of only 25 16S rRNA gene copies per 
OTU.6 This low LOD allows for the detection of bacterial OTUs at very low abundances, 
or can confirm the absence of 16S rRNA gene copies in culture-negative results. Based 
on these findings, the authors suggested that the micPCR/NGS protocol could possess 
distinct advantages when processing clinical samples for microbiota profiling compared 
to traditional (semi-quantitative) 16S rRNA gene NGS methods that remain vulnerable 
to false-positive results (e.g. chimeric sequences or contaminant DNA) and inaccurate 
measurements of the OTU relative abundances in polymicrobial clinical samples due 
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to template-specific variations in PCR efficiencies (i.e. PCR competition). However, the 
analysis of 16S rRNA gene NGS data depends on the use of bioinformatics tools that 
are complex for non-bioinformatics educated technicians/clinicians to utilize and the 
required bioinformatics skills are nowadays mostly absent in clinical diagnostic labora-
tories.
In this publication, we designed an ‘easy-to-use’ bioinformatics pipeline to determine 
bacterial taxa from 16S rRNA gene sequences that together with the micPCR/NGS strat-
egy is part of an ‘end-to-end’ microbiota profiling platform (MYcrobiota). The bioinfor-
matics pipeline enables the full analyses of the NGS data obtained, from raw sequence 
files to final web reports that summarizes the quantitative microbiota profiles, without 
the knowledge of command-line scripts that would normally be required by 16S rRNA 
gene NGS users. As a proof of principle, we explored the utility of MYcrobiota for use in 
the clinical diagnostic laboratory by processing a total of 47 clinical samples and then 
comparing the results to conventional ‘gold standard’ culture results. The samples tested 
included 40 specimens that were obtained from a variety of damaged skin conditions for 
which a polymicrobial biomass was expected, and an additional 7 specimens, obtained 
from patients who were suspected of having (prosthetic) joint infections, for which a low 
bacterial biomass was expected.
MAteriAlS And MetHodS
ethics statement
An acknowledged national ethics committee from the Netherlands (Medisch Ethische 
Toetsingscommissie Noord-Holland, http://www.metc.nl) approved the study protocol 
(M015–021) and all experiments were performed on leftover material of the included 
clinical samples in accordance with the relevant guidelines and regulations. The national 
ethics committee waived the need for participant consent as all data were anonymized 
and analysed retrospectively under code.
Sample collection and study design
This study was performed retrospectively using 47 clinical samples obtained from 47 
subjects. The results obtained by routine bacterial culturing methods had been used 
to guide patient treatment and care. In this study, we re-analysed these samples using 
MYcrobiota and compared the results to the initial outcome of the culture results. The 47 
samples included in this study were derived from wounds (22), ulcers (10), abscesses (5), 
puss (1), erysipelas (1), erythema (1), and 7 synovial fluids obtained from patients with 
suspected (prosthetic) joint infections.
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routine bacterial culture
All samples were cultured according to standard laboratory protocols performed in our 
laboratory and stored at −80°C for subsequent MYcrobiota analysis. The routine bacte-
rial culture methods included a 48-h incubation at 35°C on tryptic soy agar plates with 
5% sheep blood (TSASB, Oxoid), colistin aztreonam blood agar plates (CAP, Oxoid) and 
cystine lactose electrolyte deficient agar plats (CLED, Oxoid) under aerobic conditions, a 
48-h incubation at 35°C on chocolate agar plates with Vitox supplement (CHOCV, Oxoid) 
under 5% CO2 conditions, and a 48-h incubation at 35°C on TSASB under anaerobic con-
ditions. All Gram-negative rods, beta-haemolytic streptococci, Staphylococcus aureus, 
Staphylococcus lugdunensis and anaerobic bacteria cultured were reported as poten-
tially relevant bacteria, of which the identification of aerobic bacteria was obtained 
using MALDI-TOF mass spectrometry (Bruker). Note that in this study we did not focus 
on optimizing culturing methods to increase the sensitivity of the culture results and the 
routine bacterial culture methods used may not 100% efficient for culturing the bacteria 
that were detected with MYcrobiota.
Micelle Pcr and nGS
DNA was extracted from all 47 samples using the High Pure PCR Template Preparation 
Kit (Roche) according to the manufacturer’s instructions. In addition, DNA from the ac-
companying elution buffer was extracted as a NEC at the same time in order to allow the 
subtraction of contaminating bacterial DNA after NGS processing. The total number of 
16S rRNA gene copies within each DNA extract was measured using a 16S rRNA gene 
quantitative PCR (qPCR) according to Yang et al.,7 after which each DNA extract was 
normalized to contain either 10,000, or <1,000 16S rRNA gene copies per microliter. A 
synthetic microbial community (SMC) sample, containing 10,000 16S rRNA gene copies 
of Moraxella catarrhalis (ATCC 25240), Staphylococcus aureus (ATCC 43300), Haemophilus 
influenzae (ATCC 10211), and Clostridium perfringens (ATCC 12915), was processed with 
each batch of clinical samples as a positive control (PC) sample. Prior to amplification by 
micPCR, 1,000, or 100 16S rRNA gene copies of Synechococcus DNA were added respec-
tively as IC to the normalized DNA extracts containing 10,000, or <1,000 16S rRNA gene 
copies per microliter. One hundred 16S rRNA gene copies of Synechococcus DNA were 
also added to the NEC DNA extract. The IC was used to express the resulting OTUs as a 
measure of 16S rRNA gene copies by the use of a correction factor (sample OTU copies = 
sample OTU reads x (initial IC copies/IC OTU reads)) as previously validated elsewhere.6
16S rRNA gene amplicon library preparation using micPCR was performed as previ-
ously published,6 but we utilized a different micPCR primer set that made it possible 
to replace the former Roche 454 NGS platform with the Illumina MiniSeq platform. In 
this study, micPCR amplification was performed using modified 515F (5’-TCG TCG GCA 
GCG TCA GAT GTG TAT AAG AGA CAG TGY CAG CMG CCG CGG TAA-3’) and 806R (5’-
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GTC TCG TGG GCT CGG AGA TGT GTA TAA GAG ACA GGA CTA CNV GGG TWT CTA AT-3’) 
primers that amplified the V4 regions of 16S rRNA genes as recommended for Illumina 
NGS and which incorporated universal sequence tails at their 5’ ends to allow for a two-
step amplification strategy. During the second round of amplification, dual indices and 
Illumina sequencing adapters were attached using the Nextera XT Index kit (Illumina). 
Paired-end sequencing of the 16S rRNA gene amplicon library was performed using 
the MiniSeq system in combination with the 2x150 bp MiniSeq System High-Output 
Kit (Illumina), after which FASTQ-formatted sequences were extracted from the MiniSeq 
machine for downstream analysis. We utilized the micPCR/NGS approach to process all 
samples, including the NEC and the PC, in triplicate in order to increase accuracy and 
to correct for contaminating bacteria DNA derived from the laboratory environment as 
previously described.6
Bioinformatics pipeline
The bioinformatics pipeline designed during this study consists of 23 well-established 
mothur tools (v.1.36)8 and an additional 9 custom-made tools developed by the authors 
that have been integrated and combined in Galaxy as a full analysis service to deliver 
16S rRNA gene analysis for micPCR/NGS experiments. Essentially, we have incorporated 
the functionality of mothur in Galaxy, which is a project dedicated to simplify the use 
of complex command-line bioinformatics tools (such as mothur) using a user-friendly 
web interface,9-11 and added new calculator tools to allow for a completely automatic 
processing of quantitative micPCR/NGS data. Importantly, the bioinformatics pipeline 
presents the microbiota results, together with an extensive overview of the quality 
control measurements performed during the micPCR/NGS data analysis, to the user 
in an organized fashion via an interactive web report. The complete workflow of the 
bioinformatics pipeline is visualized in Figure 1. All the tools required for the bioin-
formatics pipeline can be found in Galaxy’s Tool Shed (https://toolshed.g2.bx.psu.
edu). A workflow definition file can be downloaded from GitHub (https://github.com/
ErasmusMC-Bioinformatics/MYcrobiota) and may be imported to any Galaxy platform, 
thereby offering the required set of bioinformatics tools. For more information on how 
to install and use this pipeline, please refer to the documentation in GitHub (https://
github.com/ErasmusMC-Bioinformatics/MYcrobiota).
Quantitative Pcr methods
The total bacterial biomass within each DNA extract was measured using a 16S rRNA 
gene qPCR that targets the 16S rRNA gene V5-V7 region, which is a different region of 
the 16S rRNA gene compared to MYcrobiota.7 Therefore, the 16S rRNA gene qPCR is a 
complementary technique that enables the validation of the MYcrobiota process when 
determining the total number of 16S rRNA gene copies. For this, CT-values were related 
89
Development and evaluation of MYcrobiota for clinical diagnostics
6
to a serial dilution of the previous calibrated and normalized SMC sample that contained 
mixed and equimolar concentrations of four bacterial species and ranged from a total of 
100 to 10,000 16S rRNA gene copies per PCR. In addition, the S. aureus specific biomass 
was assessed within each DNA extract using a S. aureus qPCR that employs a S. aureus 
specific marker as described by Martineau et al.12 Here, CT-values were related to a serial 
dilution of only the calibrated S. aureus (ATCC 43300) DNA stock that ranged from a total 
of 10 to 10,000 copy numbers of the Martineau fragment. The PCRs were performed 
in 10 μL reaction volumes using the LightCycler 480 Probes Master (Roche) with the 
addition of 0.5 μM and 1.0 μM of each PCR primer for the 16S rRNA gene and S. aureus 
qPCRs respectively. Also, 0.25 μM of a Fam-labelled probe was added for the real-time 
detection of the 16S rRNA gene amplification and 1x Resolight Dye (Roche) was added 
to the S. aureus qPCR in order to measure the S. aureus DNA amplification. All PCRs were 
performed on a LightCycler 480 instrument (Roche), using the following conditions: 
initial denaturation at 95°C for 5 minutes followed by 45 cycles of PCR, with cycling 
conditions of 5 seconds at 95°C, 10 seconds at 55°C, and 30 seconds at 72°C.
Availability of data and materials
The datasets generated and analysed during the current study are available in the Se-
quence Read Archive repository with accession number SRP109023.
reSultS
development of an ‘easy-to-use’ bioinformatics pipeline
In order to analyse 16S rRNA gene NGS data obtained using micPCR/NGS, we designed 
a Galaxy-based bioinformatics pipeline for use in clinical diagnostics. This workflow is 
largely based on the well-established standard operating procedure (SOP) defined by 
the creators of mothur.13 We have adapted the SOP to our specific use-case by integrat-
ing several custom-made tools that allows for the subsampling of large datasets, the av-
eraging over multiple technical replicates, converting the number of obtained sequence 
reads per OTU to 16S rRNA gene copies per OTU via the use of an IC, and correction for 
contaminating bacterial DNA via the use of NECs. All results are presented to the user 
as a single, interactive web report in Galaxy using the iReport tool.14 The iReport was 
designed to visualize the resultant microbiota profiles using KRONA,15 list quantitative 
microbiota profiles in OTU tables (with the microbial load per OTU reported as 16S rRNA 
gene copies), summarize results of diversity calculators, and provide an extensive over-
view of the quality control measurements during the analysis. Importantly, the iReport 
is relatively small in size (~ 6 MB per sample for our datasets) that enables easy sharing 
and storage of 16S rRNA gene NGS results (Figure 1).
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validation of the Mycrobiota process
As shown in Figure 2, MYcrobiota results obtained from the PC that was profiled in three 
independent experiments showed a median value of only a 1.3-fold (± 0.2) difference 
between the measured 16S rRNA gene copies per bacterial species and the expected 
10,000 16S rRNA gene copies per bacterial species present in the PC. In addition, com-











Taxonomy Quality control Diversity 
Input FASTQ processing steps 
OTU 16S rRNA gene copies Kingdom Phylum Class Order Family Genus BLAST 
Otu0002 8,265 Bacteria Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Morganella send to BLAST 
Otu0004 6,607 Bacteria Bacteroidetes Bacteroidia Bacteroidales Prevotellaceae Alloprevotella send to BLAST 
Otu0005 3,868 Bacteria Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus send to BLAST 
Otu0006 502 Bacteria Firmicutes Bacilli Bacillales Staphylococcaceae Staphylococcus send to BLAST 
Otu0020 321 Bacteria Firmicutes Bacilli Lactobacillales Streptococcaceae Streptococcus send to BLAST 
Otu0023 120 Bacteria Firmicutes Clostridia Clostridiales Family_XI Finegoldia send to BLAST 
Otu0053 80 Bacteria Firmicutes Clostridia Clostridiales Lachnospiraceae Lachnoclostridium send to BLAST 
Otu0061 57 Bacteria Firmicutes Clostridia Clostridiales Family_XI Anaerococcus send to BLAST 
Otu0085 29 Bacteria Firmicutes Clostridia Clostridiales Ruminococcaceae unclassified send to BLAST 
Step Example_R1 
Raw sequences 20,000 
Trimming primer sequences 17,496 (-2,504; -12.5%) 
Trimming based on length 17,486 (-10; -0.1%) 
Remove ambiguous reads 17,282 (-204; -1.2%) 
Align reads to reference 17,277 (-5; -0.0%) 
Chimera removal 17,270 (-7; -0.0%) 
Remove non-prokaryotic DNA 17,263 (-7; -0.0%) 
Download removed reads at each filtering step here 
•  Read-pair merging: combines forward and reverse reads into contigs 
•  Subsample large datasets: creates a smaller subset from the original set 
•  Quality control: removes primer sequences, short reads and ambiguous reads 
•  Simplify datasets: removes duplicate reads 
•  Alignment: aligns reads to a customized reference alignment  
•  Chimera removal: removes potentially chimeric sequences 
•  Classify sequences: assigns reads to a reference taxonomy outline 
•  Remove non-prokaryotic DNA: removes reads classified as non-prokaryotes 
•  OTU clustering: clusters reads into OTUs at 97% similarity 
•  IC normalization: converts reads to 16S rRNA gene copies using the IC 
•  Averaging triplicates: averages results over multiple technical replicates 
•  NEC correction: corrects for contaminating bacterial DNA using the NEC 
Clinical sample 1 
R1 R2 R3 
Clinical sample N 
R1 R2 R3 
Negative extraction control (NEC) 
R1 R2 R3 
Number of reads removed at each filtering step: 
Output (iReport) 
Positive control (PC) 
R1 R2 R3 
Figure 1. Schematical overview of the bioinformatics pipeline. FASTQ-formatted sequences obtained from 
triplicate experiments using micPCR/NGS (R1, R2 and R3) are automatically processed via the use of 32 
(mothur) tools that have been integrated and combined in Galaxy as an ‘end-to-end’ analysis service. The 
results obtained per sample (average of triplicate results) are presented to the user in a single, interactive 
iReport that consist of 3 tabs. The taxonomy tab visualizes and lists the resultant microbiota profiles. The 
diversity tab summarizes the results of 3 diversity calculators (Chao1, Shannon and Simpson). The quality 
control tab provides an extensive overview of the quality control measurements during the analysis.
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samples using MYcrobiota compared to qPCR results revealed an average of only a 
1.5-fold (± 0.5) and a 1.3-fold (± 0.4) difference for the total bacterial biomass and the 
Staphylococcus OTU-specific biomass respectively. Of note, 10 of the 47 clinical samples 
included in this study resulted in culture-negative results and the absence of bacterial 
DNA in these samples was confirmed with both qPCR and MYcrobiota methods. Also, 
one discrepant sample was detected that showed a 20-fold higher abundance of staphy-
lococci detected by MYcrobiota compared to qPCR. This result can be explained by the 
presence of S. aureus and S. non-aureus within this sample. In fact, the S. aureus qPCR 
showed a 100% specificity compared to S. aureus culture-positive results and indicates 
the presence of S. non-aureus bacteria within 7 additional samples in which the Staphy-
lococcus OTU was detected using MYcrobiota but no S. aureus could be cultured. Taken 
together, these data demonstrate the accuracy of the MYcrobiota process and the ability 









PC OTU-specific biomass 
Total bacterial biomass 
Staphylococcus OTU-specific biomass 
Figure 2. Accuracy of 16S rRNA gene copy determination using MYcrobiota. The expected number of 16S 
rRNA gene copies within the positive control (PC) was compared to the measured number of 16S rRNA 
gene copies using MYcrobiota (green dots). The PC contained 10,000 16S rRNA gene copies of four differ-
ent bacterial species and was processed in three independent MYcrobiota experiments. The indirect es-
timation of the total bacterial biomass within 37 clinical samples using MYcrobiota was compared to the 
total 16S rRNA gene copies measured directly using a 16S rRNA gene qPCR (blue dots). The Staphylococcus 
OTU-specific biomass from 13 S. aureus culture-positive samples was compared to the S. aureus biomass 
detected directly using a S. aureus-specific qPCR (yellow dots). In order to compare the number of S. aureus 
genome copies estimated using qPCR to the number of 16S rRNA gene copies detected using MYcrobiota, 
the estimated S. aureus genome copies were first multiplied by a factor of 6 to correct for differences in 
copy numbers of the Martineau fragment and the 16S rRNA gene present on the S. aureus genome. The 
calculated differences between methods were plotted using a binary logarithmic scale.
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comparing Mycrobiota results to routine bacterial culture
In order to explore the utility of MYcrobiota in the field of clinical diagnostics, we 
processed a total of 47 clinical samples and compared the results to routine bacterial 
culture. All bacterial genera detected using culture and MYcrobiota are reported per 
sample in Table 1. Using standard bacterial culture techniques, our laboratory detected 
a total of 38 potentially relevant aerobic bacterial genera within 25 clinical samples and 
obtained a positive culture of a mixture of anaerobic bacteria in 3 samples. No bacteria 
were cultured from 10 samples and an additional 10 samples resulted in the growth of 
bacteria that were all presumed to be commensal flora. In contrast, using MYcrobiota 
we detected a total of 448 bacterial operational taxonomic units (OTUs) in 39 samples 
of which 337 OTUs (75%) could be identified as anaerobic bacterial genera that were 
detected in 21 samples. No bacterial DNA was measured in 8 out of 10 culture-negative 
samples. The sensitivity for bacterial culture detection by MYcrobiota was determined at 
100% and the specificity at 83% using culture as ‘gold standard’.
The majority of bacterial genera identified with culture were also identified using MY-
crobiota. As shown in Table 2, MYcrobiota detected 36 of all 38 aerobic bacteria cultured 
on a genus-level taxonomy and confirmed the growth for anaerobic bacteria in 3 samples 
(sensitivity 95%; specificity 95%). Important to note, the two discrepant bacterial genera 
were measured using the micPCR/NGS strategy, but below the technique’s LOD of 25 
16S rRNA gene copies per OTU. In contrast, the vast majority of bacterial genera identi-
fied with MYcrobiota were presumed to belong to the commensal flora using culture 
or were not cultured at all (Table 1). These additional taxa include potential pathogens 
such as the Kingella OTU that was detected from a synovial fluid sample obtained from a 
juvenile patient that was not detected using culture and was confirmed using a Kingella 
kingae-specific PCR.
table 1. Bacterial genera identified from 47 clinical samples using routine bacterial culture and MYcrobiota.
Sample routine bacterial culture Mycrobiota
01_U Commensal flora (1+)
Anaerobic bacteria (346,300), Corynebacterium 
(10,725)
02_U Commensal flora (2+) Staphylococcus (941)
03_W Commensal flora (1+)
Anaerobic bacteria (263), Streptococcus (33), 
Staphylococcus (25)
04_U Pseudomonas (3+), Staphylococcus (2+)
Pseudomonas (4,706), Staphylococcus (848), 
Enterococcus (135), Anaerobic bacteria (102)
05_U
Proteus (2+), Enterobacteriaceae* (2+), 
Streptococcus (1+), Commensal flora (1+)
Anaerobic bacteria (8,271), Proteus (3,510), 
Streptococcus (632), Enterobacteriaceae* (333)
06_U Commensal flora (1+) Moraxella (8,947), Corynebacterium (734)
07_W Enterobacteriaceae (1+) Enterobacteriaceae* (5,386), Bacillus (44)
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table 1. Bacterial genera identified from 47 clinical samples using routine bacterial culture and MYcrobiota. 
(continued)
Sample routine bacterial culture Mycrobiota
08_W Negative Negative
09_W Commensal flora (1+) Anaerobic bacteria (523), Staphylococcus (31)
10_A
Anaerobic bacteria (2+), Pasteurella (2+), 
Streptococcus (2+)
Anaerobic bacteria (3,704,750), Pasteurella (242,250), 
Streptococcus (28,625)
11_W
Enterobacteriaceae* (3+), Staphylococcus 
(3+)
Enterobacteriaceae* (3,420,786), Acinetobacter 
(1,126,632), Staphylococcus (32,760)
12_A
Enterobacteriaceae* (2+), Streptococcus 
(2+)
Enterobacteriaceae* (18,046), Streptococcus (6,409), 
Enterococcus (67)
13_Es Commensal flora (1+)
Staphylococcus (344), Anaerobic bacteria (150), 
Dermabacteraceae* (93), Haemophilus (64), 
Corynebacterium (53)
14_W Commensal flora (1+) Staphylococcus (31)
15_U Staphylococcus (4+) Staphylococcus (17,035)
16_U
Enterobacteriaceae* (3+), 
Stenotrophomonas (2+), Commensal flora 
(2+), Proteus (1+), Pseudomonas (1+)
Enterobacteriaceae* (828,310), Proteus (250,670), 
Stenotrophomonas (11,760)
17_W Staphylococcus (1+), Commensal flora (1+) Staphylococcus (4,886)
18_W Staphylococcus (3+), Commensal flora (2+) Staphylococcus (141,120), Corynebacterium (4,959)
19_W Streptococcus (2+), Staphylococcus (1+)
Streptococcus (114,257), Staphylococcus (44,772), 
Corynebacterium (8,749), Anaerobic bacteria (897)
20_W
Enterobacteriaceae* (3+), Staphylococcus 
(2+)
Enterobacteriaceae* (4,574,310)
21_U Commensal flora (2+)
Moraxella (1,066,608), Acinetobacter (142,155), 
Pseudomonas (30,051), Anaerobic bacteria (30,051), 
Corynebacterium (23,976), Alkanindiges (2,187)
22_W Staphylococcus (2+), Commensal flora (1+) Staphylococcus (105,648)
23_Et Staphylococcus (2+), Commensal flora (2+) Staphylococcus (14,803), Corynebacterium (66)
24_U
Staphylococcus (3+), Streptococcus (3+), 
Commensal flora (2+)
Staphylococcus (231,756), Anaerobic bacteria (96,740), 
Streptococcus (15,904), Enterococcus (1,680)
25_W Staphylococcus (3+), Commensal flora (2+)
Staphylococcus (23,175), Corynebacterium (15,488), 
Anaerobic bacteria (1,271)
26_W Commensal flora (1+)
Staphylococcus (4,142), Anaerobic bacteria (101), 
Corynebacterium (94), Streptococcus (47)
27_A Streptococcus (1+)
Anaerobic bacteria (1,062,060), Streptococcus (5,490), 
Treponema (3,435), Gemella (1,425), Mycoplasma 
(870), Tannerella (720)
28_W Commensal flora (2+), Streptococcus (2+) Anaerobic bacteria (114,004), Streptococcus (43,208)
29_A Streptococcus (1+)
Streptococcus (12,225), Anaerobic bacteria (3,384), 
Gemella (299), Enterococcus (295), Haemophilus 
(221), Capnocytophaga (156), Granulicatella (122), 




table 1. Bacterial genera identified from 47 clinical samples using routine bacterial culture and MYcrobiota. 
(continued)
Sample routine bacterial culture Mycrobiota
31_U
Acinetobacter (2+), Enterobacteriaceae* 
(2+), Commensal flora (2+)
Acinetobacter (518,396), Stenotrophomonas (423,320), 
Enterobacteriaceae* (12,046), Corynebacterium (5,928), 
Bordetella (4,636), Brevibacterium (988)
32_W Staphylococcus (2+), Commensal flora (1+)
Anaerobic bacteria (251,692), Streptococcus (30,408), 
Staphylococcus (8,960)
33_W Staphylococcus (1+), Commensal flora (1+)
Staphylococcus (466), Anaerobic bacteria (171), 
Streptococcus (105), Acinetobacter (84), Corynebacterium 
(41)
34_W Staphylococcus (3+) Staphylococcus (218,141)
35_W Commensal flora (2+)
Staphylococcus (5,121), Anaerobic bacteria (769), 
Roseomonas (40)
36_W
Anaerobic bacteria (3+), Commensal flora 
(1+)
Anaerobic bacteria (493,183), Streptococcus (1,045)
37_W Streptococcus (2+) Streptococcus (11,457)
38_W Anaerobic bacteria (3+) Anaerobic bacteria (830,531)
39_P Streptococcus (2+) Streptococcus (10,277,376)
40_A Negative
Anaerobic bacteria (94,633), Enterobacteriaceae* 







47_S Negative Kingella (25)
Samples were derived from wounds (W), ulcers (U), abscesses (A), puss (P), erysipelas (Es), erythema (Et), 
and suspected joint infections (S). Cultured bacteria other than Gram-negative rods, beta-haemolytic 
streptococci, S. aureus, S. lugdunensis and anaerobic bacteria were reported as commensal flora. The semi-
quantitative culture results are presented as 1+, 2+, 3+, or 4+, depending on which quadrants demonstrate 
bacterial growth. The presence of anaerobic bacteria was reported as either a positive or negative result. 
Bacterial species and OTUs detected using culture and MYcrobiota respectively are grouped at the genus 
level to compare results. Red shades indicate bacterial genera that were only identified by culture and blue 
shades indicate bacterial genera that were only identified by MYcrobiota (with ‘commensal flora’ culture 
results representing a positive detection signal for any kind of aerobic bacterial OTU identified by MYcro-
biota). The number of 16S rRNA genes measured using MYcrobiota are indicated between brackets. (*) 
Several bacterial genera that belong to the Enterobacteriaceae and Dermabacteraceae families could not be 
differentiated at a 97% similarity level using MYcrobiota.
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6diScuSSion
In this study, we developed and explored the utility of an ‘end-to-end’ microbiota 
profiling platform (MYcrobiota) – consisting of our previously published 16S rRNA gene 
sequencing methodology (micPCR/NGS) in combination with an ‘easy-to-use’ bioinfor-
matics pipeline – to investigate human samples for the clinical diagnostics laboratories. 
The bioinformatics pipeline designed during this study allows for a fully automated 
sequence interpretation of 16S rRNA gene NGS data that is obtained using the validated 
micPCR/NGS protocol without the need for advanced bioinformatics skills that are often 
unavailable in the clinical diagnostic laboratories. The MYcrobiota results are presented 
using (interactive) visualizations and tables, including an overview of all removed se-
quences during the analysis that allows for a manual evaluation of the quality measure-
ments pre-installed within the bioinformatics pipeline. Moreover, connections of OTU 
representative sequences to the external NCBI database are available and can be used 
to ensure that the taxonomic identification of bacterial genera is correct.16 Importantly, 
the summarizing reports are relatively small in size and storage of these files enables 
the traceability of patient test results that is required for clinical diagnostic laboratories 
according to quality requirements.
Using MYcrobiota, we processed a total of 47 clinical samples and compared the 
results to routine bacterial culture. Our results showed that the majority of bacteria 
table 2. Comparison of the cultured bacterial taxa to MYcrobiota results.
Bacterial taxa
number of positive samples
Sensitivity Specificity
routine bacterial culture Mycrobiota
Acinetobacter 1 4 100% 98%
Enterobacteriaceae* 7 8 100% 98%
Pasteurella 1 1 100% 100%
Proteus 2 2 100% 100%
Pseudomonas 2 2 67% 100%
Staphylococcus 14 20 93% 100%
Stenotrophomonas 1 2 100% 100%
Streptococcus 10 16 100% 97%
Anaerobic bacteria 3 21 100% 71%
total 41 76 95% 95%
The culture results are restricted to genus-level classifications in order to compare the OTUs detected using 
MYcrobiota to the culture-based results. The presence of anaerobic bacteria was reported as either a posi-
tive or negative result. ‘Commensal flora’ culture results were interpreted as a positive detection signal for 
any kind of aerobic bacterial OTU identified by MYcrobiota to perform specificity calculations. (*) Several 




identified with culture were also identified with MYcrobiota, but the majority of bacterial 
taxa identified with MYcrobiota were not identified using culture. Many of the additional 
bacterial taxa identified using MYcrobiota are obligate anaerobes that were commonly 
detected as a large component of the microbial population in samples obtained from 
damaged skin sites, which is consistent with previous studies.17,18 Indeed, it is well-
known that anaerobic bacteria are able to cause serious and life-threatening infections 
but are often overlooked due to their requirement for appropriate methods of collec-
tion, transportation and cultivation.19 Therefore, the culture-free MYcrobiota profiling 
platform can play an important role in the identification of the bacteriological aetiology 
of anaerobic infections, or any other infections caused by fastidious microorganisms. 
Of note, it could be argued that the development of extensive culture techniques 
(so-called ‘culturomics’) may eventually facilitate the successful culture of supposedly 
‘non-culturable’ microbial isolates.20
In addition to the accurate detection and identification of bacterial OTUs within clini-
cal samples, MYcrobiota also provide the relative abundances in combination with the 
absolute abundances for each detected bacterial OTU. This feature allows clinicians to 
obtain a comprehensive overview of the microbial composition of the clinical sample so 
that each quantified bacterial OTU, as well as the bacterial community as a whole, might 
be taken into account in clinical decision-making. Additionally, MYcrobiota allows for 
the removal of contaminating DNA from environmental sources in order to accurately 
and reliably investigate very low bacterial biomass, or no bacterial biomass, clinical 
samples.6 For example, MYcrobiota confirmed the absence of 16S rRNA gene copies in 8 
of the 10 samples that generated culture-negative results. The two discrepant samples 
contained either anaerobic bacteria or low amounts of the fastidious Kingella bacterium 
respectively. The ability to confirm culture-negative results improves the reliability of 
culture-negative diagnostic results. Additionally, the ability of MYcrobiota to detect bac-
terial OTUs at very low abundances makes MYcrobiota a suitable method to investigate 
normally sterile body sites, such as synovial fluids, cerebrospinal fluids, blood samples, 
etc. It should be noted however, that the authors are aware of the fact that the develop-
ment of MYcrobiota is only a first step in the transition of microbiota research into actual 
clinical diagnostics. Extensive clinical and financial validation studies will be needed in 
order to validate and justify the routine introduction of molecular microbiota profiling 
methods into clinical diagnostic laboratories.
In conclusion, the stepwise development of MYcrobiota paves the way to introduce 
quantitative microbiota profiling into the clinical diagnostic laboratory. The method 
provides an highly accurate and comprehensive overview of the microbial composi-
tion of clinical samples or, alternatively, confirms the absence of 16S rRNA gene copies 
in culture-negative samples, using a standardized and validated 16S rRNA gene NGS 
workflow. Despite some shortcomings e.g. lack of species identification and the inabil-
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ity to provide detailed information on antibiotic susceptibility, our data illustrates that 
MYcrobiota has promising applications in the field of clinical diagnostics and warrants 
investment in future studies to accurately evaluate the clinical relevance of 16S rRNA 
gene NGS results in clinical samples.
AcknowledGeMentS
This work has received funding from the European Union’s Seventh Framework Pro-





 1. Fournier PE, Raoult D. Prospects for the future using genomics and proteomics in clinical micro-
biology. Annu Rev Microbiol 2011; 65: 169-188.
 2. Rhoads DD, Wolcott, RD, Sun Y, et al. Comparison of culture and molecular identification of bacte-
ria in chronic wounds. Int J Mol Sci 2012; 13: 2535-2550.
 3. Salipante SJ, Sengupta DJ, Rosenthal C, et al.   Rapid 16S rRNA next-generation sequencing of 
polymicrobial clinical samples for diagnosis of complex bacterial infections. PloS one 2013; 8: 
e65226.
 4. Hiergeist A, Reischl U, Priority Program Intestinal Microbiota Consortium/quality assessment par-
ticipants, et al. Multicenter quality assessment of 16S ribosomal DNA-sequencing for microbiome 
analyses reveals high inter-center variability. Int J Med Microbiol 2016; 306: 334-342.
 5. Boers SA, Hays JP, Jansen R. Micelle PCR reduces chimera formation in 16S rRNA profiling of 
complex microbial DNA mixtures. Sci Rep 2015; 5: 14181.
 6. Boers SA, Hays JP, Jansen R. Novel micelle PCR-based method for accurate, sensitive and quantita-
tive microbiota profiling. Sci Rep 2017; 7: 45536.
 7. Yang S, Lin S, Kelen GD, et al.  Quantitative multiprobe PCR assay for simultaneous detection and 
identification to species level of bacterial pathogens. J Clin Microbiol 2002; 40: 3449-3454.
 8. Schloss PD, Westcott SL, Ryabin T, et al.  Introducing mothur: open-source, platform-independent, 
community-supported software for describing and comparing microbial communities. Appl 
Environ Microbiol 2009; 75: 7537-7541.
 9. Giardine B, Riemer C, Hardison RC, et al.   Galaxy: a platform for interactive large-scale genome 
analysis. Genome Res 2005; 15: 1451-1455.
 10. Blankenberg D, Von Kuster G, Coraor N, et al.   Galaxy: a web-based genome analysis tool for 
experimentalists. Curr Protoc Mol Biol 2010; 89: 19.10.1-19.10.21.
 11. Goecks J, Nekrutenko A, Taylor J, et al. Galaxy: a comprehensive approach for supporting ac-
cessible, reproducible, and transparent computational research in the life sciences. Genome Biol 
2010; 11: R86.
 12. Martineau F, Picard FJ, Roy PH, et al. Species-specific and ubiquitous-DNA-based assays for rapid 
identification of Staphylococcus aureus. J Clin Microbiol 1998; 36: 618-623.
 13. Kozich JJ, Westcott SL, Baxter NT, et al. Development of a dual-index sequencing strategy and 
curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing 
platform. Appl Environ Microbiol 2013; 79: 5112-5120.
 14. Hiltemann S, Hoogstrate Y, van der Spek P, et al. iReport: a generalised Galaxy solution for inte-
grated experimental reporting. Gigascience 2014; 3: 19.
 15. Ondov BD, Bergman NH, Phillippy AM. Interactive metagenomic visualization in a Web browser. 
BMC Bioinformatics 2011; 12: 385.
 16. Boers SA, Jansen R, Hays JP. Suddenly everyone is a microbiota specialist. Clin Microbiol Infect 
2016; 22: 581-582.
 17. Price LB, Liu CM, Melendez JH, et al.   Community analysis of chronic wound bacteria using 16S 
rRNA gene-based pyrosequencing: impact of diabetes and antibiotics on chronic wound micro-
biota. PloS one 2009; 4: e6462.
99
Development and evaluation of MYcrobiota for clinical diagnostics
6
 18. Smith K, Collier A, Townsend EM, et al.  One step closer to understanding the role of bacteria in 
diabetic foot ulcers: characterising the microbiome of ulcers. BMC Microbiol 2016; 16: 54.
 19. Brook I. Clinical review: bacteremia caused by anaerobic bacteria in children. Crit Care 2002; 6: 
205-211.
 20. Lagier JC, Hugon P, Khelaifia S, et al. The rebirth of culture in microbiology through the example 
of culturomics to study human gut microbiota. Clin Microbiol Rev 2015; 28: 237- 264.

 Chapter 7
Detection of bacterial DNA in septic arthritis 











Bacterial septic arthritis is considered a medical emergency that may lead to disability 
or death. While the majority of these infections are described to be caused by gram-
positive bacteria, clinicians should be aware of less common bacterial causes of septic 
arthritis that are not detected by routine bacterial culture strategies. Therefore, we 
investigated 23 joint fluid samples that were obtained from 19 patients with suspected 
bacterial septic arthritis using a culture-free 16S rRNA gene next-generation sequencing 
(NGS) platform (MYcrobiota) and compared the results to routine diagnostic testing.
Methods
In this cross-sectional descriptive study, all samples were collected over a period of three 
months in 2017 and processed retrospectively using our previously validated and pub-
lished MYcrobiota platform without prior knowledge of their culture, PCR or traditional 
sequencing results.
results
All joint fluid samples tested were found to be culture-negative and MYcrobiota con-
firmed the absence of bacterial operational taxonomic units (OTUs) in 13/23 samples. 
However, MYcrobiota detected the presence of either an Enterococcus, Kingella, Par-
vimonas, Prevotella, Ruminococcus, Turicella, or Ureaplasma OTU in the other 10 samples. 
Four out of seven OTUs detected by MYcrobiota confirmed the additional diagnostic test 
results (i.e. blood culture results and molecular test results) that has led to an effective 
targeted antibiotic treatment for four patients.
conclusions
The accurate detection of bacterial OTUs using MYcrobiota greatly improves the iden-
tification of the aetiology of bacterial septic arthritis compared to routine diagnostic 
testing.
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Bacterial septic arthritis is an inflammation in native (non-prosthetic) joints with an 
incidence that ranges between 4-29 cases per 100,000 people per year, depending on 
population variables and pre-existing structural joint abnormalities.1 Most infections are 
introduced into the joints as a result of bacteraemia, though the joints may also become 
infected directly via trauma or an infection around the joint.2 In routine procedures, the 
diagnosis of bacterial septic arthritis is confirmed by detection of bacteria in joint fluid 
samples using culture-based techniques. However, a substantial proportion of joint fluid 
samples are culture-negative, even from patients with typical signs of septic arthritis, 
suggesting a role of ‘difficult-to-culture’ microorganisms (e.g. anaerobic or fastidious 
bacteria) in such clinical presentations.1,3 The failure of bacterial culture will delay an 
effective antimicrobial treatment of the septic arthritis patients who may suffer the de-
struction of the joint tissue.4 With this in mind, we investigated to what extent a culture-
independent 16S rRNA gene next-generation sequencing (NGS) platform (MYcrobiota) 
could add to the microbiological diagnosis obtained by culturing of joint fluid samples. 
For this, we tested 23 joint fluids that were obtained from 19 patients with suspected 
bacterial septic arthritis using MYcrobiota and compared the results to routine bacterial 
cultures.
MYcrobiota is a consolidated tool that includes a validated, quantitative micelle 
PCR/NGS methodology and a dedicated bioinformatics pipeline that was specifically 
designed for use in clinical diagnostic laboratories.5 The MYcrobiota platform enables 
the detection, quantification and characterization of bacterial DNA derived from live, 
fastidious, and dead bacterial cells present within clinical samples, and takes account 
of possible bacterial DNA contamination derived from laboratory reagents and/or the 
laboratory environment. This is achieved by quantifying contaminating 16S rRNA gene 
copies within negative extraction controls and subtracting these 16S rRNA gene cop-
ies from the quantitative microbiota profiles obtained from actual samples.6 Therefore, 
MYcrobiota possess a much lower limit of detection compared to (semi-quantitative) 
conventional 16S rRNA gene NGS methods, which allows the detection of bacterial 
operational taxonomic units (OTUs) at very low abundances, or alternatively, can reliably 
confirm the absence of bacterial DNA in culture-negative joint fluids.
The joint fluid samples were collected from the Regional Laboratory of Public Health 
Kennemerland and processed retrospectively using MYcrobiota, with no prior knowl-
edge of specimen culture results. An acknowledged national ethics committee from the 
Netherlands (Medisch Ethische Toetsingscommisie Noord-Holland, http://www.metc.nl) 
approved the study protocol (M015-021) and all experiments were performed in accor-
dance with relevant national guidelines and regulations. The national ethics committee 
waived the need for participant consent as all data were anonymized and analysed ret-
rospectively under code. The joint fluid samples were cultured directly on a blood-based 
agar (under aerobic and anaerobic conditions) and chocolate-based agar (under 5% CO2 
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conditions), and after thioglycolate enrichment. The left-over specimens were stored at 
−80°C for subsequent MYcrobiota analysis that was performed as previously described.5
Bacterial culture of all joint fluid samples included in the study generated culture-
negative results. In contrast, MYcrobiota revealed the presence of bacterial OTUs in 
10/23 (43%) joint fluids and confirmed the culture-negative results in the remaining 
13 samples. As shown in Table 1, the bacterial OTUs detected using MYcrobiota were 
classified as Enterococcus, Kingella, Parvimonas, Prevotella, Ruminococcus, Turicella, 
and Ureaplasma and confirmed the clinician’s suspicion of bacterial septic arthritis in 
seven patients that were found to be culture negative. From two patients, we received 
and processed multiple joint fluid samples that resulted in identical results from each 
sample. Specifically, four distinct joint fluid samples taken from one patient all tested 
positive for a Parvimonas OTU and two joint fluid samples obtained from a different 
patient confirmed the absence of bacterial DNA in both of these culture-negative joint 
fluids.
table 1. Seven different bacterial OTUs were detected from 23 joint fluid samples using MYcrobiota and 
confirmed the suspicion of bacterial septic arthritis in 7 patients (including serial samples from individual 






16S rrnA gene 
copies/μl
clinical decision
Enterococcus 1 1 6,600 NA
Kingella 1 1 25
On the basis of additional molecular testing, 
treatment was started with amoxicillin/clavulanic 
acid, directed against Kingella.
Parvimonas (4/4) 1 4 1,500 – 51,000 NA
Prevotella 1 1 71,000
On the basis of additional blood culture results, 
treatment was switched from flucloxacillin/
gentamycin to intravenous amoxicillin/clavulanic 
acid and later oral clindamycin, directed against 
Prevotella
Ruminococcus 1 1 192,000
On the basis of additional molecular testing, 
treatment was switched from vancomycin/
rifampin to intravenous penicillin, directed against 
Ruminococcus
Turicella 1 1 50 NA
Ureaplasma 1 1 1,200
On the basis of additional molecular testing, 
clindamycin was switched to doxycycline, directed 
against Ureaplasma
Negative 12 13 0
Empirical antibiotic treatment was stopped in one 
case. In the other cases, MYcrobiota data were 
not available during treatment or no empirical 
antibiotics were given.
NA: MYcrobiota data were produced in retrospective analysis and were not available during the clinical 
treatment period.
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In all bacterial OTU positive cases, only a single bacterial genus was identified per 
sample with bacterial loads that ranged from 25 to 192,000 16S rRNA gene copies per 
microliter of DNA extract used. Importantly, although 16S rRNA gene copies can provide 
some relevant information on bacterial load (tens of copies versus thousands of copies 
for example), it should be noted that it is not possible to accurately translate 16S rRNA 
gene copies into an actual number of bacterial genomes or cells present within a sample. 
This is because different bacterial species may carry different copy numbers of 16S rRNA 
genes in their genomes and copy numbers for all bacterial species are not known.
All bacterial genera detected using MYcrobiota, except Turicella, have been previously 
described as unconventional pathogens in bacterial septic arthritis.7-12 Although Turi-
cella otitidis (the only Turicella species described) is usually isolated from ear exudates, 
this bacterium has been previously identified as a cause for bacteraemia in at least two 
independent cases.13 Further, the main discrepancies between routine bacterial culture 
and MYcrobiota results could be explained by a difficulty in culturing anaerobic bacteria 
e.g. Parvimonas spp., Prevotella spp., and Ruminococcus spp., as well as fastidious bac-
teria e.g. Kingella spp. and Ureaplasma spp. Interestingly, some culture-negative joint 
fluid samples were found to contain DNA from ‘easily-culturable’ bacteria, including 
Enterococcus spp. and Turicella spp.
Although all routine bacterial cultures from all joint fluid samples included in this 
study generated culture-negative results, additional diagnostic testing – including 
blood cultures, specific PCRs, and 16S rRNA gene PCR/Sanger sequencing – was per-
formed to confirm the initial culture results. However, these additional diagnostic tests 
revealed the presence of four different bacterial pathogens (Kingella, Prevotella, Rumino-
coccus and Ureaplasma) in four joint fluid samples, which led to the subscription of an 
effective targeted antibiotics treatment for four patients with bacterial septic arthritis 
(Table 1). These patients received antibiotic treatment for six weeks in a routine clinical 
setting, including routine clinical follow up of treatment outcome that showed clinical 
and laboratory evidence of successful treatment. The additional diagnostic test results 
were later confirmed by our retrospective MYcrobiota analysis in all four cases. However, 
MYcrobiota detected an additional three OTUs (Enterococcus, Parvimonas and Turicella) 
in three joint fluids that were not identified using additional diagnostic testing. Unfor-
tunately, we were unable to find an explanation for these discrepancies. Nonetheless, 
these data illustrate that MYcrobiota is an accurate diagnostic platform and its results 
can be used to start, or switch to, targeted therapeutic strategies for patients presenting 
with suspected bacterial septic arthritis. Importantly, MYcrobiota provides this clini-
cal relevant information without the dependence on ‘traditional’ molecular tests that 
require a priori knowledge of the likely pathogen present within the sample (i.e. specific 
PCRs), or those that can only process monomicrobial samples with a bacterial load that 
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exceeds the inevitable background DNA contamination derived from the experimental 
set-up (i.e. 16S rRNA gene Sanger sequencing methods).
Joint infection is generally secondary to haematogenous dissemination of bacteria 
from other sites within the human body. Interestingly, for two patients, we were able to 
causally link the bacterial OTU detected by MYcrobiota to recent invasive surgery and 
dental procedures. The first patient underwent gastrointestinal surgery after which DNA 
derived from the Ruminococcus bacterium – that normally resides within the gastroin-
testinal tract – was detected within his joint, and in a second patient we identified DNA 
derived from the odontogenic Parvimonas bacterium following a tooth extraction. Taken 
together, these data further support the need to consider unconventional bacteria as 
causes of bacterial septic arthritis, especially in those patients who recently underwent 
surgical procedures of the digestive tract or in the mouth.
In conclusion, obtaining accurate quantitative microbiota profiles using MYcrobiota 
enables the identification of bacteria present within joint fluid samples that were not 
identified using routine bacterial culture strategies. Therefore, continued suspicion of 
bacterial septic arthritis despite culture-negative results should lead clinicians to con-
sider the use of culture-free 16S rRNA gene NGS techniques, such as the MYcrobiota 
platform.
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Drinking water utilities currently rely on a range of microbiological detection techniques 
to evaluate the quality of their drinking water (DW). However, microbiota profiling using 
culture-free 16S rRNA gene next-generation sequencing (NGS) provides an opportunity 
for improved monitoring of the microbial ecology and quality of DW. Here, we evaluated 
the utility of a previously validated microbiota profiling platform (MYcrobiota) to inves-
tigate the microbial dynamics of a full-scale, non-chlorinated DW distribution system 
(DWDS). In contrast to conventional methods, we observed spatial and temporal bacte-
rial genus changes (expressed as operational taxonomic units - OTUs) within the DWDS. 
Further, a small subset of bacterial OTUs dominated with abundances that shifted across 
the length of the DWDS, and were particularly affected by a post-disinfection step. We 
also found seasonal variation in OTUs within the DWDS and that many OTUs could not 
be identified, even though MYcrobiota is specifically designed to reduce potential PCR 
sequencing artefacts. This suggests that our current knowledge about the microbial 
ecology of DW communities is limited. Our findings demonstrate that the user-friendly 
MYcrobiota platform facilitates culture-free, standardized microbial dynamics monitor-
ing and has the capacity to facilitate the introduction of microbiota profiling into the 
management of drinking water quality.
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introduction
Drinking water distribution systems (DWDSs) are complex ecosystems where microor-
ganisms can actively grow and reproduce. In fact, several studies have shown that the 
bacterial composition within drinking water (DW) samples are highly diverse,1,2 with 
total cell concentrations that typically range from 1,000 to 100,000 bacterial cells per 
millilitre.3 Importantly, the presence of (opportunistic) pathogenic bacteria within DW 
may present an emerging public-health risk.4 Moreover, certain bacteria may also cause 
operational problems within DWDSs due to bacterial induced corrosion of iron pipes,5 or 
produce metabolites that affect the taste, odour and colour of DW.6 To reduce the risks 
of bacterial growth, DW utilities employ a combination of several treatment processes 
to minimize the number of microorganisms, as well as the microbial growth supporting 
nutrients, in the DW produced. These treatments commonly involve primary disinfec-
tion processes e.g. chlorination, ozonation, or UV/H2O2 advanced oxidation, which are 
also used for oxidation of natural organic matter, combined with filtration processes, 
such as active carbon, rapid or slow sand filtration, soil infiltration, or membrane fil-
tration methods.7 However, despite these efforts, eliminating all microorganisms and 
nutrients during treatment is impossible using current treatment processes, meaning 
that bacterial growth in the DWDS can occur and that DW utilities are compelled to 
monitor microbiological changes during DW treatment and distribution.
Current microbiological characterization of DW relies heavily on conventional cul-
turing techniques such as heterotrophic plate counts (HPC) and selective plating for 
Aeromonas spp., Legionella spp. and faecal indicator bacteria. Importantly however, 
these culture-based methods are time-consuming and it is well-known that they often 
detect only a small proportion of the total microbial population present in DWDSs.8 
Therefore, multiple culture-independent methods have been developed over the past 
decade to overcome these limitations. Most notably, flow cytometry (FCM) has emerged 
as a promising tool for the rapid assessment of DW quality that enables the detection 
and quantification of relevant microbial dynamics throughout a DWDS with high sensi-
tivity.9 Although FCM is useful for counting the total and viable number of bacterial cells 
throughout a DWDS, it does not generate taxonomic information about the microbial 
composition within DWDSs. The identification and quantification of bacterial taxa is 
required in order to adequately evaluate the complex nature of microbial communities 
within DW samples and to determine whether potentially (opportunistic) pathogenic 
bacteria are present within the DWDS. In contrast to FCM, microbiota profiling methods 
using 16S rRNA gene next-generation sequencing (NGS) techniques are able to dif-
ferentiate the composition of microbial communities on a taxonomic level and these 
methods have already been applied to DWDSs.2,10,11 Importantly however, obtaining ac-
curate 16S rRNA gene profiles requires careful consideration of (often overlooked) PCR 
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amplification biases and bacterial DNA contamination that can be introduced during the 
many steps of sample processing and sequencing.12 These inevitable biases frustrate the 
accurate validation of current 16S rRNA gene NGS methods and, consequently, impedes 
the transition of these powerful tools from research into industrial diagnostic practice.
Recently, the authors published a validated micelle PCR/NGS (micPCR/NGS) method-
ology that significantly reduces PCR amplification biases in microbiota profiles via the 
clonal amplification of targeted 16S rRNA gene molecules.13 The micPCR/NGS method 
drastically reduces chimera formation compared with traditional 16S rRNA gene NGS 
methods and prevents PCR competition due to unequal amplification rates of different 
16S rRNA gene template molecules. This is of particular importance for the accurate 
analysis of microbial compositions within high-diversity samples, such as DW samples, 
as these samples are more vulnerable to chimera formation and PCR competition 
compared to low-diversity samples.13 Further, by adding an internal calibrator (IC) to 
the micPCR/NGS methodology, we are able to quantify the absolute abundances of the 
bacterial operational taxonomic units (OTUs) detected within the samples under inves-
tigation, which enables the subtraction of any non-sample associated contaminating 
bacterial DNA that is invariably present in the laboratory environment and chemicals/
reagents mixes used via the processing of negative extraction control (NEC) samples.14 
Therefore, the micPCR/NGS methodology possess a much higher accuracy and a lower 
limit of detection (LOD) compared with traditional 16S rRNA gene NGS methods that 
allows for the accurate detection of minor microbial variations within DWDSs. Another 
problem associated with the introduction of 16S rRNA gene NGS methodologies into 
industrial processes involves the complexity associated with establishing a 16S rRNA 
gene analysis workflow that can be operated by non-bioinformatics educated users. To 
overcome this limitation, we previously developed a dedicated bioinformatics pipeline 
that enables the full analyses of our quantitative micPCR/NGS data, without knowledge 
of command-line scripts that would normally be required. This user-friendly analytical 
workflow together with the validated micPCR/NGS strategy is part of the microbiota 
profiling platform named ‘MYcrobiota’, which has already shown promising applications 
in routine clinical microbiological diagnostics.15
In this study, the authors evaluated the utility of MYcrobiota for studying micro-
bial dynamics within a non-chlorinated DWDS. We characterized microbial changes 
at consecutive locations along a full-scale DWDS in the Netherlands during a 5-month 
period with one-month intervals. The MYcrobiota results were compared to results of 
conventional microbiological analysis, including HPC, bacterial adenosine-triphosphate 
measurements (bATP), and intact bacterial cell concentrations assessed with FCM. Ad-
ditionally, we were able to use the MYcrobiota results to detect and identify spatial and 
temporal bacterial dynamics within the DWDS under investigation that may be used to 
evaluate the success of DW treatment processes.
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reSultS
total bacterial biomass variations observed within the dwdS
A total of 30 DW samples were collected from an operational DWDS. From July till No-
vember 2016, each month the DWDS was sampled at six consecutive locations and the 
DW at each location processed using MYcrobiota (Figure 1). The sequencing and quality 
parameters obtained are shown in Supplementary Table 1. In addition, HPC, bATP, and 
intact bacterial cell concentrations were measured and compared to the results obtained 
using MYcrobiota from all DW samples (Supplementary Table 2). These comparisons 
revealed that FCM and MYcrobiota were both able to detect microbiological changes 
within the DWDS that were not observed using HPC and bATP measurements. As 
shown in Figure 2, FCM and MYcrobiota detected a clear reduction of bacterial biomass 
between locations A and B (with the exception of DW samples taken in September), 
after which time, the bacterial biomass increased towards location C, followed by a more 
stable bacterial biomass concentration towards location F. However, the concentration 
of intact bacterial cells as detected by FCM was higher in 29 out of 30 DW samples than 
the concentration of 16S rRNA gene copies detected with MYcrobiota, with an average 
of a 4.9-fold (± 2.5) difference. In order to investigate the accuracy of the quantitative 
MYcrobiota data, we compared the number of 16S rRNA gene copies obtained using 
MYcrobiota with the number of 16S rRNA gene copies measured using a 16S rRNA 
gene quantitative PCR (qPCR).16 This comparison revealed an average of only a 1.3-fold 
(± 0.3) difference between both quantitative methods, demonstrating the accuracy of 
MYcrobiota in determining the number of 16S rRNA gene copies in DW. In contrast, the 
accuracy of the FCM method could not be confirmed using complementary techniques 
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Figure 1. Sampling scheme. The sampling points, labelled A (effluent of water treatment plant, after chlo-
rine dioxide dosage and after DW reservoir), B (effluent of intermediate pumping station and storage reser-
voir), C and D (transport pipelines), E (distribution pipeline), and F (tap water), are indicated by red arrows. 
The position of the chlorine dioxide (ClO2) dosage is indicated by the blue arrow. The distance between 
sampling points are shown in kilometres (km).
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Spatial microbial dynamics observed within the dwdS
The use of MYcrobiota revealed that the DWDS investigated in this study consisted of a 
highly diverse bacterial environment with a median of 69 (± 16) OTUs – defi ned by 97% 
16S rRNA gene sequence similarity – per DW sample (Supplementary Table 1). Only six 
of these OTUs were detected with a median relative abundance higher than 5% per 
sampled location. These dominating OTUs were classifi ed as Comamonadaceae, Defer-
risoma, Gallionellaceae, Nitrospira, Parcubacteria, and Peribacterales. Interestingly, DW 
samples taken at the start of the DWDS were dominated by the Peribacterales (median 
relative abundance: 23%), Parcubacteria (7%), and Gallionellaceae (7%) OTUs, whereas 
DW samples taken at the end of the DWDS were dominated by the Comamonadaceae 
(21%), Deferrisoma (11%), and Nitrospira (6%) OTUs as shown in Figure 3. In contrast, 
138 distinct OTUs – representing 14 diff erent prokaryotic phyla – were detected with a 
median relative abundance lower than 5% per sampled location. Only 30 of these OTUs 
(22%) could be classifi ed to the genus taxonomic level using public 16S rRNA gene refer-
ence databases, indicating that the vast majority of prokaryotic species present within 
DWDSs remain unknown or poorly understood.
A shift in the microbial composition tended to occur between locations A and C within 
the DWDS. As shown in Figure 4, the number of 16S rRNA gene copies for the majority 
of OTUs decreased between locations A and B, including the dominating Peribacterales, 
Parcubacteria, and Gallionellaceae OTUs. In contrast, the number of 16S rRNA gene cop-
ies measured for most OTUs increased between locations B and C, including the domi-
nant Comamonadaceae, Deferrisoma, and Nitrospira OTUs, but not the Peribacterales, 
Parcubacteria, and Gallionellaceae OTUs. Importantly, no signifi cant increase of 16S rRNA 
gene copies per OTU was detected within the fi nal stage of the DWDS (locations C to F), 
which includes the home plumbing system of the consumer – beyond the maintenance 
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Figure 2. Variations of bacterial biomass measured at six consecutive locations within the DWDS. Coloured 
lines represent 16S rRNA gene copies (left) and intact bacterial cell concentrations (right) measured from 6 
consecutive locations (A-F) over a 5-month period.
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temporal microbial dynamics observed within the dwdS
In order to investigate temporal trends in bacterial community structure, we compared 
the medians of 16S rRNA gene copies per OTU that were measured over the six consecu-
tive DWDS locations to each month-of-sampling. From this dataset, only a single OTU 
– belonging to the genus of Thioalkalispira – could be detected during specifi c months 
only (July, August, and September, but not October and November). In contrast, the 
other six dominating OTUs described above were detected in all sampled months and 
























Figure 3. Variations in the relative abundances of six dominating OTUs detected at consecutive locations 
within the DWDS. The medians of 16S rRNA gene copies per OTU that were measured over a 5-month 
period are shown using 100% stacked bars for each consecutive location (A-F). OTUs with > 5% relative 
abundance at the start of the DWDS are shown in shades of green, whereas OTUs with > 5% relative abun-
dance at the end of the DWDS are shown in shades of blue. All other OTUs with < 5% relative abundance 















Figure 4. Diff erences in absolute abundances of OTUs detected at consecutive locations within the DWDS. 
OTU-level diff erences between DWDS locations (A-F) were calculated by dividing the number of 16S rRNA 
gene copies per OTU derived from two consecutive locations. For this, the medians of 16S rRNA gene copies 
per OTU that were measured over a 5-month period were used and their diff erences between two consecu-
tive locations plotted using a binary logarithmic scale. OTUs with a relative abundance of < 5% per sampled 
location are shown as grey dots, whereas OTUs with > 5% relative abundance at location A (Peribacterales, 
Parcubacteria, and Gallionellaceae) are shown as green dots and OTUs with > 5% relative abundance at loca-
tion F (Comamonadaceae, Deferrisoma, and Nitrospira) are shown as blue dots. Diff erences with more than a 
2-fold increase/decrease (dotted lines) were considered as signifi cant diff erences that cannot be explained 
by technical variations introduced during sample processing.
Chapter 8
116
solute abundance of these OTUs throughout the DWDS, although these trends became 
weaker as water temperatures decreased (Figure 5). Importantly, a single DW sample 
obtained from location B in September showed a sudden increase of Comamonadaceae 
16S rRNA gene copies by a factor of 138 compared to location A. In fact, we measured 
an increase of 16S rRNA gene copies for another 42 out of 143 OTUs (30%) by at least 
a factor of 2 at location B in September, although their relative abundances remained 
below the threshold of 5%. These observations explain the deviating curve that was 
obtained when comparing the variations of total bacterial biomass within consecutive 
DW samples taken in September, namely an increase in bacterial abundance between 
locations A and B, while the abundance decreased at other months between these two 
locations (Figure 2).
otu Month / temp. A B c d e F rs relative abundance (range)
Peribacterales
  JUL / 17.9°C 123 52 64 11 10 9 -0.94 ** 4% (1% - 26%)
  AUG / 19.4°C 72 7 6 0 0 0 -0.94 ** 0% (0% - 11%)
  SEPT / 20.2°C 128 16 7 0 0 0 -0.94 ** 0% (0% - 16%)
  OCT / 15.7°C 383 44 18 16 6 10 -0.94 ** 2% (2% - 25%)
  NOV / 10.1°C 143 12 48 38 30 36 -0.37 11% (9% - 28%)
Parcubacteria
  JUL / 17.9°C 73 35 24 5 0 0 -0.99 ** 2% (0% - 16%)
  AUG / 19.4°C 45 5 0 0 0 0 -0.85 * 0% (0% - 7%)
  SEPT / 20.2°C 26 7 0 0 0 0 -0.85 * 0% (0% - 3%)
  OCT / 15.7°C 41 6 0 0 0 0 -0.85 * 0% (0% - 3%)
  NOV / 10.1°C 3 0 0 0 0 0 -0.66 0% (0% - 1%)
Gallionellaceae
  JUL / 17.9°C 10 4 7 4 4 0 -0.82 * 1% (0% - 2%)
  AUG / 19.4°C 45 3 5 0 0 0 -0.88 * 0% (0% - 7%)
  SEPT / 20.2°C 37 4 0 0 0 0 -0.85 * 0% (0% - 5%)
  OCT / 15.7°C 40 2 0 0 0 0 -0.85 * 0% (0% - 3%)
  NOV / 10.1°C 5 0 0 0 0 0 -0.66 0% (0% - 1%)
Comamonadaceae
  JUL / 17.9°C 7 25 274 318 252 512 0.83 * 33% (1% - 42%)
  AUG / 19.4°C 9 8 73 26 29 41 0.60 6% (1% - 12%)
  SEPT / 20.2°C 4 593 518 401 697 416 0.31 40% (1% - 47%)
  OCT / 15.7°C 11 12 535 224 104 111 0.49 23% (1% - 67%)
  NOV / 10.1°C 5 65 55 40 30 46 0.03 12% (1% - 52%)
Deferrisoma
  JUL / 17.9°C 0 0 21 51 50 97 0.93 ** 4% (0% - 8%)
  AUG / 19.4°C 0 0 30 64 91 80 0.93 ** 8% (0% - 14%)
  SEPT / 20.2°C 0 0 31 50 95 61 0.93 ** 4% (0% - 6%)
  OCT / 15.7°C 0 0 4 20 13 21 0.93 ** 1% (0% - 4%)
  NOV / 10.1°C 0 0 0 3 2 3 0.83 * 0% (0% - 1%)
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diScuSSion
In this study, we evaluated the use of the user-friendly MYcrobiota platform as a culture-
free monitoring tool to be used for microbiological DW quality assessment. For this, a 
full-scale DWDS served as a model system to investigate the performance, advantages 
and drawbacks of MYcrobiota compared to conventional microbiological screening 
methods. Our results show that MYcrobiota facilitates the accurate quantification of the 
total bacterial biomass present in the DWDS, as the dynamic bacterial trends – based 
upon the total bacterial biomass estimated using MYcrobiota – are in close agreement 
with the dynamic bacterial trends observed using FCM – which measures intact bacte-
rial cell concentrations. This result indicates that MYcrobiota is not hindered by the pres-
ence of cell-free bacterial DNA derived from dead bacterial cells. Surprisingly however, 
the number of 16S rRNA gene copies measured using MYcrobiota was lower compared 
to the number of intact cells detected using FCM within the same DW samples. These 
differences are likely caused by a systematic loss of bacterial cells and/or bacterial DNA 
during sample processing (e.g. filtration and DNA extraction) since the accuracies of 
both methods were demonstrated in this study or elsewhere.17 Note however that the 
otu Month / temp. A B c d e F rs relative abundance (range)
Nitrospira
  JUL / 17.9°C 4 4 38 38 31 59 0.79 4% (1% - 5%)
  AUG / 19.4°C 8 2 48 29 41 30 0.54 5% (1% - 8%)
  SEPT / 20.2°C 17 8 31 36 50 31 0.70 3% (1% - 4%)
  OCT / 15.7°C 12 2 6 25 11 14 0.43 2% (1% - 3%)
  NOV / 10.1°C 3 0 4 4 3 4 0.53 1% (0% - 1%)
Thioalkalispira
  JUL / 17.9°C 77 35 50 58 63 69 0.14 8% (5% - 16%)
  AUG / 19.4°C 24 2 5 3 6 5 -0.06 1% (1% - 4%)
  SEPT / 20.2°C 2 0 0 0 0 0 -0.66 0% (0% - 0%)
  OCT / 15.7°C 0 0 0 0 0 0 N/A 0% (0% - 0%)
  NOV / 10.1°C 0 0 0 0 0 0 N/A 0% (0% - 0%)
Figure 5. Detailed quantitative measurements of seven OTUs detected at six consecutive locations within 
the DWDS. The number of 16S rRNA gene copies that belong to the Peribacterales, Parcubacteria, Gallio-
nellaceae, Comamonadaceae, Deferrisoma, Nitrospira, and Thioalkalispira OTUs were measured in 5 sample 
series and shown as a heatmap using white shades for low absolute abundances and red shades for high 
absolute abundances. Values within the coloured boxes represent the calculated number of 16S rRNA gene 
copies/100μL. Sample series are presented per month following consecutive locations within the DWDS 
(A-F) and includes the average water temperature that was measured at each sampled location. Spearman 
correlations (Rs) and its associated significances (**: p-value < 0.01; *: p-value < 0.05) were calculated to 
check for significant increases/decreases in the absolute abundance of these OTUs throughout the DWDS. 
The relative abundance represents the median percentage of the number of 16S rRNA gene copies belong-
ing to each OTU measured per sample compared to the total number of 16S rRNA gene copies measured 
per sample with the range given between brackets.
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differences in absolute quantification of intact bacterial cell concentrations and 16S 
rRNA gene copies did not affect the dynamic trends observed in this study.
The sensitive and accurate measurement of quantitative bacterial biomass allowed us 
to assess the changes in bacterial communities during water transport and distribution 
within a DWDS. This was illustrated by a small, but reproducible, decrease of bacterial 
biomass between locations A and B, which was not detected using conventional HPC 
and bATP measurements. The decrease of bacterial biomass is most likely the result of 
chlorine dioxide dosage before storage in the DW reservoir. Despite a residence time 
of 1 to 2 hours on average in the DW reservoir located between the chlorine dioxide 
dosage point and sampling location A, the disinfection process may still be happening 
in the subsequent transport section and intermediate reservoir located before sampling 
location B. This effect may be causing a decrease in bacterial biomass between locations 
A and B, with a decrease in intact bacterial cells, as well as a decrease in 16S rRNA gene 
copies of individual OTUs. Besides providing additional contact time with chlorine diox-
ide, the intermediate storage reservoir may also contribute to the decrease of bacterial 
biomass through e.g. settling, though the specific role of reservoirs was not specifically 
studied here. However, the disinfectant residual is not maintained in the transport and 
distribution system after location B, which results in an increase in bacterial biomass be-
tween locations B and C, indicating re-growth of bacteria. Importantly, further microbial 
re-growth could not be detected from location C to location F. The absence of changes 
in bacterial biomass concentration as well as community composition after location C is 
surprising. While locations C and D are located in large transport mains (500 to 900 mm 
diameter), sampling location E is situated in a small distribution pipe (152 mm diam-
eter), and location F inside a consumer household. It has been shown earlier that small 
diameter pipes and low flow velocities or even stagnation have a great impact on bacte-
rial growth and/or interaction between bulk water bacteria and biofilm.18-20 Therefore, 
one would expect further growth and/or shifts in bacterial communities in these later 
sections. It should be noted however that DW samples were taken at location F after 
flushing of the taps, in order to avoid the household plumbing effect.
DW samples obtained from all locations sampled in September showed a similar num-
ber of 16S rRNA gene copies and intact bacterial cell concentrations, which suggested the 
presence of a stable bacterial biomass concentration across all of the locations sampled 
(Figure 2). However, the use of MYcrobiota showed that these apparently stable bacterial 
loads actually involved unexpected increases and expected decreases of 16S rRNA gene 
copies derived from multiple OTUs (Figure 5). Since the OTU dynamics between loca-
tions A and B in September were completely different compared to the general reduc-
tion of 16S rRNA gene copies measured between both locations for the other months, 
we speculate that this unexpected increase of bacterial biomass for certain OTUs in 
September was caused by deviation in the water quality leaving the treatment plant. 
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In this period, turbidity was 2 to 3 times higher than normal in the water at location A, 
which suggests that the water contained more particles and/or more microorganisms. 
The particles and microorganisms would react with the chlorine dioxide and accelerate 
the chlorine dioxide decay, which is even enhanced by higher temperatures – note that 
the highest temperatures were measured in September throughout the whole study. 
A faster disinfectant decay would allow earlier re-growth in the transport pipe and/or 
reservoir, which would result in higher numbers of 16S rRNA gene copies and intact 
bacterial cell concentrations than at other times of the year. Although the reduction 
of bacterial biomass between locations A and B was restored in the following months, 
these results highlight the ability of MYcrobiota to detect specific bacterial taxa that 
might be linked to possible problematic scenarios, such as (sudden) excessive bacterial 
growth, and opens the possibility of continual monitoring and the implementation of 
rapid action to maintain water quality using MYcrobiota.
The MYcrobiota results indicated only a small subset of bacteria dominating the 
DWDS, despite its high bacterial diversity. These bacteria comprised seven distinct 
OTUs (at a cut-off of 97% sequence similarity) that were classified as Comamonadaceae, 
Deferrisoma, Gallionellaceae, Nitrospira, Parcubacteria (also known as candidate phylum 
OD1), Peribacterales (candidate phylum PER), and Thioalkalispira. All of these bacterial 
taxa were previously detected within other DWDS samples,2,11,21 or within other aquatic 
ecosystems.22-24 Interestingly, the Peribacterales, Parcubacteria and Gallionellaceae OTUs 
dominated the start of the DWDS, but were ‘replaced’ by the Comamonadaceae, Defer-
risoma, and Nitrospira OTUs at the end of the DWDS. This finding was independent of 
the month of sampling and suggests that temporal variations are minor compared to 
spatial variations within this DWDS during the 5-month period of sampling. It should 
be noted however that most bacterial OTUs detected within this DWDS could not be 
identified at the genus taxonomic level due to the basic lack of 16S rRNA gene refer-
ence sequences derived from members of DW microbial communities in large publicly 
accessible reference databases (e.g. SILVA, RDP, GreenGenes, or NCBI). It is very likely 
that these OTU sequences belong to novel lineages for which there are no available 
culturable representatives, as the MYcrobiota protocol has been specifically established 
to help prevent the formation of PCR artefacts (i.e. chimeric sequences). This suggests 
that our current knowledge about the ecology of DW microbial communities is currently 
limited and requires further investigation with respect to the presence of potential (as 
yet unknown) bacterial pathogens in DW. Further, it is impossible to link bacterial taxa 
identified by MYcrobiota to their function in DWDSs. Only additional functional testing, 
or the identification of genes with well-established functions will provide insights into 
the functionality of the DW microbiome. For example, Di Rienzi and colleagues elegantly 
demonstrated that groundwater samples harbour non-photosynthetic bacteria belong-
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ing to a new candidate phylum sibling to Cyanobacteria via the use of metagenomic 
sequencing and metabolic reconstruction.25
Recently, there is a discussion about whether OTU-based strategies – such as imple-
mented within MYcrobiota – should be replaced by newly developed amplicon sequence 
variants (ASV)-based methods as the standard to delineate microbial taxa.26 These ASV-
based methods avoid clustering sequences at arbitrary thresholds that define OTUs (e.g. 
97%) by using only unique, identical marker gene sequences for downstream analysis. 
Unlike OTUs, ASVs can be resolved to single-nucleotide differences over the sequenced 
gene region using specialized ‘de-noising’ algorithms that is expected to increase taxo-
nomic resolution.27 However, Glassman and Martiny recently illustrated that OTU-based 
and ASV-based methods will often reveal similar ecological results when using the 16S 
rRNA gene.28 This finding can be explained by the fact that 16S rRNA gene sequence 
types may not reflect ecologically or phylogenetically cohesive populations.29 Therefore, 
in this study, we employed a traditional OTU-based strategy to simplify the identification 
of (sub-sets) of bacterial taxa that changed in abundance across the sampled locations. 
Of note, future versions of MYcrobiota could potentially include ASV-based analysis 
as part of its software, depending on the requirement to obtain fine-scale taxonomy 
results.
In conclusion, MYcrobiota is an alternative for the culture-free monitoring of bacteria 
that reside within DWDSs and allows DW providers to gain accurate insights into the 
spatial and temporal microbial dynamics within their DWDS that are not observed us-
ing conventional methods. Using information obtained by MYcrobiota facilitates the 
continual assessment of the desired ‘biological stability’ over the whole DWDS, thereby 
helping ensure that safe and high-quality DW reaches the consumer.
MAteriAlS And MetHodS
drinking water sample collection
A total of 30 DW samples were collected from a full-scale DW transport and distribution 
network in the Netherlands. The transported DW was produced from surface water, us-
ing coagulation/sedimentation, rapid sand filtration, advanced oxidation, and activated 
carbon filtration. Chlorine dioxide (ClO2) was added to the water prior to storage at the 
DW reservoir. The residual ClO2 after storage is 0.03 mg/L on average, but is not main-
tained during DW transport and distribution. DW samples were taken at six locations 
throughout the DWDS, from the treatment plant towards the studied distribution area, 
as follows: (A) effluent of water treatment plant, after ClO2 dosage and after DW reservoir, 
(B) effluent of intermediate pumping station and storage reservoir after a first transport 
pipe (800-900 mm), (C and D) at sampling points in the second and third transport pipe 
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sections (800-900 mm and 500-700 mm), (E) at a sampling point within the distribution 
pipe (40 – 300 mm) and (F) at a household tap (Figure 1). High-density polyethylene 
(HD-PE) plastic bottles (Identipack BV) containing 2 mL L-1 of a mixed solution of sodium 
thiosulfate (20 g L-1) and of nitrilotriacetic acid (25 g L-1) were used to collect DW for HPC, 
bATP, FCM, and MYcrobiota analysis, as routinely used by accredited laboratories for DW 
analysis in the Netherlands. The DW samples were transported and stored at 4°C until 
analysis, and processed within 24 hours after sampling.
conventional parameters
HPC was measured according to the Dutch standard procedure (NEN-EN-ISO 6222, 
1999). In short, 1 mL per DW sample was transferred to a sterile Petri dish and mixed 
with 20 mL of yeast extract agar. The agar was kept at 44°C before plating. The samples 
were incubated at 22°C for 3 days. ATP was measured as described previously by Magic-
Knežev and van der Kooij.30 The ATP measurement is based on the emission of light 
resulting from the reaction between the ATP molecule and a luciferin/luciferase reagent 
(LuminATE, Celsis). For total ATP determination, ATP was first released from suspended 
microbial cells with nucleotide-releasing buffer (LuminEX, Celsis), while this step was 
not performed for the assessment of free ATP. The intensity of the emitted light was 
measured using a luminometer (Celsis AdvanceTM) that was calibrated with solutions 
of free ATP (Biotherma) in autoclaved tap water following the procedure given by the 
reagent manufacturer. Bacterial ATP concentrations were calculated by subtracting free 
ATP from total ATP concentrations. Finally, FCM analysis were performed following the 
protocol described by Prest et al.17,31 In short, DW samples (100 µL) were pre-heated 
to 37°C for 4 minutes, stained with fluorescent dyes and incubated in the dark for 10 
minutes at 35°C before measurement. Bacterial staining with 10 µL per mL of a work-
ing solution containing a mixture of SYBR Green I (1:100 dilution in DMSO; Molecular 
Probes) and propidium iodide (0.5 mg/mL) was used for the assessment of intact bacte-
rial cell concentrations. FCM measurements were performed using a BD Accuri C6 FCM 
(BD Accuri Cytometers) equipped with a 50 mW laser emitting at a fixed wavelength of 
488 nm. The FCM is equipped with volumetric counting hardware, calibrated to measure 
the number of particles in a 50 µL volume fraction of a 100 µL sample. Measurements 
were performed at a pre-set flow rate of 35 µL per minute. A threshold value of 450 a.u. 
was applied on the green fluorescence channel (FL1). Bacterial signals were selected and 
distinguished from inorganic particles and instrument background on the BD Accuri 
CFlow software using electronic gating on density plots of green fluorescence (FL1; 533 




One litre of water from each DW sample was filtered through a 0.2 μm pore-size polycar-
bonate membrane filter (Sartorius) within 5 hours of sampling, using sterile (autoclaved) 
filtration units. The filters were stored at -20°C until processing. DNA was extracted from 
the collected biomass using the PowerBiofilm DNA Isolation Kit Sample (MO BIO Labo-
ratories) according to the manufacturer’s instructions. In addition, DNA from a sterile 
filter was extracted as a NEC at the same time in order to allow for the subtraction of 
contaminating bacterial DNA after NGS processing. Amplicon library preparation us-
ing micPCR that clonally amplified the V4 regions of 16S rRNA genes was performed 
as previously published,15 but with a slight modification. In this study, the IC to deter-
mine the absolute quantity of 16S rRNA gene copies consisted of quantified genomic 
DNA from a Campylobacter jejuni bacterium (ATCC 700819). Importantly, prior to the 
addition of the IC, the absence of Campylobacter species within each DNA extract was 
established using a Campylobacter specific PCR according to Lund et al.32 We utilized the 
micPCR/NGS approach to process all samples, including the NEC, in triplicate in order 
to increase accuracy and to correct for contaminating bacterial DNA derived from the 
laboratory environment as previously described.14 FASTQ-formatted sequences were 
extracted after paired-end sequencing of the 16S rRNA gene amplicon library using the 
MiniSeq system (Illumina) and processed using our previously developed bioinformatics 
analysis service.15 This bioinformatics pipeline consists of 23 well-established mothur 
tools (v.1.36)33 and an additional 9 custom-made tools that have been integrated and 
combined in Galaxy,34 and allows for a fully automated sequence interpretation of 16S 
rRNA gene micPCR/NGS data. The sequencing data that are connected to this article are 
uploaded to the Sequence Read Archive database with accession number SRP114562.
Quantification of 16S rrnA gene molecules
The total number of 16S rRNA gene molecules within each DNA extract was measured 
using a 16S rRNA gene quantitative qPCR as described previously.16 For this, CT-values 
were related to a 10-fold dilution series of a synthetic microbial community (SMC) 
sample, containing 10,000 16S rRNA gene copies of Moraxella catarrhalis (ATCC 25240), 
Staphylococcus aureus (ATCC 43300), Haemophilus influenzae (ATCC 10211), and Clos-
tridium perfringens (ATCC 12915). The qPCRs were performed in 10 μL reaction volumes 
using the LightCycler 480 Probes Master (Roche) with the addition of 0.5 μM of each PCR 
primer and 0.25 μM of a Fam-labelled probe for the real-time detection of the 16S rRNA 
gene amplification. All qPCRs were performed using the following conditions: initial 
denaturation at 95°C for 5 minutes followed by 45 cycles of PCR, with cycling conditions 
of 5 seconds at 95°C, 10 seconds at 55°C, and 30 seconds at 72°C.
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Statistical analysis
Spearman’s correlation coefficients were calculated to check for significant increases/
decreases in the absolute abundance of OTUs measured over the DWDS (SPSS version 
23, IBM Corporation).
SuPPleMentAry dAtA
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SuMMArizinG diScuSSion
As mentioned in the introduction to this thesis (chapter 1), next-generation sequenc-
ing (NGS) and phylogenetic analysis of 16S ribosomal RNA (rRNA) genes provided the 
foundation for modern study of microbial communities, generating many hundreds of 
publications. However, there has been very little focus on the development and applica-
tion of these culture-independent 16S rRNA gene NGS methods into routine diagnos-
tics. Therefore, the aim of this thesis was to develop and apply an accurate 16S rRNA 
gene NGS protocol for use in routine (clinical) microbiological diagnostic laboratories. 
Specifically, this thesis describes the development of an ‘end-to-end’ microbiota profil-
ing platform (MYcrobiota), consisting of a novel calibrated micelle-based PCR (micPCR) 
amplification strategy coupled to a dedicated and ‘easy-to-use’ bioinformatics pipeline, 
which was validated and evaluated using a range of samples, including synthetic micro-
bial community (SMC) mixes, samples from the clinic, and environmental samples. The 
main findings of the research performed relating to: i) the development and validation 
of MYcrobiota, and ii) the evaluation of MYcrobiota for routine clinical and environmen-
tal microbiological diagnostic use, are summarized and discussed in the following thesis 
chapter. In addition, the main conclusions of this thesis are listed and recommendations 
for future research are made.
development and validation of Mycrobiota
In order to advance 16S rRNA gene NGS methods to a more standardized and routine 
(clinical) microbiological diagnostic procedure, it is essential to establish uniform and 
validated standard operating procedures (SOPs) throughout laboratories for maintain-
ing consistent test performance. With this in mind, MYcrobiota was designed to over-
come the most important experimental pitfalls and biases of current 16S rRNA gene 
NGS methods that have previously hampered the introduction of these methods into 
the routine (clinical) microbiological diagnostic laboratories (Table 1, chapters 1 and 
2). Specifically, MYcrobiota was designed to: i) prevent chimera formation, ii) reduce PCR 
competition induced bias, iii) standardize microbiota profiling results via the absolute 
quantification of each microorganism present within microbial samples, iv) remove con-
taminating DNA derived from the experimental set-up, and v) simplify bioinformatics 
analysis that can be operated by non-bioinformaticians. In the following section, each of 
these technical improvements of the 16S rRNA gene NGS process that were realized with 
the development of MYcrobiota will be discussed in more detail.
Prevention of chimera formation. Current 16S rRNA gene NGS methods apply multi-
template PCR strategies in order to amplify all 16S rRNA gene template molecules 
simultaneously within a single reaction tube. However, the use of multi-template PCRs 
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table 1. Overview of the potential experimental pitfalls and biases generated using ‘traditional’ 16S rRNA 
gene NGS methods and the technical improvements that were realized with the development of MYcro-
biota.
experimental pitfalls and biases* General remarks and Mycrobiota improvements
Step 1: Sampling collection
- Sampling protocol - The sampling protocol depends on the sample type to be 
investigated.
- Transport and storage conditions - Optimal preservation of microbial samples involves 
immediate freezing followed by long-term storage at -80°C.
Step 2: DNA extraction
- Lysis method - The choice of the most efficient lysis method is dependent 
on the sample type and target microbial species under 
investigation.
Step 3: PCR amplification
- Selection of PCR primers - The most optimal PCR primer pair should be selected based 
on its primer binding capacity to the (expected) microbial 
species present within the investigated sample.
- PCR competition effects and chimera 
formation
- Mycrobiota utilizes a novel micelle PCR/NGS methodology 
that limits both the formation of PCR competition induced 
bias and chimera sequences (chapter 3).
Step 4: Next-generation sequencing
- Technical limitations of the NGS-platform 
used
- Mycrobiota targets the 16S rRNA gene V4 region, which 
allows for a large overlap of DNA sequences that are 
obtained from both ends of the PCR amplicon using 
Illumina’s MiniSeq/MiSeq NGS-platforms. This strategy 
generates the lowest error rates compared to other 16S rRNA 
gene regions used with these NGS-platforms (kozich et al., 
2013).75
Step 5: Bioinformatics analysis
- Choice of algorithms and their settings - Mycrobiota uses a standardized and validated 
bioinformatics pipeline that allows for the automated 
sequence interpretation of 16S rRNA gene NGS data without 
the requirement for advanced bioinformatics skills (chapters 
5 and 6).
- Quality/completeness of reference 
databases
- Mycrobiota allows for a manual evaluation of the taxonomic 
identifications of bacterial genera (chapter 6).
Miscellaneous
- Contamination - Mycrobiota determines the absolute quantity of microbial 
genera present within a sample, which improves the 
standardization of 16S rRNA gene NGS results and 
enables the removal of contaminating DNA derived from 
the experimental set-up via the processing of negative 
(extraction) control samples (chapter 4).
*: The experimental pitfalls and biases are described in more detail in chapter 1 of this thesis.
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results in the formation of chimeric sequences, which are composed of multiple distinct 
DNA sequences that are wrongfully joined together. The presence of chimeric 16S rRNA 
gene sequences artificially increases microbial diversity calculations, as these sequence 
artefacts are a major source of spurious operational taxonomic units (OTUs) in micro-
biota studies.1,2 In addition, chimeric sequences that are comprised of 16S rRNA gene 
sequences derived from different taxonomic lineages could be misinterpreted as novel 
prokaryotic genera, thereby turning the microbiologist unwittingly into a microbial 
creationist.3 Current strategies to reduce the amount of chimeric sequences generated 
by 16S rRNA gene NGS methods involve the use of optimized PCR protocols to reduce 
the chance of chimeric formation during PCR amplification,4,5 as well as the use of com-
plex computational algorithms that facilitate the removal of chimeric sequences after 
the PCR amplification and DNA sequencing processes are complete.3,6-8 Unfortunately 
however, none of these methods has been shown to completely eliminate chimeric 
sequences from 16S rRNA gene NGS datasets entirely.9
Therefore, in order to try to completely eliminate the formation of chimeric sequences, 
we developed a novel micPCR amplification strategy whereby template DNA molecules 
are separated into a large number of physically distinct reaction compartments using 
water-in-oil emulsions (chapter 3). This template DNA molecule compartmentalization 
drastically reduced the formation of chimera sequences due to the statistical presence 
of a single template DNA molecule in each droplet of the emulsion. For example, our re-
sults show that the use of micPCR followed by NGS (micPCR/NGS) reduced the formation 
of chimeric sequences by a factor of 71 (0.2% vs. 17.4%) compared with traditional PCR/
NGS methods (chapters 3 and 4). The fact that small numbers of chimeric sequences 
were still being detected even when using the micPCR/NGS method can be explained 
by the possibility that some micelles still host more than one template DNA molecule 
during micPCR amplification or through the generation of false positive chimera results 
by downstream computational methods. This observation shows that the number of 
template DNA molecules have to be carefully adjusted for each micPCR/NGS experiment 
in order to try to achieve a balance of one template DNA molecule per micelle. Nonethe-
less, inevitable sequence-errors introduced by PCR polymerases,10 and NGS-platforms in 
general,9 result in ‘noisy’ 16S rRNA gene NGS reads that can be misidentified as chimeric 
artefacts by the chimera checking software tool used. These false-positive chimera 
results could explain the very low numbers of chimeric sequences that are regularly 
detected within micPCR/NGS datasets, even when optimized numbers of template DNA 
molecules are used.
The vast reduction in chimeric sequences results in more accurate microbial diversity 
estimates. This can be illustrated using rarefaction analyses, in which the researcher plots 
the number of OTUs as a function of the number of 16S rRNA gene NGS reads obtained. 
Rarefaction curves generally grow rapidly at first, as the most common OTUs are found, 
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but the curves soon reach a plateau, as only the rarest OTUs remain to be sampled. As 
shown in chapter 3, rarefaction curves rapidly reached a plateau phase using micPCR/
NGS at the expected 20 OTU level when using a SMC sample that contained 20 differ-
ent bacterial species. This result indicates that micPCR/NGS generates an accurate view 
of microbial diversity within these samples. In contrast, a traditional PCR/NGS method 
(used as comparator) resulted in 72 OTUs, with rarefaction analysis showing that the 
number of OTUs per sample steadily increased as the number of 16S rRNA gene NGS 
reads increased. Importantly, it was found that this excess of OTUs consisted of chimeric 
sequences that had not been recognized as chimeras by the chimera checking software 
tool used. In addition, samples obtained from human healthy volunteers (including low 
biomass nasal swab samples and high biomass faecal samples), as well as highly diverse 
environmental sludge samples, revealed that chimeric sequences were reduced in all 
samples when using micPCR/NGS, resulting in decreased diversity estimates among all 
samples compared to traditional PCR-based results (chapter 3). Therefore, micPCR/NGS 
drastically reduces chimera formation without the reliance on complex downstream 
computational methods, resulting in more accurate microbial diversity estimates com-
pared to traditional PCR/NGS methods.
reduction of Pcr competition induced bias. Another important factor that can im-
pact 16S rRNA gene NGS results is PCR competition between different 16S rRNA gene 
template molecules in polymicrobial samples, resulting in unequal amplification rates 
for certain template DNA sequences. This biased amplification of 16S rRNA gene tem-
plate molecules can lead to over- or underestimations of particular OTUs.11,12 However, 
the clonal amplification of each template DNA molecule during micPCR prevents the 
generation of PCR competition artefacts because all template DNA molecules (as well 
as potentially competing non-template DNA molecules) are limited to a single micelle 
and amplified to the extend until all limited resources contained within this host micelle 
are depleted. As a result, equal amplicon yields are obtained for each targeted template 
DNA molecule (independently of template-specific PCR amplification efficiencies) that 
accurately represents the template ratios in the test sample. In contrast, the unequal 
amplification rate of certain template DNA molecules during multi-template PCRs could 
yield (unpredictable) amplicon ratio’s that might not represent the original sample 
composition.13 Therefore micPCR/NGS allows for a more accurate interpretation of the 
actual microbiota profile ratio compared to traditional PCR/NGS methods. For example, 
micPCR/NGS data showed an average of only a 0.85-fold difference (range: 0.28-fold - 
1.73-fold difference) between the measured and expected relative abundances of OTUs 
obtained from an SMC sample comprising 20 different bacterial species, whereas the 
traditional PCR/NGS data revealed an average of 0.65-fold difference (range: 0.04-fold 
– 2.31-fold difference) using the same SMC sample (chapter 3). Importantly, biased 
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PCR amplification efficiencies led to different interpretations of microbial content when 
using actual samples of unknown composition. For example, micPCR/NGS showed a 
3.3-fold reduction in Staphylococcus abundance among two nasal swab samples (2.4% 
vs. 7.8%), whereas traditional PCR/NGS showed a 4.7-fold increase in Staphylococcus 
abundance among the same two nasal swab samples (12.2% vs. 2.6%). Although the 
actual composition of these investigated nasal swab samples is unknown, the relative 
abundances obtained using micPCR/NGS likely represents a more accurate reflection of 
the true relative abundances as indicated using the SMC samples.
The reduction of PCR competition induced bias by micPCR/NGS would also improve 
the accurate characterisation of microbial communities that are investigated using other 
genetic markers, such as the internal transcribed spacer (ITS) region. For example, the 
ITS regions are often used to investigate fungal communities,14 and the prokaryotic vari-
ant can be employed to improve the resolution of prokaryotic species identification.15 
However, these ITS fragments are known to be of uneven lengths, even among highly 
genetically related species, for which traditional PCR methods may promote preferential 
amplification of shorter ITS fragments compared to longer ITS fragments, resulting in 
biased microbiota profiles.16 In contrast, the compartmentalization of template DNA 
molecules using micPCR reduces the type of PCR competition normally observed 
between fragments of different lengths,17 and therefore would result in more accurate 
quantification of microbial relative abundances.
Standardization of microbiota profiling results. Current microbiota profiling studies 
use semi-quantitative 16S rRNA gene NGS methods, where the microbiota results are 
presented as proportional abundances rather than absolute abundances. This limitation 
lowers the reproducibility of 16S rRNA gene NGS results and complicates cross-study 
comparability.18 For example, the interpretation of microbial community dynamics 
based on relative abundances can be misleading because fluctuations in the absolute 
abundance of one microorganism may cause an apparent change in the measured 
relative abundance of all other microorganisms.19 To overcome this limitation, micPCR/
NGS can be performed in combination with an internal calibrator (IC) to determine the 
composition and absolute quantity of microbial genera (chapter 4). This IC consists of 
quantified genomic DNA from a bacterium that is selected for its absence in the natural 
microbial flora of the investigated samples and is added to each DNA extract prior to 
micPCR amplification. After NGS processing, the IC is used to calculate a correction fac-
tor that in turn is used to convert the obtained 16S rRNA gene NGS reads per OTU to 
16S rRNA gene copies per OTU (equation 1). Because micPCR/NGS is less vulnerable to 
inevitable PCR amplification biases (chimera formation and PCR competition) compared 
to traditional PCR/NGS methods, micPCR allows for the utilization of just a single cor-
rection factor, obtained from a single IC, to convert all 16S rRNA gene NGS reads to 
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16S rRNA gene copies for each individual OTU detected within a polymicrobial sample. 
In contrast, alternative spike-in approaches that employ traditional PCR amplification 
methods, such as the SCML protocol,20 or the use of artificial 16S rRNA gene spike-ins,21 
remain vulnerable to template-specific variations in PCR efficiencies and could easily 
result in erroneous quantitative microbiota profiles. Importantly, note that each sample 
is processed in triplicate using our ‘calibrated’ micPCR/NGS method, in order to average 
out any possible quantification bias generated due to differences in the distribution of 
micelle sizes between independent micPCR experiments.




16S rRNA gene copies (IC) ⎞
⎟
⎠16S rRNA gene NGS reads (IC)
equation 1. Calculation of 16S rRNA gene copies using micPCR/NGS in combination with an internal cali-
brator (IC).
In order to validate our calibrated micPCR/NGS method, we investigated the trueness 
and precision of the technique. Trueness is a term defined as the proximity of the mea-
sured result obtained compared to the actual ‘true’ reference value, whilst precision is a 
term defined as the closeness of agreement among a set of results. As shown in chapter 
4, both the calibrated micPCR/NGS and traditional PCR/NGS methods (used as compara-
tor) generated similar average log2 fold-changes between the measured 16S rRNA gene 
copies compared to the expected number of 16S rRNA gene copies within a 10-fold dilu-
tion series of an SMC sample, indicating a similar and good trueness. However, the dis-
persal of replicate results obtained using the calibrated micPCR/NGS strategy was much 
smaller compared to the traditional PCR/NGS method, indicating the higher precision of 
the calibrated micPCR/NGS method. This is illustrated by SMC samples containing 2,500, 
250, 25 and 2.5 16S rRNA gene copies per bacterial species, for which the traditional 
PCR/NGS generated 70, 3, 25 and 97-fold differences, respectively, between the actual 
measured and reference number of 16S rRNA gene copies. In contrast, the calibrated 
micPCR/NGS approach resulted in only 3, 3, 5 and 7-fold differences, respectively, within 
the same SMC samples. Importantly, the higher precision of the calibrated micPCR/NGS 
methodology lowers the number of random errors within the 16S rRNA gene NGS mea-
surements and therefore increases the repeatability of quantitative microbiota profiling 
results.
The accuracy of the calibrated micPCR/NGS method for determining the number of 
16S rRNA gene copies in samples with unknown composition was evaluated by compar-
ing the results to direct measurements of the total 16S rRNA gene copies obtained using 
a 16S rRNA gene quantitative PCR (qPCR). These comparisons revealed an average of 
only a 1.4-fold difference (± 0.4) between both quantitative methods for 71 clinical and 
environmental samples that were included over multiple studies described in this thesis 
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(chapters 4, 6, 8). Importantly, the 16S rRNA gene qPCR used for these comparisons 
utilizes a different universal 16S rRNA gene primer set,22 targeting a different region of 
the 16S rRNA gene compared to the calibrated micPCR/NGS method. Therefore, the 16S 
rRNA gene qPCR is a complementary technique that enables the accurate validation of 
the calibrated micPCR/NGS method when determining the total numbers of 16S rRNA 
gene copies. In addition, an experimental comparison was made between a Staphylococ-
cus OTU-specific biomass and a Staphylococcus aureus qPCR using an S. aureus-specific 
genetic marker,23 which revealed an average of only a 1.3-fold (± 0.4) difference between 
the two methodologies when using 13 S. aureus culture-positive samples (chapter 6). 
This result demonstrates (again) the intrinsic accuracy of the calibrated micPCR/NGS 
method, but also highlights the ability to incorporate quantitative results obtained from 
additional (species-specific) qPCRs into the calibrated micPCR/NGS results. This unique 
feature is particularly useful if the researcher wants to obtain quantitative species-level 
data, noting that the sequencing of partial 16S rRNA genes (currently the most com-
monly used method for 16S rRNA gene NGS) often lacks the discriminatory power to 
differentiate prokaryotes at the species taxonomic level.24
removal of contaminating dnA. DNA contamination derived from the (laboratory) en-
vironment and consumables used in the experimental set-up can significantly influence 
the results of 16S rRNA gene NGS methods. Potential sources of DNA contamination 
include DNA extraction kits,25,26 PCR reagents,27,28 and possibly contaminating human 
(skin, oral, and respiratory) microbiota from the researchers themselves. Importantly, 
the inevitable introduction of DNA contamination within 16S rRNA gene NGS experi-
ments is a particular challenge for researchers working with samples containing a low 
microbial biomass, for example anterior nasal swabs. In these samples, the microbiota 
DNA levels present on swabs may not be high enough to generate a significant ‘signal’ 
above the ‘signal’ obtained from background contaminating DNA, resulting in unreliable 
microbiota profiles.29 Although several methods have been published that are designed 
to eliminate and/or reduce background impurities from DNA reagents (including irradia-
tion with UV light, enzymatic degradation, treatment with ethidium monoazide (EMA), 
etc.), these methods tend to suffer from poor reproducibility or impact negatively on 
PCR sensitivity.30-32 In this respect, Biesbroek et al. suggested the use of a ‘lower bacterial 
density threshold’ of 106 bacteria per mL and 1 pg/μL of template DNA, when working 
with low biomass samples.33 However, this suggestion results in the automatic exclusion 
of many low biomass clinical samples from 16S rRNA gene NGS investigation, including 
such microbiologically interesting low biomass samples such as joint fluids, cerebro-
spinal fluids, blood samples or other samples derived from normally ‘sterile’ body sites. 
To overcome this limitation and to facilitate the investigation of low biomass (clinical) 
samples using 16S rRNA gene NGS methods, we developed and validated an alterna-
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tive strategy that enables the mathematical removal of contaminating DNA from low 
biomass (clinical) samples (chapter 4).
The mathematical removal of contaminating DNA using the calibrated micPCR/NGS 
protocol comprises two steps. First, randomly occurring DNA contamination (derived 
from the sample-processing environment) are eliminated via the mathematical removal 
of OTUs that cannot be reproducibly measured in triplicate measurements of the test 
sample. Secondly, the intrinsic DNA contamination obtained from DNA extraction kits 
and PCR reagents/consumables is removed via the subtraction of the number of 16S 
rRNA gene copies that have been amplified, in triplicate, from negative extraction con-
trols (NECs). As shown in chapter 4, correcting for both types of DNA contamination 
resulted in the complete removal of contaminating 16S rRNA gene copies from SMC 
samples using the calibrated micPCR/NGS method. In contrast, using the same two-step 
strategy to remove contaminating DNA, but in combination with a traditional PCR/
NGS method, still resulted in contaminating 16S rRNA gene copies being reported for 
SMC samples, even after mathematical correction. This finding can be explained by the 
higher accuracy of the calibrated micPCR/NGS method to quantify contaminating DNA 
from NEC samples and illustrates the requirement of the clonal-based micPCR amplifica-
tion strategy for the accurate subtraction of contaminating DNA from actual samples. 
Consequently, the limit of detection (LOD) of the calibrated micPCR/NGS method was 
determined at only 25 16S rRNA gene copies per OTU in SMC samples, which is lower 
than the LOD of the traditional PCR/NGS method that was estimated as 250 16S rRNA 
gene copies per OTU using the same SMC samples. Importantly however, traditional 
PCR/NGS, in contrast to calibrated micPCR/NGS, was not able to generate any 16S rRNA 
gene amplicons from actual low biomass clinical samples included in our study as this 
method only generated non-specific, low molecular weight amplicons (presumed to 
be of human DNA origin). This result indicates that the LOD for the traditional PCR/
NGS method is even higher for actual clinical samples than was estimated using SMC 
samples. Thus, the high accuracy and low LOD of the calibrated micPCR/NGS, makes 
this method the preferential method to determine accurate and quantitative microbiota 
profiles for low biomass samples that are hampered by contaminating prokaryotic DNA.
Simplification of bioinformatics analysis. 16S rRNA gene NGS analysis is provided 
by an extensive array of sophisticated bioinformatics programs, such as mothur and 
QIIME,34,35 with an overview outlined in a recent review by Nilakanta et al.36 Whilst some 
of these bioinformatics programs have a graphical user interface (GUI) to provide access 
to these technologies for the research or clinical scientist, their use remains complex 
for non-bioinformatics educated users. To address this challenge, together with col-
leagues, we have integrated the full set of 125+ mothur tools into Galaxy, which is a 
project dedicated to simplify the use of complex command-line bioinformatics tools 
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using a ‘user-friendly’ web interface (chapter 5).37-40 These tools are collectively called 
the ‘Galaxy mothur Toolset (GmT)’, which provide access to all of the individual mothur 
components as separate tools, whilst retaining the full flexibility of mothur by creat-
ing custom bioinformatics pipelines. In addition, GmT supports the integration of third 
party visualization tools, including KRONA and Phinch,41,42 as well as reporting tools 
such as iReport,43 allowing for the easy interpretation, sharing and storage of the results 
obtained from 16S rRNA gene NGS experiments. The GmT is freely accessible for all users 
via the ‘Galaxy’s Tool Shed’ at https://toolshed.g2.bx.psu.edu.
In order to process 16S rRNA gene NGS data that is generated using the calibrated 
micPCR/NGS method, we adjusted a GmT-based bioinformatics pipeline to our specific 
use-case (chapter 6). This dedicated bioinformatics pipeline performs all of the ‘standard’ 
steps (e.g. quality filtering, OTU clustering, sequence classification, etc.) involved with 
16S rRNA gene NGS analysis, but also performs ‘calibrated micPCR/NGS-specific’ steps 
that include: i) averaging over multiple technical replicates, ii) converting the number 
of obtained 16S rRNA gene NGS reads per OTU to 16S rRNA gene copies per OTU via the 
use of an IC and iii) correcting for contaminating DNA using the two-step DNA contami-
nation removal strategy previously described above. All these processes are started and 
executed via a single push of the button, with the results being presented to the user 
via an interactive web report in Galaxy using the iReport tool. This standardized report 
visualizes the resultant microbiota profiles and summarizes the results of three diversity 
estimators (Chao1, Shannon and Simpson indices). In addition, an extensive overview of 
the quality control measurements taken during this automatically performed 16S rRNA 
gene NGS analysis is also provided, allowing the user to manually evaluate the results 
using the quality measurements pre-installed within the bioinformatics pipeline. The 
newly developed GmT bioinformatics pipeline has been combined with the calibrated 
micPCR/NGS methodology to create an ‘end-to-end’ microbiota profiling platform that 
is referred to as ‘MYcrobiota’.
evaluation of Mycrobiota for routine diagnostic use
Microbiota analysis has promising applications in the field of routine (clinical) micro-
biological diagnostics. However, 16S rRNA gene NGS methods have not yet made the 
transition from research into routine clinical/environmental diagnostic practice due 
to the lack of a validated protocol and the requirement for expert bioinformaticians to 
analyse the NGS data obtained.18,44 As described in the previous part of this chapter, the 
MYcrobiota platform overcomes both of these limitations and therefore, we evaluated 




clinical microbiological diagnostics. The application of MYcrobiota for routine clini-
cal microbiological diagnostics use was evaluated by investigating a total of 63 clinical 
samples, including 40 (polymicrobial) clinical samples obtained from patients presenting 
a variety of damaged skin conditions (chapter 6) and 23 low biomass clinical samples 
obtained from patients who were suspected to have bacterial septic arthritis (chapter 
7). The results obtained with MYcrobiota were compared to the results obtained with 
culture-based methods, which are the current ‘gold standard’ methods for pathogen 
detection in the routine clinical microbiological diagnostic laboratory. As shown in 
chapter 6, 36 of the 38 aerobic bacteria identified within the damaged skin samples 
using routing culturing methods were also identified using MYcrobiota, although the 
majority of the 447 bacterial taxa identified using MYcrobiota were presumed to be-
long to the commensal flora or were not cultured at all. These results indicate that the 
resolution power of MYcrobiota was superior compared to the culture-based methods 
commonly used in routine clinical microbiological diagnostic laboratories. The vast 
majority of the additional bacteria identified using MYcrobiota represented bacteria 
that are obligate anaerobes, which are difficult to culture within a laboratory environ-
ment.45 Importantly, anaerobic bacteria are a common cause of endogenous bacterial 
infections and their culture-free detection by MYcrobiota would provide clinicians with 
very useful information about the aetiologies of such infections that cannot be (eas-
ily) provided using routine culturing methods. It should be noted however that partial 
16S rRNA genes, which are currently targeted using MYcrobiota, lack the discriminative 
power to differentiate prokaryotes to the species taxonomic level.24 This species-level 
determination is often seen as essential for clinical diagnostics, as only specific species 
within a genus may be pathogenic. Importantly however, the identification of bacte-
rial species using species-specific qPCRs is one way to circumvent this limitation (as 
described above), while other strategies would require relatively simple adjustments 
to be made to the MYcrobiota platform that enables the micelle-based amplification, 
sequencing and analysis of multiple hypervariable 16S rRNA gene regions,46 or other 
genetic markers, such as rpoB,47 gyrB,48 the ITS region,15 and many other candidates that 
enables taxonomic discrimination at the species-level.49
The availability of relative abundance results in combination with absolute abundance 
results using MYcrobiota generates a highly accurate and comprehensive overview of 
the microbial composition of polymicrobial clinical samples. This is in contrast to routine 
culturing methods, which are unlikely to provide a complete understanding of the mi-
crobial composition of a sample containing mixed microorganisms. In fact, routine cul-
turing methods have primary been developed to select and identify only the ‘established 
pathogens’ (for which clinicians have associative clinical experience) and often disregard 
the abundance of microorganisms that are not classified as pathogens. For example, 
the only two discrepant (culture-positive and MYcrobiota-negative) microorganisms 
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measured in the damaged skin samples described in chapter 6 were identified as Pseu-
domonas aeruginosa and Staphylococcus aureus, with estimated relative abundances of 
10% and 40% respectively, using routine culturing methods. Although both bacterial 
taxa were initially not reported by MYcrobiota, both correlating OTUs were detected 
using the calibrated micPCR/NGS method but below the method’s LOD – the relative 
abundance for the Pseudomonas OTU was 0.14% and for the Staphylococcus OTU 0.07%. 
It is very likely that the abundance of these bacterial species are overestimated using 
routine culturing methods, as both established pathogens are fast-growing bacteria 
with a clearly distinguishable colony phenotype that are more easily selected com-
pared to other microorganisms present within the same clinical sample.50 This finding 
is further supported by a recent report describing the consistent overestimation of S. 
aureus abundance in cystic fibrosis sputa samples by culture-based methods compared 
to a 16S rRNA gene NGS method.51 Importantly however, the question remains if these 
low abundant established pathogens – that are also frequently found in polymicrobial 
samples obtained from healthy individuals – are the true causative agents of an ongo-
ing infection. Indeed, recent studies suggest that low relative abundant bacteria may 
contribute to pathogenesis by altering the microenvironment to facilitate colonization 
or virulence gene expression of neighbouring microorganisms, following the ‘keystone 
pathogen’ hypothesis, but more studies are needed to identify potential keystone patho-
gens in different kinds of polymicrobial clinical samples in order to determine the actual 
prevalence of these so-called ‘keystone pathogen-induced inflammations’ compared to 
‘dominant pathogen-induced inflammations’.52 These studies would depend heavily on 
obtaining accurate and comprehensive microbiota profiles, such as generated by MY-
crobiota, that may lay the groundwork to further establish keystone pathogen-induced 
inflammations using animal disease models and to explore the mechanisms by which 
these potential keystone pathogens mediate disease. Importantly, the identification 
of keystone pathogens, and the ability to detect them using MYcrobiota as a routine 
clinical-diagnostic test, would have significant benefits as it could facilitate accurate and 
more targeted prescription of antimicrobial treatments for polymicrobial or complex 
dysbiotic diseases.
The ability of MYcrobiota to remove contaminating DNA allows the accurate detection 
of potentially pathogenic microorganisms at very low abundances, or alternatively, the 
confirmation of culture-negative results. To illustrate this potential, we investigated 23 
joint fluid samples obtained from 19 patients with suspected bacterial septic arthritis 
using routine culturing methods and MYcrobiota. As shown in chapter 7, all joint fluid 
samples resulted in culture-negative results, whereas MYcrobiota detected the presence 
of bacterial DNA in 10 out of 23 joint fluid samples, whilst confirming the culture-nega-
tive results in the other 13 joint fluid samples. Most of the additionally bacteria detected 
using MYcrobiota have been previously described as non-conventional pathogens in 
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bacterial septic arthritis cases and included not only ‘difficult-to-culture’ bacteria, such 
as anaerobic bacteria (e.g. Parvimonas, Prevotella, and Ruminococcus) and fastidious bac-
teria (e.g. Kingella and Ureaplasma), but also unexpected and ‘easy-culturable’ bacteria, 
such as Enterococcus and Turicella. These findings indicate that MYcrobiota is a very useful 
platform that enables the culture-free detection (i.e. identification and quantification) of 
anaerobic, fastidious, and (unexpected) culturable microorganisms, which will greatly 
improve the identification of the bacteriological aetiology of infections such as bacterial 
septic arthritis. However, extensive clinical validation studies will be needed in order 
to validate the routine introduction of MYcrobiota into clinical diagnostic laboratories.
environmental microbiological diagnostics. The universal applicability of MYcrobiota 
was evaluated by employing the method to assess drinking water quality. As shown 
in chapter 8, a total of 30 drinking water samples were collected at consecutive loca-
tions along an operational drinking water distribution system (DWDS) during a 5-month 
period. Using MYcrobiota, we observed spatial and temporal microbial variations within 
the drinking water samples obtained. These variations were not detected using routine 
culturing methods. The ability to detect such microbial variations with high sensitivity 
will aid the evaluation of current and future treatment strategies, such as oxidation and 
filtration processes, that are generally applied by drinking water utilities to ensure the 
delivery of safe and high-quality drinking water.53 Interestingly, MYcrobiota performed 
equally as well as flow cytometry (FCM) with regard to the measurements of bacterial 
dynamic trends over the water trajectory, with FCM being one of the techniques that is 
currently being proposed as a replacement for bacterial culture for the routine micro-
biological assessment of drinking water quality.54 However, although FCM is certainly 
useful for counting the total and viable number of bacterial cells over the water trajec-
tory,55,56 the method does not provide taxonomic information about the prokaryotes 
detected within the DWDS. The identification and quantification of prokaryotic taxa 
is however required in order to adequately evaluate the complex nature of microbial 
communities within DWDS samples. For example, although only a small subset of seven 
bacterial genera were shown to dominate the specific DWDS investigated, the absolute 
abundances of these bacteria shifted across the DWDS, illustrating large differences in 
microbial community compositions between ‘treated’ and ‘distributed’ drinking water 
samples – due to the application of drinking water treatment processes at the beginning 
of the DWDS. In summary, this study demonstrates that the use of MYcrobiota enables 
the culture-independent monitoring of bacteria that resides within DWDSs. Further, 
MYcrobiota allows drinking water utility companies to obtain accurate measurements 
of spatial and temporal microbial dynamics within their DWDS, facilitating the continual 
assessment of the desired ‘biological stability’ of drinking water over the whole drinking 
water trajectory, thereby helping maintain drinking water quality standards.
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concluSionS
1. MYcrobiota utilizes a novel micelle PCR/NGS methodology that limits both the 
formation of chimera sequences and PCR competition induced bias, thereby im-
proving the accurate characterization of microbial communities.
2. MYcrobiota provides the relative abundances and the absolute abundances for 
each individual operational taxonomic unit (OTU) present within a sample, which 
enables the subtraction of any non-sample associated contaminating OTUs via the 
processing of negative extraction controls.
3. MYcrobiota uses a dedicated and easy-to-use bioinformatics pipeline that allows 
for a fully automated sequence interpretation of 16S rRNA gene NGS data that 
is obtained using the micelle PCR methodology without the requirement for ad-
vanced bioinformatics skills.
4. MYcrobiota generates a highly accurate and comprehensive overview of the micro-
bial composition of clinical samples or, alternatively, confirms the absence of 16S 
rRNA gene copies in culture-negative clinical samples.
5. Although MYcrobiota was initially developed for use in the field of routine clinical 
microbiological diagnostics, the microbiota analysis platform is much more widely 
applicable as demonstrated in the analysis of microbial dynamics in an operational 
drinking water distribution system.
Future PerSPectiveS
MYcrobiota enables the accurate quantification of prokaryotic taxa within (polymicrobi-
al) samples through the reduction of PCR amplification artefacts (chimera formation and 
PCR competition) and the removal of contaminating 16S rRNA gene molecules derived 
from the experimental set-up. However, the possible effects of sample handling,57 DNA 
extraction,58 and primer specificity,59 are still factors affecting the complete accuracy of 
16S rRNA gene NGS results, even with the development of MYcrobiota. In fact, these 
factors should preferably be optimized for each type of test sample the researcher is 
investigating in order to ensure the generation of truly unbiased microbiota profiles. 
In addition, the micelles used for micPCR are generated by mixing water in oil using 
a standardized commercially available kit in combination with a vortex. This (uncon-
trolled) process could lead to the generation of unevenly shaped or broken micelles that 
potentially introduce quantification bias as larger/intact micelles will result in more 16S 
rRNA gene amplicons compared to smaller/broken micelles. Although this limitation 
can be overcome by processing each sample in triplicate to average out any possible 
quantification bias using our current validated micPCR protocol, the robustness and 
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quantitative accuracy of micPCR would benefit from generating micelles (or equiva-
lents) with a much higher precision and repeatability. Interestingly, generating highly 
reproducible micro-sized droplets using dedicated droplet generators are already avail-
able and additional studies are needed to investigate the utility of these droplets for 16S 
rRNA gene NGS microbiota profiling.60,61
Like all short-read 16S rRNA gene NGS methods, MYcrobiota currently lacks accurate 
prokaryotic identification at the species-level due to the lack of the discriminative power 
of the partial 16S rRNA gene used. This limitation can be overcome by incorporation 
of quantitative results obtained from additional species-specific qPCRs or through the 
implementation of specific genetic markers, as discussed previously. In addition, an 
alternative strategy to obtain prokaryotic species identification is by employing shot-
gun metagenomics approaches that have the potential to detect all genomic contents 
derived from all of the microorganisms (including bacteria, archaea, fungi, protists, and 
viruses) present in a test sample.62 These methods not only allow for the (species-level) 
characterisation of microbial communities across all domains of life, but also provides 
knowledge on the population gene composition of microbial communities, such as the 
prevalence and complexity of antibiotic resistance genes within faecal samples.63,64 This 
type of research application may eventually be important in clinical diagnostics, where 
for example, the rapid detection of antibiotic resistance genes could potentially improve 
the clinical decision-making process. To this end, multiple online platforms and bioinfor-
matics tools are available that accept sequence data as queries and return predictions 
of their antibiotic resistance gene content, often with confidence-related statistics.65,66
In addition, shotgun metagenomics approaches provide information about the abun-
dances of genes involved in functional pathways that, for example, can be explored for 
associations with diseases. These metagenome-wide association studies (MWAS) would 
provide signatures of health and disease in the microbiome that may be clearer at the 
functional level than at the taxonomic level.67 For example, Qin et al. identified approxi-
mately 60,000 microbial markers that are associated with type 2 diabetes and demon-
strated that a selection of 50 of these markers are able to distinguish between samples 
from healthy subjects and subjects with type 2 diabetes.68 Importantly however, the 
desired progression from identifying microbiome-disease associations to identifying the 
functions of the microbiome in disease is currently hindered by a basic lack of functional 
characterization of the vast majority of microbial genes that are detected via shotgun 
metagenomics approaches. Therefore, future microbiome studies should aim to provide 
more insights into gene functions within human/environmental microbiomes in order 
to improve the power of MWAS. One elegant example of research addressing this is-
sue has been recently published by Cohen et al. who ‘mined’ the human microbiota for 
genes encoding metabolites that mimic human signalling molecules.69 Interestingly, the 
bacterial metabolites identified in this study were involved in host-microbial interactions 
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that potentially regulate human physiology in healthy and disease states and represent 
a possible resource for the discovery of small-molecule therapeutics. However, such 
shotgun metagenomics approaches remain expensive, computationally challenging 
when using short-read sequences and, for clinical samples, possess a low sensitivity due 
to the relative excess of human DNA compared to prokaryotic DNA.70 These disadvan-
tages mean that the introduction of shotgun metagenomics into the routine (clinical) 
microbiological diagnostic laboratory is not yet feasible.
Recently, a third generation of sequencing platforms, including PacBio (Pacific 
Biosystems) and MinION (Oxford Nanopore Techniques) have become commercially 
available. These sequencing instruments can overcome the limitations of short-read 
NGS-platforms, because they produce sequence reads between 5,000 and 15,000 
nucleotides in length, which is much longer compared to those obtained with current 
NGS-platforms that produce sequence reads that span only a few hundred nucleotides.71 
Longer sequence reads simplify genome assemblies and also allows for a more reliable 
assignment of DNA sequences to in silico stored reference genomes compared to smaller 
sequence fragments.72 In addition, the MinION platform collects and analyses sequence 
data in real-time, which can significantly shorten the time-to-result compared to other 
NGS-platforms.73 Nonetheless, the applicability of shotgun metagenomics, or targeted 
amplicon sequencing approaches using third generation sequencing platforms is still 
far from certain, due to high costs per sample, low throughput and relatively high 
base-calling error rates.74 Until then, MYcrobiota can conveniently fill the gap between 
traditional ‘gold standard’ microbiological methods (culture and PCR) and the as yet 
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Micro-organismen, zoals virussen, bacteriën, archaea en andere eencelligen, vormen 
complexe leefgemeenschappen die op alle denkbare plaatsen op aarde aanwezig zijn, 
van de diepzee tot onze darm en van de bosbodem tot onze huid. Ze zijn de oudste en 
meest uitbundige levensvorm op aarde, zowel in hoeveelheid als diversiteit, en vervullen 
vele belangrijke functies. Zo nemen micro-organismen deel aan biochemische processen 
die het leven op onze planeet mogelijk maken. Ook is het inmiddels algemeen bekend 
dat de microbiële gemeenschappen die in en op ons lichaam voorkomen biochemisch 
van groot belang zijn en cruciaal zijn voor onze gezondheid. Om deze reden wordt de 
microbiële samenstelling, die ook wel de ‘microbiota’ wordt genoemd, intensief bestu-
deerd. Onderzocht wordt wat de samenstelling van de microbiota van verschillende 
lichaamslocaties is en men probeert de invloed van de microbiota op onze gezondheid 
vast te stellen. De bacteriële samenstelling van de microbiota wordt veelal onderzocht 
door het 16S-rRNA-gen te onderzoeken. Het 16S-rRNA-gen heeft de unieke eigenschap 
dat het aanwezig is in alle bacteriën (en archaea). Tevens bevat dit gen naast geconser-
veerde DNA-gebieden ook variabele DNA-gebieden die uniek zijn per bacteriesoort en 
dus gebruikt kunnen worden voor bacteriële identificatie. De variabele DNA-gebieden 
worden veelal in kaart gebracht door ze eerst te vermeerderen (i.e. amplificeren) met 
behulp van PCR-technieken om vervolgens de volgorde van de bouwstenen van het 
DNA te bepalen middels next-generation sequencing (NGS) technieken. Deze werkwijze 
stelt men in staat om de microbiota in een monster te onderzoeken zonder de afzon-
derlijke bacteriën te kweken. Dit laatste is een belangrijk gegeven aangezien de meeste 
bacteriën niet kweekbaar zijn in een laboratorium. Echter, deze kweek-onafhankelijke 
technieken brengen weer andere beperkingen en valkuilen met zich mee die de rap-
portage van betrouwbare microbiota resultaten in de weg kan staan (hoofdstukken 
1 en 2). Eén van de grootste uitdagingen is de standaardisatie van de 16S-rRNA-gen 
NGS-methoden in de verschillende laboratoria. Standaardisatie is essentieel, want al-
leen met gestandaardiseerde werkwijzen kunnen de data van verschillende laboratoria 
vergeleken worden waardoor er een overkoepelende kwaliteitsbewaking kan worden 
ingevoerd. Deze vorm van kwaliteitsbewaking is belangrijk voor research doeleinden, 
maar vooral ook voor de toepassing van microbiota onderzoek in routine (medisch) 
microbiologisch diagnostisch gebruik. Het doel van het onderzoek beschreven in dit 
proefschrift is dan ook om een gestandaardiseerde 16S-rRNA-gen NGS-methode te 
ontwikkelen en de toepasbaarheid van deze methode te onderzoeken in de routine 
(medisch) microbiologische diagnostiek.
De ontwikkeling van een gestandaardiseerde 16S-rRNA-gen NGS-methode vereist een 
verbetering van de nauwkeurigheid en reproduceerbaarheid van huidige 16S-rRNA-gen 
NGS-methoden. De veelgebruikte 16S-rRNA-gen NGS-methoden zijn afhankelijk van de 
PCR-techniek, waarbij (verschillende) 16S-rRNA-genen gezamenlijk, in één enkel reac-
tievaatje, geamplificeerd worden. Deze methode kent twee belangrijke nadelen: 1) het 
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ontstaan van chimeren en 2) PCR-competitie tussen verschillende 16S-rRNA-genen van 
verschillende bacteriën. Chimeren zijn samengesteld uit 16S-rRNA-genen, afkomstig 
van verschillende bacteriën, die leiden tot de foutieve detectie van niet-aanwezige of 
zelfs van niet-bestaande bacteriën. De PCR-competitie, waarbij het ene 16S-rRNA-gen 
sneller amplificeert dan het andere 16S-rRNA-gen, heeft een over- of onderschatting 
van bepaalde bacteriën als gevolg. Om deze PCR-artefacten (chimeren en PCR-com-
petitie) te voorkomen is in hoofdstuk 3 een nieuwe amplificatiemethode beschreven 
waarbij de 16S-rRNA-genen verdeeld worden over een groot aantal fysiek verschillende 
‘reactievaatjes’ die gecreëerd worden door middel van water-in-olie emulsies. Tijdens 
deze ‘micelle PCR’ (micPCR) wordt vervolgens elk afzonderlijk DNA-molecuul met een 
16S-rRNA-gen individueel geamplificeerd, elk molecuul in één druppel van de emulsie. 
In hoofdstuk 3 wordt aangetoond dat deze benadering de kans op PCR-artefacten 
drastisch verminderd en de nauwkeurigheid van microbiota bepalingen sterk verbetert.
In hoofdstuk 4 werd het micPCR/NGS-protocol verder uitgebreid met de toevoeging 
van een interne kalibrator die het mogelijk maakt om de hoeveelheid van de gedetec-
teerde bacteriën weer te geven als het aantal 16S-rRNA-genkopieën. Hiermee kan de 
micPCR/NGS-methode een weerbarstig probleem van microbiota studies oplossen, 
namelijk het probleem van het achtergrondsignaal van het al aanwezige bacterieel 
DNA uit de gebruikte reagentia. Het achtergrond signaal is met name belangrijk voor 
de analyse van monsters met een lage hoeveelheid bacteriën. De hoge nauwkeurig-
heid waarmee de gekalibreerde micPCR/NGS-methode de bacteriën kwantificeert 
maakt het nu mogelijk om het achtergrondsignaal te identificeren en te kwantificeren, 
waarmee de microbiota resultaten van het monster kunnen worden gecorrigeerd. De 
validatie-experimenten beschreven in hoofdstuk 4 tonen aan dat deze correctie leidt 
tot de volledige verwijdering van het achtergrondsignaal van de microbiota resultaten 
van monsters met een bekende microbiële samenstelling. Deze strategie maakt het 
mogelijk om de microbiota van monsters met een erg lage biomassa nauwkeurig te 
kunnen bepalen. Bovendien zullen monsters die geen bacterieel DNA bevatten ook 
daadwerkelijk een negatief microbiota resultaat opleveren.
De in hoofdstukken 3 en 4 beschreven micPCR/NGS-methode vraagt het nodige 
rekenwerk voordat het eindresultaat verkregen wordt. Om de microbiota bepalingen 
toegankelijk te maken voor routine gebruik is in hoofdstuk 5 de ontwikkeling van de 
‘Galaxy mothur Toolset (GmT)’ beschreven. Deze GmT bevat meer dan 125 verschillende 
algoritmen, elk met vooraf ingestelde ‘standaard’ instellingen, waarmee de gebruiker 
zelf zijn eigen 16S-rRNA-gen NGS-data ‘analyse-workflow’ kan samenstellen middels 
een gebruiksvriendelijke webinterface. Daarnaast biedt GmT ondersteuning voor 
diverse visualisatie- en rapportagehulpmiddelen zodat de microbiota resultaten een-
voudig kunnen worden geïnterpreteerd, gedeeld en opgeslagen. Voor het verwerken 




ontwikkeld waarbij de ruwe NGS-data met één druk op de knop kan worden verwerkt 
tot kwantitatieve microbiota resultaten (hoofdstuk 6). Deze op maat gemaakte GmT 
analyse-workflow maakt samen met de gekalibreerde micPCR/NGS-methode deel uit 
van het gestandaardiseerde microbiota detectieplatform: ‘MYcrobiota’.
In de hoofdstukken 6 en 7 werd het gebruik van MYcrobiota in de routine medisch 
microbiologische diagnostiek geëvalueerd waarbij de MYcrobiota resultaten vergeleken 
werden met de resultaten van routine kweekmethoden. In hoofdstuk 6 werden pus- 
en wondmonsters onderzocht en in hoofdstuk 7 onderzochten we gewrichtsvochten 
van ontstoken heup-, schouder- en kniegewrichten. Deze studies toonden aan dat de 
meeste gekweekte pathogene bacteriën ook werden geïdentificeerd met MYcrobiota. 
Tevens kan met MYcrobiota de normale (niet-pathogene) flora en de niet- of moeilijk-
kweekbare bacteriën in kaart gebracht worden. Onder de niet- of moeilijk-kweekbare 
bacteriën, werden vooral zuurstof intolerante (obligaat anaerobe) bacteriën aangetrof-
fen. Aangezien MYcrobiota niet gevoelig is voor bacterie-specifieke kweekcondities 
kan dit platform dan ook een belangrijke rol spelen bij het aantonen van potentieel 
pathogene bacteriën in anaerobe infecties, of andere infecties veroorzaakt door niet- of 
moeilijk-kweekbare bacteriën, die niet worden gedetecteerd met routine kweekme-
thoden. Zo bleken 10 van de 23 gewrichtsvochten, waaruit geen bacteriën kon worden 
gekweekt, toch positief voor bacterieel DNA met MYcrobiota die het vermoeden van 
de arts op bacteriële septische artritis in deze patiënten bevestigde (hoofdstuk 7). 
Het moet echter wel opgemerkt worden dat de gedeeltelijke 16S-rRNA-genen, die 
momenteel gebruikt worden voor de microbiële identificatie middels MYcrobiota, niet 
voldoen om bacteriën te classificeren op het species niveau wat zeer wenselijk is voor 
de medische toepassing. Het gebruik van andere genen, zoals rpoB of gyrB die wel dit 
taxonomisch onderscheidt kunnen maken, zou uitkomst kunnen bieden, maar behoeft 
wel enkele (relatief eenvoudige) aanpassingen aan het MYcrobiota-platform.
Het MYcrobiota-platform is ontwikkeld voor toepassing in de medische microbiologie. 
In hoofdstuk 8 wordt het universeel toepasbare karakter van het MYcrobiota-platform 
aangetoond door het bepalen van de bacteriële samenstelling van drinkwater. In dit 
onderzoek werden drinkwatermonsters geanalyseerd van zes opeenvolgende locaties 
binnen een operationeel drinkwater-distributiesysteem (DWDS). In tegenstelling tot de 
gangbare kweekmethode, was MYcrobiota in staat om (kleine) bacteriële variaties te 
detecteren tussen de verschillende locaties binnen het DWDS. Deze variaties konden 
worden verklaard als gevolg van de drinkwater-behandelingsstrategieën die aan het 
begin van het DWDS werden toegepast om de levering van veilig en hoogwaardig 
drinkwater te waarborgen. Het vermogen om dergelijke variaties te detecteren met 
behulp van MYcrobiota kan daarom van groot belang zijn voor de continue monitoring 
van de effecten van de toegepaste drinkwater-behandelingsstrategieën en biedt drink-
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waterbedrijven de mogelijkheid om in te grijpen als de beoogde ‘biologische stabiliteit’ 
binnen het DWDS verstoord wordt.
Samenvattend, de ontwikkeling van het MYcrobiota-platform beschreven in dit 
proefschrift realiseert een gestandaardiseerde en gevalideerde bepaling van de micro-
biota. MYcrobiota is ontwikkeld voor de medische microbiologie, maar is veel breder 
toepasbaar zoals aangetoond in het drinkwateronderzoek. Verwacht wordt dat de im-
plementatie van MYcrobiota een bijdrage kan leveren aan onze kennis van de complexe 













Na een intensieve periode van 4 jaar is het zover. Met het schrijven van dit dankwoord 
leg ik de laatste hand aan mijn proefschrift. Graag wil ik alle collega’s van zowel het 
Streeklaboratorium Haarlem als het Erasmus MC, familie en vrienden bedanken die mij 
de afgelopen jaren – direct of indirect – hebben geholpen gedurende mijn promotietra-
ject. Ook wil ik de medeauteurs van de verschillende onderzoeken bedanken voor hun 
bijdrage aan dit proefschrift, op welke manier dan ook. De volgende personen wil graag 
in het bijzonder bedanken:
dr. Jansen, beste ruud. Jij hebt me door de jaren heen opgeleid van jonge analist naar 
de onderzoeker die ik nu ben, met als resultaat dit proefschrift. We werken al meer dan 
12 jaar samen en gedurende deze tijd heb je mij geleerd om met een kritische houding 
onderzoek te doen. Ik heb het altijd erg prettig gevonden om met jou te brainstormen 
over nieuwe ideeën, of om gewoon een kletspraatje te maken, die bij voorkeur plaats-
vonden onder het genot van een glaasje wijn en een stukje kaas. Het was fijn dat we 
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